id	sid	tid	token	lemma	pos
aji-154	1	1	_	_	PUNCT
aji-154	2	1	_	_	PUNCT
aji-154	3	1	_	_	PUNCT
aji-154	4	1	_	_	PUNCT
aji-154	5	1	_	_	PUNCT
aji-154	6	1	_	_	PUNCT
aji-154	7	1	_	_	PUNCT
aji-154	8	1	_	_	PUNCT
aji-154	9	1	_	_	PUNCT
aji-154	10	1	_	_	PUNCT
aji-154	11	1	_	_	PUNCT
aji-154	12	1	_	_	PUNCT
aji-154	13	1	_	_	PUNCT
aji-154	14	1	_	_	PUNCT
aji-154	15	1	_	_	PUNCT
aji-154	16	1	_	_	PUNCT
aji-154	17	1	_	_	PUNCT
aji-154	18	1	_	_	PUNCT
aji-154	19	1	_	_	PUNCT
aji-154	20	1	_	_	PUNCT
aji-154	21	1	_	_	PUNCT
aji-154	22	1	_	_	PUNCT
aji-154	23	1	_	_	PUNCT
aji-154	24	1	_	_	PUNCT
aji-154	25	1	_	_	PUNCT
aji-154	26	1	_	_	PUNCT
aji-154	27	1	_	_	PUNCT
aji-154	28	1	_	_	PUNCT
aji-154	29	1	_	_	PUNCT
aji-154	30	1	_	_	PUNCT
aji-154	31	1	_	_	PUNCT
aji-154	32	1	_	_	PUNCT
aji-154	33	1	_	_	PUNCT
aji-154	34	1	_	_	PUNCT
aji-154	35	1	_	_	PUNCT
aji-154	36	1	_	_	PUNCT
aji-154	37	1	_	_	PUNCT
aji-154	38	1	_	_	PUNCT
aji-154	39	1	_	_	PUNCT
aji-154	40	1	_	_	PUNCT
aji-154	41	1	_	_	PUNCT
aji-154	42	1	_	_	PUNCT
aji-154	43	1	_	_	PUNCT
aji-154	44	1	_	_	PUNCT
aji-154	45	1	_	_	PUNCT
aji-154	46	1	_	_	PUNCT
aji-154	47	1	_	_	PUNCT
aji-154	48	1	_	_	PUNCT
aji-154	49	1	_	_	PUNCT
aji-154	50	1	_	_	PUNCT
aji-154	51	1	_	_	PUNCT
aji-154	52	1	_	_	PUNCT
aji-154	53	1	_	_	PUNCT
aji-154	54	1	_	_	PUNCT
aji-154	55	1	_	_	PUNCT
aji-154	56	1	_	_	PUNCT
aji-154	57	1	_	_	PUNCT
aji-154	58	1	_	_	PUNCT
aji-154	59	1	_	_	PUNCT
aji-154	60	1	_	_	PUNCT
aji-154	61	1	_	_	PUNCT
aji-154	62	1	_	_	PUNCT
aji-154	63	1	_	_	PUNCT
aji-154	64	1	_	_	PUNCT
aji-154	65	1	_	_	PUNCT
aji-154	66	1	_	_	PUNCT
aji-154	67	1	_	_	PUNCT
aji-154	68	1	_	_	PUNCT
aji-154	69	1	_	_	PUNCT
aji-154	70	1	_	_	PUNCT
aji-154	71	1	_	_	PUNCT
aji-154	72	1	_	_	PUNCT
aji-154	73	1	_	_	PUNCT
aji-154	74	1	_	_	PUNCT
aji-154	75	1	_	_	PUNCT
aji-154	76	1	_	_	PUNCT
aji-154	77	1	_	_	PUNCT
aji-154	78	1	_	_	PUNCT
aji-154	79	1	_	_	PUNCT
aji-154	80	1	_	_	PUNCT
aji-154	81	1	_	_	PUNCT
aji-154	82	1	_	_	PUNCT
aji-154	83	1	_	_	PUNCT
aji-154	84	1	_	_	PUNCT
aji-154	85	1	_	_	PUNCT
aji-154	86	1	_	_	PUNCT
aji-154	87	1	_	_	PUNCT
aji-154	88	1	_	_	PUNCT
aji-154	89	1	_	_	PUNCT
aji-154	90	1	_	_	PUNCT
aji-154	91	1	_	_	PUNCT
aji-154	92	1	_	_	PUNCT
aji-154	93	1	_	_	PUNCT
aji-154	94	1	_	_	PUNCT
aji-154	95	1	_	_	PUNCT
aji-154	96	1	_	_	PUNCT
aji-154	97	1	_	_	PUNCT
aji-154	98	1	_	_	PUNCT
aji-154	99	1	_	_	PUNCT
aji-154	100	1	_	_	PUNCT
aji-154	101	1	_	_	PUNCT
aji-154	102	1	*	*	PUNCT
aji-154	102	2	corresponding	correspond	VERB
aji-154	102	3	author	author	NOUN
aji-154	102	4	:	:	PUNCT
aji-154	102	5	e	e	NOUN
aji-154	102	6	-	-	NOUN
aji-154	102	7	mail	mail	NOUN
aji-154	102	8	:	:	PUNCT
aji-154	102	9	celso@alergoimuno.med.br	celso@alergoimuno.med.br	ADJ
aji-154	102	10	;	;	PUNCT
aji-154	102	11	cite	cite	VERB
aji-154	102	12	as	as	ADP
aji-154	102	13	:	:	PUNCT
aji-154	102	14	olivier	olivier	PROPN
aji-154	102	15	,	,	PUNCT
aji-154	102	16	celso	celso	PROPN
aji-154	102	17	eduardo	eduardo	PROPN
aji-154	102	18	,	,	PUNCT
aji-154	102	19	daiana	daiana	PROPN
aji-154	102	20	guedes	guedes	PROPN
aji-154	102	21	pinto	pinto	PROPN
aji-154	102	22	,	,	PUNCT
aji-154	102	23	ana	ana	PROPN
aji-154	102	24	paula	paula	PROPN
aji-154	102	25	monezzi	monezzi	PROPN
aji-154	102	26	teixeira	teixeira	PROPN
aji-154	102	27	,	,	PUNCT
aji-154	102	28	cibele	cibele	PROPN
aji-154	102	29	silva	silva	PROPN
aji-154	102	30	miguel	miguel	PROPN
aji-154	102	31	,	,	PUNCT
aji-154	102	32	raquel	raquel	PROPN
aji-154	102	33	acácia	acácia	PROPN
aji-154	102	34	pereira	pereira	PROPN
aji-154	102	35	gonçalves	gonçalves	PROPN
aji-154	102	36	santos	santos	PROPN
aji-154	102	37	,	,	PUNCT
aji-154	102	38	jhéssica	jhéssica	PROPN
aji-154	102	39	letícia	letícia	PROPN
aji-154	102	40	santos	santo	VERB
aji-154	102	41	santana	santana	PROPN
aji-154	102	42	,	,	PUNCT
aji-154	102	43	and	and	CCONJ
aji-154	102	44	regiane	regiane	VERB
aji-154	102	45	patussi	patussi	PROPN
aji-154	102	46	santos	santos	PROPN
aji-154	102	47	lima	lima	PROPN
aji-154	102	48	.	.	PUNCT
aji-154	102	49	2024	2024	NUM
aji-154	102	50	.	.	PUNCT
aji-154	103	1	“	"	PUNCT
aji-154	103	2	assessing	assess	VERB
aji-154	103	3	cellular	cellular	ADJ
aji-154	103	4	and	and	CCONJ
aji-154	103	5	humoral	humoral	ADJ
aji-154	103	6	immunoreactivity	immunoreactivity	NOUN
aji-154	103	7	to	to	ADP
aji-154	103	8	lanolin	lanolin	NOUN
aji-154	103	9	:	:	PUNCT
aji-154	103	10	a	a	DET
aji-154	103	11	retrospective	retrospective	ADJ
aji-154	103	12	cohort	cohort	NOUN
aji-154	103	13	study	study	NOUN
aji-154	103	14	in	in	ADP
aji-154	103	15	atopic	atopic	NOUN
aji-154	103	16	and	and	CCONJ
aji-154	103	17	contact	contact	NOUN
aji-154	103	18	dermatitis	dermatitis	NOUN
aji-154	103	19	patients	patient	NOUN
aji-154	103	20	”	"	PUNCT
aji-154	103	21	.	.	PUNCT
aji-154	104	1	asian	asian	ADJ
aji-154	104	2	journal	journal	NOUN
aji-154	104	3	of	of	ADP
aji-154	104	4	immunology	immunology	NOUN
aji-154	104	5	7	7	NUM
aji-154	104	6	(	(	PUNCT
aji-154	104	7	1):316	1):316	NUM
aji-154	104	8	-	-	SYM
aji-154	104	9	25	25	NUM
aji-154	104	10	.	.	PUNCT
aji-154	105	1	https://doi.org/10.9734/aji/2024/v7i1154	https://doi.org/10.9734/aji/2024/v7i1154	PROPN
aji-154	105	2	.	.	PUNCT
aji-154	106	1	asian	asian	ADJ
aji-154	106	2	journal	journal	PROPN
aji-154	106	3	of	of	ADP
aji-154	106	4	immunology	immunology	NOUN
aji-154	106	5	volume	volume	NOUN
aji-154	106	6	7	7	NUM
aji-154	106	7	,	,	PUNCT
aji-154	106	8	issue	issue	NOUN
aji-154	106	9	1	1	NUM
aji-154	106	10	,	,	PUNCT
aji-154	106	11	page	page	NOUN
aji-154	106	12	316	316	NUM
aji-154	106	13	-	-	SYM
aji-154	106	14	325	325	NUM
aji-154	106	15	,	,	PUNCT
aji-154	106	16	2024	2024	NUM
aji-154	106	17	;	;	PUNCT
aji-154	106	18	article	article	NOUN
aji-154	106	19	no.aji.128121	no.aji.128121	AUX
aji-154	106	20	assessing	assess	VERB
aji-154	106	21	cellular	cellular	ADJ
aji-154	106	22	and	and	CCONJ
aji-154	106	23	humoral	humoral	ADJ
aji-154	106	24	immunoreactivity	immunoreactivity	NOUN
aji-154	106	25	to	to	ADP
aji-154	106	26	lanolin	lanolin	NOUN
aji-154	106	27	:	:	PUNCT
aji-154	106	28	a	a	DET
aji-154	106	29	retrospective	retrospective	ADJ
aji-154	106	30	cohort	cohort	NOUN
aji-154	106	31	study	study	NOUN
aji-154	106	32	in	in	ADP
aji-154	106	33	atopic	atopic	NOUN
aji-154	106	34	and	and	CCONJ
aji-154	106	35	contact	contact	NOUN
aji-154	106	36	dermatitis	dermatitis	NOUN
aji-154	106	37	patients	patient	NOUN
aji-154	106	38	celso	celso	PROPN
aji-154	106	39	eduardo	eduardo	PROPN
aji-154	106	40	olivier	olivier	PROPN
aji-154	106	41	a	a	PROPN
aji-154	106	42	*	*	PROPN
aji-154	106	43	,	,	PUNCT
aji-154	106	44	daiana	daiana	PROPN
aji-154	106	45	guedes	guede	VERB
aji-154	106	46	pinto	pinto	NOUN
aji-154	106	47	a	a	PRON
aji-154	106	48	,	,	PUNCT
aji-154	106	49	ana	ana	PROPN
aji-154	106	50	paula	paula	PROPN
aji-154	106	51	monezzi	monezzi	PROPN
aji-154	106	52	teixeira	teixeira	PROPN
aji-154	106	53	a	a	PROPN
aji-154	106	54	,	,	PUNCT
aji-154	106	55	cibele	cibele	PROPN
aji-154	106	56	silva	silva	PROPN
aji-154	106	57	miguel	miguel	PROPN
aji-154	106	58	a	a	PROPN
aji-154	106	59	,	,	PUNCT
aji-154	106	60	raquel	raquel	NOUN
aji-154	106	61	acácia	acácia	PROPN
aji-154	106	62	pereira	pereira	PROPN
aji-154	106	63	gonçalves	gonçalves	PROPN
aji-154	106	64	santos	santos	PROPN
aji-154	106	65	a	a	PRON
aji-154	106	66	,	,	PUNCT
aji-154	106	67	jhéssica	jhéssica	PROPN
aji-154	106	68	letícia	letícia	PROPN
aji-154	106	69	santos	santo	VERB
aji-154	106	70	santana	santana	PROPN
aji-154	106	71	b	b	PROPN
aji-154	106	72	and	and	CCONJ
aji-154	106	73	regiane	regiane	VERB
aji-154	106	74	patussi	patussi	PROPN
aji-154	106	75	santos	santos	PROPN
aji-154	106	76	lima	lima	PROPN
aji-154	106	77	c	c	PROPN
aji-154	106	78	a	a	DET
aji-154	106	79	instituto	instituto	PROPN
aji-154	106	80	alergoimuno	alergoimuno	PROPN
aji-154	106	81	de	de	X
aji-154	106	82	americana	americana	PROPN
aji-154	106	83	,	,	PUNCT
aji-154	106	84	brazil	brazil	PROPN
aji-154	106	85	.	.	PUNCT
aji-154	107	1	b	b	PROPN
aji-154	107	2	instituto	instituto	PROPN
aji-154	107	3	de	de	PROPN
aji-154	107	4	ensino	ensino	PROPN
aji-154	107	5	e	e	PROPN
aji-154	107	6	pesquisa	pesquisa	NOUN
aji-154	107	7	do	do	VERB
aji-154	107	8	hospital	hospital	NOUN
aji-154	107	9	de	de	X
aji-154	107	10	amor	amor	PROPN
aji-154	107	11	de	de	X
aji-154	107	12	barretos	barretos	PROPN
aji-154	107	13	,	,	PUNCT
aji-154	107	14	brazil	brazil	PROPN
aji-154	107	15	.	.	PUNCT
aji-154	108	1	c	c	PROPN
aji-154	108	2	lavoisier	lavoisier	PROPN
aji-154	108	3	laboratórios	laboratórios	PROPN
aji-154	108	4	,	,	PUNCT
aji-154	108	5	são	são	PROPN
aji-154	108	6	paulo	paulo	PROPN
aji-154	108	7	,	,	PUNCT
aji-154	108	8	brazil	brazil	PROPN
aji-154	108	9	.	.	PUNCT
aji-154	109	1	authors	author	NOUN
aji-154	109	2	’	’	PART
aji-154	109	3	contributions	contribution	NOUN
aji-154	109	4	this	this	DET
aji-154	109	5	work	work	NOUN
aji-154	109	6	was	be	AUX
aji-154	109	7	carried	carry	VERB
aji-154	109	8	out	out	ADP
aji-154	109	9	in	in	ADP
aji-154	109	10	collaboration	collaboration	NOUN
aji-154	109	11	among	among	ADP
aji-154	109	12	all	all	DET
aji-154	109	13	authors	author	NOUN
aji-154	109	14	.	.	PUNCT
aji-154	110	1	the	the	DET
aji-154	110	2	author	author	NOUN
aji-154	110	3	ceo	ceo	NOUN
aji-154	110	4	is	be	AUX
aji-154	110	5	responsible	responsible	ADJ
aji-154	110	6	for	for	ADP
aji-154	110	7	the	the	DET
aji-154	110	8	conceptualization	conceptualization	NOUN
aji-154	110	9	,	,	PUNCT
aji-154	110	10	data	data	NOUN
aji-154	110	11	curation	curation	NOUN
aji-154	110	12	,	,	PUNCT
aji-154	110	13	formal	formal	ADJ
aji-154	110	14	analysis	analysis	NOUN
aji-154	110	15	,	,	PUNCT
aji-154	110	16	literature	literature	NOUN
aji-154	110	17	review	review	NOUN
aji-154	110	18	,	,	PUNCT
aji-154	110	19	and	and	CCONJ
aji-154	110	20	writing	write	VERB
aji-154	110	21	the	the	DET
aji-154	110	22	original	original	ADJ
aji-154	110	23	draft	draft	NOUN
aji-154	110	24	.	.	PUNCT
aji-154	111	1	authors	author	NOUN
aji-154	111	2	dgp	dgp	PROPN
aji-154	111	3	,	,	PUNCT
aji-154	111	4	apmt	apmt	PROPN
aji-154	111	5	,	,	PUNCT
aji-154	111	6	csm	csm	NOUN
aji-154	111	7	,	,	PUNCT
aji-154	111	8	jlss	jlss	PROPN
aji-154	111	9	and	and	CCONJ
aji-154	111	10	rpsl	rpsl	VERB
aji-154	111	11	performed	perform	VERB
aji-154	111	12	laboratory	laboratory	NOUN
aji-154	111	13	procedures	procedure	NOUN
aji-154	111	14	.	.	PUNCT
aji-154	112	1	author	author	NOUN
aji-154	112	2	rapgs	rapgs	PROPN
aji-154	112	3	performed	perform	VERB
aji-154	112	4	cutaneous	cutaneous	ADJ
aji-154	112	5	tests	test	NOUN
aji-154	112	6	.	.	PUNCT
aji-154	113	1	all	all	DET
aji-154	113	2	authors	author	NOUN
aji-154	113	3	read	read	VERB
aji-154	113	4	and	and	CCONJ
aji-154	113	5	approved	approve	VERB
aji-154	113	6	the	the	DET
aji-154	113	7	final	final	ADJ
aji-154	113	8	manuscript	manuscript	NOUN
aji-154	113	9	.	.	PUNCT
aji-154	114	1	article	article	NOUN
aji-154	114	2	information	information	PROPN
aji-154	114	3	doi	doi	PROPN
aji-154	114	4	:	:	PUNCT
aji-154	114	5	https://doi.org/10.9734/aji/2024/v7i1154	https://doi.org/10.9734/aji/2024/v7i1154	PROPN
aji-154	114	6	open	open	ADJ
aji-154	114	7	peer	peer	NOUN
aji-154	114	8	review	review	NOUN
aji-154	114	9	history	history	NOUN
aji-154	114	10	:	:	PUNCT
aji-154	114	11	this	this	DET
aji-154	114	12	journal	journal	NOUN
aji-154	114	13	follows	follow	VERB
aji-154	114	14	the	the	DET
aji-154	114	15	advanced	advance	VERB
aji-154	114	16	open	open	ADJ
aji-154	114	17	peer	peer	NOUN
aji-154	114	18	review	review	NOUN
aji-154	114	19	policy	policy	NOUN
aji-154	114	20	.	.	PUNCT
aji-154	115	1	identity	identity	NOUN
aji-154	115	2	of	of	ADP
aji-154	115	3	the	the	DET
aji-154	115	4	reviewers	reviewer	NOUN
aji-154	115	5	,	,	PUNCT
aji-154	115	6	editor(s	editor(s	NOUN
aji-154	115	7	)	)	PUNCT
aji-154	115	8	and	and	CCONJ
aji-154	115	9	additional	additional	ADJ
aji-154	115	10	reviewers	reviewer	NOUN
aji-154	115	11	,	,	PUNCT
aji-154	115	12	peer	peer	NOUN
aji-154	115	13	review	review	NOUN
aji-154	115	14	comments	comment	NOUN
aji-154	115	15	,	,	PUNCT
aji-154	115	16	different	different	ADJ
aji-154	115	17	versions	version	NOUN
aji-154	115	18	of	of	ADP
aji-154	115	19	the	the	DET
aji-154	115	20	manuscript	manuscript	NOUN
aji-154	115	21	,	,	PUNCT
aji-154	115	22	comments	comment	NOUN
aji-154	115	23	of	of	ADP
aji-154	115	24	the	the	DET
aji-154	115	25	editors	editor	NOUN
aji-154	115	26	,	,	PUNCT
aji-154	115	27	etc	etc	X
aji-154	115	28	are	be	AUX
aji-154	115	29	available	available	ADJ
aji-154	115	30	here	here	ADV
aji-154	115	31	:	:	PUNCT
aji-154	115	32	https://www.sdiarticle5.com/review-history/128121	https://www.sdiarticle5.com/review-history/128121	PROPN
aji-154	115	33	received	receive	VERB
aji-154	115	34	:	:	PUNCT
aji-154	115	35	24/10/2024	24/10/2024	NUM
aji-154	115	36	accepted	accept	VERB
aji-154	115	37	:	:	PUNCT
aji-154	115	38	26/12/2024	26/12/2024	NUM
aji-154	115	39	published	publish	VERB
aji-154	115	40	:	:	PUNCT
aji-154	115	41	28/12/2024	28/12/2024	NUM
aji-154	115	42	original	original	ADJ
aji-154	115	43	research	research	NOUN
aji-154	115	44	article	article	NOUN
aji-154	115	45	https://doi.org/10.9734/aji/2024/v7i1154	https://doi.org/10.9734/aji/2024/v7i1154	VERB
aji-154	116	1	https://www.sdiarticle5.com/review-history/128121	https://www.sdiarticle5.com/review-history/128121	PROPN
aji-154	116	2	olivier	olivier	PROPN
aji-154	116	3	et	et	PROPN
aji-154	116	4	al	al	PROPN
aji-154	116	5	.	.	PROPN
aji-154	116	6	;	;	PUNCT
aji-154	116	7	asian	asian	PROPN
aji-154	116	8	j.	j.	PROPN
aji-154	116	9	immunol	immunol	PROPN
aji-154	116	10	.	.	PROPN
aji-154	116	11	,	,	PUNCT
aji-154	116	12	vol	vol	NOUN
aji-154	116	13	.	.	PROPN
aji-154	116	14	7	7	NUM
aji-154	116	15	,	,	PUNCT
aji-154	116	16	no	no	INTJ
aji-154	116	17	.	.	NOUN
aji-154	116	18	1	1	NUM
aji-154	116	19	,	,	PUNCT
aji-154	116	20	pp	pp	ADJ
aji-154	116	21	.	.	PUNCT
aji-154	117	1	316	316	NUM
aji-154	117	2	-	-	SYM
aji-154	117	3	325	325	NUM
aji-154	117	4	,	,	PUNCT
aji-154	117	5	2024	2024	NUM
aji-154	117	6	;	;	PUNCT
aji-154	117	7	article	article	NOUN
aji-154	117	8	no.aji.128121	no.aji.128121	VERB
aji-154	117	9	317	317	NUM
aji-154	117	10	abstract	abstract	ADJ
aji-154	117	11	background	background	NOUN
aji-154	117	12	:	:	PUNCT
aji-154	117	13	several	several	ADJ
aji-154	117	14	publications	publication	NOUN
aji-154	117	15	report	report	VERB
aji-154	117	16	lanolin	lanolin	NOUN
aji-154	117	17	as	as	ADP
aji-154	117	18	responsible	responsible	ADJ
aji-154	117	19	for	for	ADP
aji-154	117	20	hypersensitivity	hypersensitivity	NOUN
aji-154	117	21	reactions	reaction	NOUN
aji-154	117	22	in	in	ADP
aji-154	117	23	patients	patient	NOUN
aji-154	117	24	with	with	ADP
aji-154	117	25	atopic	atopic	NOUN
aji-154	117	26	dermatitis	dermatitis	NOUN
aji-154	117	27	and/or	and/or	CCONJ
aji-154	117	28	contact	contact	NOUN
aji-154	117	29	dermatitis	dermatitis	NOUN
aji-154	117	30	,	,	PUNCT
aji-154	117	31	as	as	SCONJ
aji-154	117	32	diagnosed	diagnose	VERB
aji-154	117	33	by	by	ADP
aji-154	117	34	in	in	ADP
aji-154	117	35	vivo	vivo	ADJ
aji-154	117	36	provocation	provocation	NOUN
aji-154	117	37	tests	test	NOUN
aji-154	117	38	.	.	PUNCT
aji-154	118	1	there	there	PRON
aji-154	118	2	is	be	VERB
aji-154	118	3	no	no	DET
aji-154	118	4	standardized	standardized	ADJ
aji-154	118	5	lab	lab	NOUN
aji-154	118	6	exam	exam	NOUN
aji-154	118	7	that	that	PRON
aji-154	118	8	can	can	AUX
aji-154	118	9	endotype	endotype	VERB
aji-154	118	10	the	the	DET
aji-154	118	11	mechanisms	mechanism	NOUN
aji-154	118	12	responsible	responsible	ADJ
aji-154	118	13	for	for	ADP
aji-154	118	14	these	these	DET
aji-154	118	15	phenotypes	phenotype	NOUN
aji-154	118	16	.	.	PUNCT
aji-154	119	1	aim	aim	NOUN
aji-154	119	2	:	:	PUNCT
aji-154	119	3	to	to	PART
aji-154	119	4	evaluate	evaluate	VERB
aji-154	119	5	the	the	DET
aji-154	119	6	potential	potential	NOUN
aji-154	119	7	of	of	ADP
aji-154	119	8	the	the	DET
aji-154	119	9	tube	tube	NOUN
aji-154	119	10	titration	titration	NOUN
aji-154	119	11	of	of	ADP
aji-154	119	12	precipitins	precipitin	NOUN
aji-154	119	13	(	(	PUNCT
aji-154	119	14	ttp	ttp	NOUN
aji-154	119	15	)	)	PUNCT
aji-154	119	16	and	and	CCONJ
aji-154	119	17	the	the	DET
aji-154	119	18	leukocyte	leukocyte	NOUN
aji-154	119	19	adherence	adherence	NOUN
aji-154	119	20	inhibition	inhibition	NOUN
aji-154	119	21	test	test	NOUN
aji-154	119	22	(	(	PUNCT
aji-154	119	23	lait	lait	NOUN
aji-154	119	24	)	)	PUNCT
aji-154	119	25	to	to	PART
aji-154	119	26	discriminate	discriminate	VERB
aji-154	119	27	and	and	CCONJ
aji-154	119	28	endotype	endotype	VERB
aji-154	119	29	immunoreactivity	immunoreactivity	NOUN
aji-154	119	30	against	against	ADP
aji-154	119	31	lanolin	lanolin	NOUN
aji-154	119	32	in	in	ADP
aji-154	119	33	patients	patient	NOUN
aji-154	119	34	with	with	ADP
aji-154	119	35	atopic	atopic	NOUN
aji-154	119	36	dermatitis	dermatitis	NOUN
aji-154	119	37	and/or	and/or	CCONJ
aji-154	119	38	contact	contact	NOUN
aji-154	119	39	dermatitis	dermatitis	NOUN
aji-154	119	40	.	.	PUNCT
aji-154	120	1	methods	method	NOUN
aji-154	120	2	:	:	PUNCT
aji-154	120	3	we	we	PRON
aji-154	120	4	retrospectively	retrospectively	ADV
aji-154	120	5	examined	examine	VERB
aji-154	120	6	the	the	DET
aji-154	120	7	medical	medical	ADJ
aji-154	120	8	charts	chart	NOUN
aji-154	120	9	of	of	ADP
aji-154	120	10	two	two	NUM
aji-154	120	11	cohorts	cohort	NOUN
aji-154	120	12	of	of	ADP
aji-154	120	13	patients	patient	NOUN
aji-154	120	14	diagnosed	diagnose	VERB
aji-154	120	15	with	with	ADP
aji-154	120	16	atopic	atopic	NOUN
aji-154	120	17	dermatitis	dermatitis	NOUN
aji-154	120	18	and/or	and/or	CCONJ
aji-154	120	19	contact	contact	NOUN
aji-154	120	20	dermatitis	dermatitis	NOUN
aji-154	120	21	with	with	ADP
aji-154	120	22	clinical	clinical	ADJ
aji-154	120	23	suspicion	suspicion	NOUN
aji-154	120	24	of	of	ADP
aji-154	120	25	lanolin	lanolin	PROPN
aji-154	120	26	hypersensitivity	hypersensitivity	NOUN
aji-154	120	27	,	,	PUNCT
aji-154	120	28	who	who	PRON
aji-154	120	29	were	be	AUX
aji-154	120	30	investigated	investigate	VERB
aji-154	120	31	with	with	ADP
aji-154	120	32	the	the	DET
aji-154	120	33	help	help	NOUN
aji-154	120	34	of	of	ADP
aji-154	120	35	ttp	ttp	PROPN
aji-154	120	36	or	or	CCONJ
aji-154	120	37	ex	ex	PRON
aji-154	120	38	vivo	vivo	NOUN
aji-154	120	39	challenge	challenge	NOUN
aji-154	120	40	tests	test	NOUN
aji-154	120	41	monitored	monitor	VERB
aji-154	120	42	by	by	ADP
aji-154	120	43	lait	lait	NOUN
aji-154	120	44	against	against	ADP
aji-154	120	45	lanolin	lanolin	PROPN
aji-154	120	46	.	.	PUNCT
aji-154	121	1	the	the	DET
aji-154	121	2	registered	register	VERB
aji-154	121	3	results	result	NOUN
aji-154	121	4	were	be	AUX
aji-154	121	5	distributed	distribute	VERB
aji-154	121	6	in	in	ADP
aji-154	121	7	ranges	range	NOUN
aji-154	121	8	through	through	ADP
aji-154	121	9	cascade	cascade	NOUN
aji-154	121	10	distribution	distribution	NOUN
aji-154	121	11	charts	chart	NOUN
aji-154	121	12	.	.	PUNCT
aji-154	122	1	the	the	DET
aji-154	122	2	statistical	statistical	ADJ
aji-154	122	3	characteristics	characteristic	NOUN
aji-154	122	4	of	of	ADP
aji-154	122	5	these	these	DET
aji-154	122	6	cohorts	cohort	NOUN
aji-154	122	7	were	be	AUX
aji-154	122	8	calculated	calculate	VERB
aji-154	122	9	.	.	PUNCT
aji-154	123	1	results	result	NOUN
aji-154	123	2	:	:	PUNCT
aji-154	123	3	the	the	DET
aji-154	123	4	ttp	ttp	PROPN
aji-154	123	5	results	result	NOUN
aji-154	123	6	spread	spread	VERB
aji-154	123	7	a	a	DET
aji-154	123	8	distribution	distribution	NOUN
aji-154	123	9	concentrated	concentrate	VERB
aji-154	123	10	over	over	ADP
aji-154	123	11	the	the	DET
aji-154	123	12	more	more	ADV
aji-154	123	13	diluted	diluted	ADJ
aji-154	123	14	titrations	titration	NOUN
aji-154	123	15	(	(	PUNCT
aji-154	123	16	fig	fig	NOUN
aji-154	123	17	.	.	PUNCT
aji-154	123	18	1	1	NUM
aji-154	123	19	)	)	PUNCT
aji-154	123	20	.	.	PUNCT
aji-154	124	1	there	there	PRON
aji-154	124	2	was	be	VERB
aji-154	124	3	no	no	DET
aji-154	124	4	negative	negative	ADJ
aji-154	124	5	result	result	NOUN
aji-154	124	6	.	.	PUNCT
aji-154	125	1	the	the	DET
aji-154	125	2	mean	mean	NOUN
aji-154	125	3	was	be	AUX
aji-154	125	4	estimated	estimate	VERB
aji-154	125	5	at	at	ADP
aji-154	125	6	1:343	1:343	NUM
aji-154	125	7	;	;	PUNCT
aji-154	125	8	the	the	DET
aji-154	125	9	median	median	NOUN
aji-154	125	10	was	be	AUX
aji-154	125	11	1:512	1:512	NUM
aji-154	125	12	;	;	PUNCT
aji-154	125	13	the	the	DET
aji-154	125	14	standard	standard	ADJ
aji-154	125	15	deviation	deviation	NOUN
aji-154	125	16	was	be	AUX
aji-154	125	17	estimated	estimate	VERB
aji-154	125	18	at	at	ADP
aji-154	125	19	1:187	1:187	NUM
aji-154	125	20	;	;	PUNCT
aji-154	125	21	the	the	DET
aji-154	125	22	mode	mode	NOUN
aji-154	125	23	was	be	AUX
aji-154	125	24	1:512	1:512	NUM
aji-154	125	25	(	(	PUNCT
aji-154	125	26	appeared	appear	VERB
aji-154	125	27	53	53	NUM
aji-154	125	28	times	time	NOUN
aji-154	125	29	)	)	PUNCT
aji-154	125	30	.	.	PUNCT
aji-154	126	1	the	the	DET
aji-154	126	2	lai	lai	PROPN
aji-154	126	3	ranged	range	VERB
aji-154	126	4	from	from	ADP
aji-154	126	5	0	0	NUM
aji-154	126	6	%	%	NOUN
aji-154	126	7	to	to	PART
aji-154	126	8	95	95	NUM
aji-154	126	9	%	%	NOUN
aji-154	126	10	.	.	PUNCT
aji-154	127	1	the	the	DET
aji-154	127	2	mean	mean	NOUN
aji-154	127	3	was	be	AUX
aji-154	127	4	41.5	41.5	NUM
aji-154	127	5	%	%	NOUN
aji-154	127	6	;	;	PUNCT
aji-154	127	7	the	the	DET
aji-154	127	8	median	median	NOUN
aji-154	127	9	was	be	AUX
aji-154	127	10	41.5	41.5	NUM
aji-154	127	11	%	%	NOUN
aji-154	127	12	;	;	PUNCT
aji-154	127	13	the	the	DET
aji-154	127	14	standard	standard	ADJ
aji-154	127	15	deviation	deviation	NOUN
aji-154	127	16	was	be	AUX
aji-154	127	17	27.3	27.3	NUM
aji-154	127	18	%	%	NOUN
aji-154	127	19	;	;	PUNCT
aji-154	127	20	the	the	DET
aji-154	127	21	mode	mode	NOUN
aji-154	127	22	was	be	AUX
aji-154	127	23	0	0	NUM
aji-154	127	24	%	%	NOUN
aji-154	127	25	(	(	PUNCT
aji-154	127	26	appeared	appear	VERB
aji-154	127	27	sixteen	sixteen	NUM
aji-154	127	28	times	time	NOUN
aji-154	127	29	)	)	PUNCT
aji-154	127	30	.	.	PUNCT
aji-154	128	1	the	the	DET
aji-154	128	2	cascade	cascade	NOUN
aji-154	128	3	distribution	distribution	NOUN
aji-154	128	4	demonstrates	demonstrate	VERB
aji-154	128	5	a	a	DET
aji-154	128	6	widespread	widespread	ADJ
aji-154	128	7	distribution	distribution	NOUN
aji-154	128	8	of	of	ADP
aji-154	128	9	lai	lai	PROPN
aji-154	128	10	results	result	NOUN
aji-154	128	11	.	.	PUNCT
aji-154	129	1	conclusion	conclusion	NOUN
aji-154	129	2	:	:	PUNCT
aji-154	129	3	ttp	ttp	PROPN
aji-154	129	4	and	and	CCONJ
aji-154	129	5	lait	lait	PROPN
aji-154	129	6	performed	perform	VERB
aji-154	129	7	with	with	ADP
aji-154	129	8	lanolin	lanolin	NOUN
aji-154	129	9	solution	solution	NOUN
aji-154	129	10	were	be	AUX
aji-154	129	11	able	able	ADJ
aji-154	129	12	to	to	PART
aji-154	129	13	discriminate	discriminate	VERB
aji-154	129	14	diverse	diverse	ADJ
aji-154	129	15	degrees	degree	NOUN
aji-154	129	16	of	of	ADP
aji-154	129	17	humoral	humoral	ADJ
aji-154	129	18	and	and	CCONJ
aji-154	129	19	cellular	cellular	ADJ
aji-154	129	20	immunoreactivity	immunoreactivity	NOUN
aji-154	129	21	in	in	ADP
aji-154	129	22	patients	patient	NOUN
aji-154	129	23	suffering	suffer	VERB
aji-154	129	24	from	from	ADP
aji-154	129	25	atopic	atopic	NOUN
aji-154	129	26	and/or	and/or	CCONJ
aji-154	129	27	contact	contact	NOUN
aji-154	129	28	dermatitis	dermatitis	NOUN
aji-154	129	29	.	.	PUNCT
aji-154	130	1	it	it	PRON
aji-154	130	2	is	be	AUX
aji-154	130	3	worthwhile	worthwhile	ADJ
aji-154	130	4	conducting	conduct	VERB
aji-154	130	5	more	more	ADJ
aji-154	130	6	in	in	ADP
aji-154	130	7	-	-	PUNCT
aji-154	130	8	depth	depth	NOUN
aji-154	130	9	studies	study	NOUN
aji-154	130	10	to	to	PART
aji-154	130	11	evaluate	evaluate	VERB
aji-154	130	12	the	the	DET
aji-154	130	13	usefulness	usefulness	NOUN
aji-154	130	14	of	of	ADP
aji-154	130	15	ttp	ttp	NOUN
aji-154	130	16	and	and	CCONJ
aji-154	130	17	lait	lait	NOUN
aji-154	130	18	in	in	ADP
aji-154	130	19	endotyping	endotype	VERB
aji-154	130	20	non	non	PROPN
aji-154	130	21	–	–	PUNCT
aji-154	130	22	ige	ige	ADJ
aji-154	130	23	-	-	PUNCT
aji-154	130	24	mediated	mediate	VERB
aji-154	130	25	hypersensitivity	hypersensitivity	NOUN
aji-154	130	26	to	to	ADP
aji-154	130	27	lanolin	lanolin	NOUN
aji-154	130	28	.	.	PUNCT
aji-154	131	1	keywords	keyword	NOUN
aji-154	131	2	:	:	PUNCT
aji-154	131	3	atopic	atopic	NOUN
aji-154	131	4	dermatitis	dermatitis	NOUN
aji-154	131	5	;	;	PUNCT
aji-154	131	6	contact	contact	NOUN
aji-154	131	7	dermatitis	dermatitis	NOUN
aji-154	131	8	;	;	PUNCT
aji-154	131	9	endotype	endotype	NOUN
aji-154	131	10	;	;	PUNCT
aji-154	131	11	hypersensitivity	hypersensitivity	NOUN
aji-154	131	12	;	;	PUNCT
aji-154	131	13	lanolin	lanolin	NOUN
aji-154	131	14	;	;	PUNCT
aji-154	131	15	leukocyte	leukocyte	ADJ
aji-154	131	16	adherence	adherence	NOUN
aji-154	131	17	inhibition	inhibition	NOUN
aji-154	131	18	test	test	NOUN
aji-154	131	19	;	;	PUNCT
aji-154	131	20	precipitins	precipitin	NOUN
aji-154	131	21	;	;	PUNCT
aji-154	131	22	precision	precision	NOUN
aji-154	131	23	medicine	medicine	NOUN
aji-154	131	24	.	.	PUNCT
aji-154	132	1	abbreviations	abbreviation	NOUN
aji-154	132	2	lai	lai	NOUN
aji-154	132	3	:	:	PUNCT
aji-154	132	4	leukocyte	leukocyte	NOUN
aji-154	132	5	adherence	adherence	NOUN
aji-154	132	6	inhibition	inhibition	NOUN
aji-154	132	7	lait	lait	NOUN
aji-154	132	8	:	:	PUNCT
aji-154	132	9	leukocyte	leukocyte	ADJ
aji-154	132	10	adherence	adherence	NOUN
aji-154	132	11	inhibition	inhibition	NOUN
aji-154	132	12	test	test	NOUN
aji-154	132	13	ttp	ttp	NOUN
aji-154	132	14	:	:	PUNCT
aji-154	132	15	tube	tube	NOUN
aji-154	132	16	titration	titration	NOUN
aji-154	132	17	of	of	ADP
aji-154	132	18	precipitins	precipitin	NOUN
aji-154	132	19	1	1	NUM
aji-154	132	20	.	.	PUNCT
aji-154	132	21	introduction	introduction	NOUN
aji-154	132	22	in	in	ADP
aji-154	132	23	the	the	DET
aji-154	132	24	past	past	NOUN
aji-154	132	25	,	,	PUNCT
aji-154	132	26	when	when	SCONJ
aji-154	132	27	synthetic	synthetic	ADJ
aji-154	132	28	garments	garment	NOUN
aji-154	132	29	were	be	AUX
aji-154	132	30	not	not	PART
aji-154	132	31	yet	yet	ADV
aji-154	132	32	produced	produce	VERB
aji-154	132	33	,	,	PUNCT
aji-154	132	34	natural	natural	ADJ
aji-154	132	35	wools	wool	NOUN
aji-154	132	36	were	be	AUX
aji-154	132	37	dominant	dominant	ADJ
aji-154	132	38	allergens	allergen	NOUN
aji-154	132	39	in	in	ADP
aji-154	132	40	cold	cold	ADJ
aji-154	132	41	months	month	NOUN
aji-154	132	42	,	,	PUNCT
aji-154	132	43	associated	associate	VERB
aji-154	132	44	with	with	ADP
aji-154	132	45	atopic	atopic	NOUN
aji-154	132	46	dermatitis	dermatitis	NOUN
aji-154	132	47	,	,	PUNCT
aji-154	132	48	eczema	eczema	NOUN
aji-154	132	49	,	,	PUNCT
aji-154	132	50	or	or	CCONJ
aji-154	132	51	textile	textile	NOUN
aji-154	132	52	contact	contact	NOUN
aji-154	132	53	dermatitis	dermatitis	NOUN
aji-154	132	54	,	,	PUNCT
aji-154	132	55	especially	especially	ADV
aji-154	132	56	in	in	ADP
aji-154	132	57	infants	infant	NOUN
aji-154	132	58	[	[	X
aji-154	132	59	1	1	NUM
aji-154	132	60	]	]	PUNCT
aji-154	132	61	.	.	PUNCT
aji-154	133	1	wool	wool	PROPN
aji-154	133	2	allergy	allergy	NOUN
aji-154	133	3	has	have	AUX
aji-154	133	4	been	be	AUX
aji-154	133	5	traditionally	traditionally	ADV
aji-154	133	6	diagnosed	diagnose	VERB
aji-154	133	7	by	by	ADP
aji-154	133	8	scratch	scratch	NOUN
aji-154	133	9	,	,	PUNCT
aji-154	133	10	patch	patch	NOUN
aji-154	133	11	,	,	PUNCT
aji-154	133	12	and	and	CCONJ
aji-154	133	13	intracutaneous	intracutaneous	ADJ
aji-154	133	14	tests	test	NOUN
aji-154	133	15	with	with	ADP
aji-154	133	16	wool	wool	NOUN
aji-154	133	17	extracts	extract	NOUN
aji-154	133	18	[	[	X
aji-154	133	19	2	2	NUM
aji-154	133	20	]	]	PUNCT
aji-154	133	21	.	.	PUNCT
aji-154	134	1	wool	wool	PROPN
aji-154	134	2	allergy	allergy	NOUN
aji-154	134	3	has	have	AUX
aji-154	134	4	been	be	AUX
aji-154	134	5	successfully	successfully	ADV
aji-154	134	6	treated	treat	VERB
aji-154	134	7	by	by	ADP
aji-154	134	8	desensitization	desensitization	NOUN
aji-154	134	9	since	since	SCONJ
aji-154	134	10	the	the	DET
aji-154	134	11	1930s	1930	NOUN
aji-154	134	12	[	[	X
aji-154	134	13	3	3	NUM
aji-154	134	14	]	]	PUNCT
aji-154	134	15	.	.	PUNCT
aji-154	135	1	concomitantly	concomitantly	ADV
aji-154	135	2	,	,	PUNCT
aji-154	135	3	the	the	DET
aji-154	135	4	cause	cause	NOUN
aji-154	135	5	of	of	ADP
aji-154	135	6	wool	wool	NOUN
aji-154	135	7	allergy	allergy	NOUN
aji-154	135	8	was	be	AUX
aji-154	135	9	attributed	attribute	VERB
aji-154	135	10	to	to	ADP
aji-154	135	11	the	the	DET
aji-154	135	12	wool	wool	NOUN
aji-154	135	13	fat	fat	NOUN
aji-154	135	14	:	:	PUNCT
aji-154	135	15	lanolin	lanolin	NOUN
aji-154	136	1	[	[	X
aji-154	136	2	4	4	NUM
aji-154	136	3	]	]	PUNCT
aji-154	136	4	.	.	PUNCT
aji-154	137	1	lanolin	lanolin	PROPN
aji-154	137	2	is	be	AUX
aji-154	137	3	a	a	DET
aji-154	137	4	complex	complex	ADJ
aji-154	137	5	mixture	mixture	NOUN
aji-154	137	6	of	of	ADP
aji-154	137	7	free	free	ADJ
aji-154	137	8	fatty	fatty	NOUN
aji-154	137	9	acids	acid	NOUN
aji-154	137	10	,	,	PUNCT
aji-154	137	11	fatty	fatty	NOUN
aji-154	137	12	acid	acid	NOUN
aji-154	137	13	esters	ester	NOUN
aji-154	137	14	,	,	PUNCT
aji-154	137	15	cholesterols	cholesterol	NOUN
aji-154	137	16	,	,	PUNCT
aji-154	137	17	and	and	CCONJ
aji-154	137	18	other	other	ADJ
aji-154	137	19	hydrocarbons	hydrocarbon	NOUN
aji-154	137	20	extracted	extract	VERB
aji-154	137	21	from	from	ADP
aji-154	137	22	sheep	sheep	NOUN
aji-154	137	23	's	's	PART
aji-154	137	24	wool	wool	NOUN
aji-154	137	25	[	[	X
aji-154	137	26	5	5	NUM
aji-154	137	27	]	]	PUNCT
aji-154	137	28	.	.	PUNCT
aji-154	138	1	lanolin	lanolin	PROPN
aji-154	138	2	is	be	AUX
aji-154	138	3	produced	produce	VERB
aji-154	138	4	from	from	ADP
aji-154	138	5	the	the	DET
aji-154	138	6	secretion	secretion	NOUN
aji-154	138	7	of	of	ADP
aji-154	138	8	the	the	DET
aji-154	138	9	sebaceous	sebaceous	ADJ
aji-154	138	10	glands	gland	NOUN
aji-154	138	11	of	of	ADP
aji-154	138	12	sheep	sheep	NOUN
aji-154	138	13	to	to	PART
aji-154	138	14	serve	serve	VERB
aji-154	138	15	as	as	ADP
aji-154	138	16	a	a	DET
aji-154	138	17	wool	wool	NOUN
aji-154	138	18	's	's	PART
aji-154	138	19	protective	protective	ADJ
aji-154	138	20	coating	coating	NOUN
aji-154	138	21	,	,	PUNCT
aji-154	138	22	which	which	PRON
aji-154	138	23	is	be	AUX
aji-154	138	24	a	a	DET
aji-154	138	25	composition	composition	NOUN
aji-154	138	26	that	that	PRON
aji-154	138	27	varies	vary	VERB
aji-154	138	28	according	accord	VERB
aji-154	138	29	to	to	ADP
aji-154	138	30	the	the	DET
aji-154	138	31	breed	breed	NOUN
aji-154	138	32	of	of	ADP
aji-154	138	33	sheep	sheep	NOUN
aji-154	138	34	,	,	PUNCT
aji-154	138	35	geographic	geographic	ADJ
aji-154	138	36	location	location	NOUN
aji-154	138	37	,	,	PUNCT
aji-154	138	38	method	method	NOUN
aji-154	138	39	of	of	ADP
aji-154	138	40	extraction	extraction	NOUN
aji-154	138	41	,	,	PUNCT
aji-154	138	42	and	and	CCONJ
aji-154	138	43	level	level	NOUN
aji-154	138	44	of	of	ADP
aji-154	138	45	purification	purification	NOUN
aji-154	138	46	[	[	X
aji-154	138	47	6	6	NUM
aji-154	138	48	]	]	PUNCT
aji-154	138	49	.	.	PUNCT
aji-154	139	1	the	the	DET
aji-154	139	2	first	first	ADJ
aji-154	139	3	extraction	extraction	NOUN
aji-154	139	4	of	of	ADP
aji-154	139	5	this	this	DET
aji-154	139	6	"	"	PUNCT
aji-154	139	7	wool	wool	NOUN
aji-154	139	8	wax	wax	NOUN
aji-154	139	9	"	"	PUNCT
aji-154	139	10	is	be	AUX
aji-154	139	11	attributed	attribute	VERB
aji-154	139	12	to	to	ADP
aji-154	139	13	the	the	DET
aji-154	139	14	ancient	ancient	ADJ
aji-154	139	15	greeks	greeks	PROPN
aji-154	139	16	,	,	PUNCT
aji-154	139	17	who	who	PRON
aji-154	139	18	documented	document	VERB
aji-154	139	19	,	,	PUNCT
aji-154	139	20	in	in	ADP
aji-154	139	21	700	700	NUM
aji-154	139	22	bc	bc	ADJ
aji-154	139	23	,	,	PUNCT
aji-154	139	24	boiling	boil	VERB
aji-154	139	25	wool	wool	NOUN
aji-154	139	26	in	in	ADP
aji-154	139	27	water	water	NOUN
aji-154	139	28	produced	produce	VERB
aji-154	139	29	a	a	DET
aji-154	139	30	top	top	ADJ
aji-154	139	31	layer	layer	NOUN
aji-154	139	32	of	of	ADP
aji-154	139	33	greasy	greasy	ADJ
aji-154	139	34	froth	froth	NOUN
aji-154	139	35	that	that	PRON
aji-154	139	36	could	could	AUX
aji-154	139	37	be	be	AUX
aji-154	139	38	skimmed	skim	VERB
aji-154	139	39	[	[	X
aji-154	139	40	7	7	NUM
aji-154	139	41	]	]	PUNCT
aji-154	139	42	.	.	PUNCT
aji-154	140	1	in	in	ADP
aji-154	140	2	1882	1882	NUM
aji-154	140	3	,	,	PUNCT
aji-154	140	4	the	the	DET
aji-154	140	5	germans	germans	PROPN
aji-154	140	6	otto	otto	PROPN
aji-154	140	7	braun	braun	PROPN
aji-154	140	8	and	and	CCONJ
aji-154	140	9	oscar	oscar	PROPN
aji-154	140	10	liebreice	liebreice	NOUN
aji-154	140	11	applied	apply	VERB
aji-154	140	12	a	a	DET
aji-154	140	13	patent	patent	NOUN
aji-154	140	14	describing	describe	VERB
aji-154	140	15	a	a	DET
aji-154	140	16	sequential	sequential	ADJ
aji-154	140	17	centrifugation	centrifugation	NOUN
aji-154	140	18	of	of	ADP
aji-154	140	19	the	the	DET
aji-154	140	20	wool	wool	NOUN
aji-154	140	21	froth	froth	VERB
aji-154	140	22	along	along	ADP
aji-154	140	23	with	with	ADP
aji-154	140	24	water	water	NOUN
aji-154	140	25	to	to	PART
aji-154	140	26	incorporate	incorporate	VERB
aji-154	140	27	both	both	DET
aji-154	140	28	elements	element	NOUN
aji-154	140	29	,	,	PUNCT
aji-154	140	30	resulting	result	VERB
aji-154	140	31	in	in	ADP
aji-154	140	32	a	a	DET
aji-154	140	33	suspension	suspension	NOUN
aji-154	140	34	which	which	PRON
aji-154	140	35	,	,	PUNCT
aji-154	140	36	after	after	ADP
aji-154	140	37	refrigeration	refrigeration	NOUN
aji-154	140	38	,	,	PUNCT
aji-154	140	39	boiling	boiling	NOUN
aji-154	140	40	,	,	PUNCT
aji-154	140	41	and	and	CCONJ
aji-154	140	42	alkalinization	alkalinization	NOUN
aji-154	140	43	became	become	VERB
aji-154	140	44	what	what	PRON
aji-154	140	45	they	they	PRON
aji-154	140	46	coined	coin	VERB
aji-154	140	47	"	"	PUNCT
aji-154	140	48	lanolin	lanolin	NOUN
aji-154	140	49	"	"	PUNCT
aji-154	140	50	(	(	PUNCT
aji-154	140	51	us	us	PROPN
aji-154	140	52	letters	letter	VERB
aji-154	140	53	patent	patent	NOUN
aji-154	140	54	no	no	PROPN
aji-154	140	55	.	.	PROPN
aji-154	140	56	271,192	271,192	NUM
aji-154	140	57	dated	date	VERB
aji-154	140	58	january	january	PROPN
aji-154	140	59	23	23	NUM
aji-154	140	60	,	,	PUNCT
aji-154	140	61	1883	1883	NUM
aji-154	140	62	)	)	PUNCT
aji-154	141	1	[	[	X
aji-154	141	2	8	8	NUM
aji-154	141	3	]	]	PUNCT
aji-154	141	4	.	.	PUNCT
aji-154	142	1	nowadays	nowadays	ADV
aji-154	142	2	,	,	PUNCT
aji-154	142	3	several	several	ADJ
aji-154	142	4	more	more	ADV
aji-154	142	5	sophisticated	sophisticated	ADJ
aji-154	142	6	modified	modify	VERB
aji-154	142	7	techniques	technique	NOUN
aji-154	142	8	are	be	AUX
aji-154	142	9	employed	employ	VERB
aji-154	142	10	to	to	PART
aji-154	142	11	produce	produce	VERB
aji-154	142	12	several	several	ADJ
aji-154	142	13	varieties	variety	NOUN
aji-154	142	14	of	of	ADP
aji-154	142	15	lanolin	lanolin	NOUN
aji-154	142	16	-	-	PUNCT
aji-154	142	17	based	base	VERB
aji-154	142	18	products	product	NOUN
aji-154	142	19	and	and	CCONJ
aji-154	142	20	derivatives	derivative	NOUN
aji-154	142	21	through	through	ADP
aji-154	142	22	physical	physical	ADJ
aji-154	142	23	and	and	CCONJ
aji-154	142	24	chemical	chemical	NOUN
aji-154	142	25	modifications	modification	NOUN
aji-154	142	26	(	(	PUNCT
aji-154	142	27	hydrolysis	hydrolysis	NOUN
aji-154	142	28	.	.	PUNCT
aji-154	143	1	hydrogenation	hydrogenation	NOUN
aji-154	143	2	,	,	PUNCT
aji-154	143	3	acetylation	acetylation	NOUN
aji-154	143	4	,	,	PUNCT
aji-154	143	5	ethoxylation	ethoxylation	NOUN
aji-154	143	6	,	,	PUNCT
aji-154	143	7	transesterification	transesterification	NOUN
aji-154	143	8	,	,	PUNCT
aji-154	143	9	and	and	CCONJ
aji-154	143	10	so	so	ADV
aji-154	143	11	forth	forth	ADV
aji-154	143	12	)	)	PUNCT
aji-154	144	1	[	[	X
aji-154	144	2	9	9	NUM
aji-154	144	3	]	]	PUNCT
aji-154	144	4	.	.	PUNCT
aji-154	145	1	very	very	ADV
aji-154	145	2	soon	soon	ADV
aji-154	145	3	,	,	PUNCT
aji-154	145	4	the	the	DET
aji-154	145	5	industrial	industrial	ADJ
aji-154	145	6	production	production	NOUN
aji-154	145	7	of	of	ADP
aji-154	145	8	lanolin	lanolin	PROPN
aji-154	145	9	was	be	AUX
aji-154	145	10	widespread	widespread	ADJ
aji-154	145	11	.	.	PUNCT
aji-154	146	1	it	it	PRON
aji-154	146	2	began	begin	VERB
aji-154	146	3	to	to	PART
aji-154	146	4	be	be	AUX
aji-154	146	5	incorporated	incorporate	VERB
aji-154	146	6	into	into	ADP
aji-154	146	7	skin	skin	NOUN
aji-154	146	8	-	-	PUNCT
aji-154	146	9	cream	cream	NOUN
aji-154	146	10	products	product	NOUN
aji-154	146	11	as	as	ADP
aji-154	146	12	an	an	DET
aji-154	146	13	emulsifier	emulsifier	NOUN
aji-154	146	14	,	,	PUNCT
aji-154	146	15	stabilizer	stabilizer	NOUN
aji-154	146	16	,	,	PUNCT
aji-154	146	17	emollient	emollient	NOUN
aji-154	146	18	,	,	PUNCT
aji-154	146	19	and	and	CCONJ
aji-154	146	20	skin	skin	NOUN
aji-154	146	21	moisturizer	moisturizer	NOUN
aji-154	146	22	,	,	PUNCT
aji-154	146	23	such	such	ADJ
aji-154	146	24	as	as	ADP
aji-154	146	25	toilet	toilet	NOUN
aji-154	146	26	articles	article	NOUN
aji-154	146	27	,	,	PUNCT
aji-154	146	28	shaving	shaving	NOUN
aji-154	146	29	creams	cream	NOUN
aji-154	146	30	,	,	PUNCT
aji-154	146	31	toilet	toilet	NOUN
aji-154	146	32	soaps	soap	NOUN
aji-154	146	33	,	,	PUNCT
aji-154	146	34	hair	hair	NOUN
aji-154	146	35	lotions	lotion	NOUN
aji-154	146	36	,	,	PUNCT
aji-154	146	37	shampoos	shampoo	NOUN
aji-154	146	38	,	,	PUNCT
aji-154	146	39	hair	hair	NOUN
aji-154	146	40	conditioners	conditioner	NOUN
aji-154	146	41	(	(	PUNCT
aji-154	146	42	to	to	PART
aji-154	146	43	prevent	prevent	VERB
aji-154	146	44	hair	hair	NOUN
aji-154	146	45	drying	dry	VERB
aji-154	146	46	,	,	PUNCT
aji-154	146	47	scaling	scaling	NOUN
aji-154	146	48	and	and	CCONJ
aji-154	146	49	brittleness	brittleness	NOUN
aji-154	146	50	)	)	PUNCT
aji-154	146	51	,	,	PUNCT
aji-154	146	52	cosmetic	cosmetic	ADJ
aji-154	146	53	creams	cream	NOUN
aji-154	146	54	,	,	PUNCT
aji-154	146	55	lipsticks	lipstick	NOUN
aji-154	146	56	,	,	PUNCT
aji-154	146	57	nail	nail	NOUN
aji-154	146	58	polish	polish	NOUN
aji-154	146	59	removers	remover	NOUN
aji-154	146	60	,	,	PUNCT
aji-154	146	61	eye	eye	NOUN
aji-154	146	62	make	make	NOUN
aji-154	146	63	-	-	PUNCT
aji-154	146	64	up	up	NOUN
aji-154	146	65	(	(	PUNCT
aji-154	146	66	for	for	ADP
aji-154	146	67	more	more	ADV
aji-154	146	68	uniformly	uniformly	ADJ
aji-154	146	69	dispersion	dispersion	NOUN
aji-154	146	70	of	of	ADP
aji-154	146	71	the	the	DET
aji-154	146	72	pigment	pigment	NOUN
aji-154	146	73	)	)	PUNCT
aji-154	146	74	,	,	PUNCT
aji-154	146	75	hair	hair	NOUN
aji-154	146	76	sprays	spray	NOUN
aji-154	146	77	(	(	PUNCT
aji-154	146	78	as	as	ADP
aji-154	146	79	a	a	DET
aji-154	146	80	plasticizer	plasticizer	NOUN
aji-154	146	81	)	)	PUNCT
aji-154	146	82	,	,	PUNCT
aji-154	146	83	hair	hair	NOUN
aji-154	146	84	bleaching	bleaching	NOUN
aji-154	146	85	agents	agent	NOUN
aji-154	146	86	,	,	PUNCT
aji-154	146	87	and	and	CCONJ
aji-154	146	88	used	use	VERB
aji-154	146	89	by	by	ADP
aji-154	146	90	pharmacists	pharmacist	NOUN
aji-154	146	91	as	as	ADP
aji-154	146	92	olivier	olivier	PROPN
aji-154	146	93	et	et	PROPN
aji-154	146	94	al	al	PROPN
aji-154	146	95	.	.	PROPN
aji-154	146	96	;	;	PUNCT
aji-154	146	97	asian	asian	PROPN
aji-154	146	98	j.	j.	PROPN
aji-154	146	99	immunol	immunol	PROPN
aji-154	146	100	.	.	PROPN
aji-154	146	101	,	,	PUNCT
aji-154	146	102	vol	vol	NOUN
aji-154	146	103	.	.	PROPN
aji-154	147	1	7	7	NUM
aji-154	147	2	,	,	PUNCT
aji-154	147	3	no	no	INTJ
aji-154	147	4	.	.	NOUN
aji-154	147	5	1	1	NUM
aji-154	147	6	,	,	PUNCT
aji-154	147	7	pp	pp	ADJ
aji-154	147	8	.	.	PUNCT
aji-154	148	1	316	316	NUM
aji-154	148	2	-	-	SYM
aji-154	148	3	325	325	NUM
aji-154	148	4	,	,	PUNCT
aji-154	148	5	2024	2024	NUM
aji-154	148	6	;	;	PUNCT
aji-154	148	7	article	article	NOUN
aji-154	148	8	no.aji.128121	no.aji.128121	VERB
aji-154	148	9	318	318	NUM
aji-154	148	10	an	an	DET
aji-154	148	11	excipient	excipient	NOUN
aji-154	148	12	for	for	ADP
aji-154	148	13	topical	topical	ADJ
aji-154	148	14	medications	medication	NOUN
aji-154	148	15	[	[	X
aji-154	148	16	10	10	NUM
aji-154	148	17	]	]	PUNCT
aji-154	148	18	.	.	PUNCT
aji-154	149	1	studies	study	NOUN
aji-154	149	2	done	do	VERB
aji-154	149	3	by	by	ADP
aji-154	149	4	freeze	freeze	NOUN
aji-154	149	5	-	-	PUNCT
aji-154	149	6	fracture	fracture	NOUN
aji-154	149	7	and	and	CCONJ
aji-154	149	8	transmission	transmission	NOUN
aji-154	149	9	electron	electron	NOUN
aji-154	149	10	microscopy	microscopy	NOUN
aji-154	149	11	of	of	ADP
aji-154	149	12	stratum	stratum	NOUN
aji-154	149	13	corneum	corneum	NOUN
aji-154	149	14	found	find	VERB
aji-154	149	15	that	that	SCONJ
aji-154	149	16	most	most	ADV
aji-154	149	17	applied	apply	VERB
aji-154	149	18	lanolin	lanolin	NOUN
aji-154	149	19	occupied	occupy	VERB
aji-154	149	20	intercellular	intercellular	ADJ
aji-154	149	21	spaces	space	NOUN
aji-154	149	22	.	.	PUNCT
aji-154	150	1	some	some	DET
aji-154	150	2	penetrated	penetrate	VERB
aji-154	150	3	corneocytes	corneocyte	NOUN
aji-154	150	4	and	and	CCONJ
aji-154	150	5	had	have	VERB
aji-154	150	6	a	a	DET
aji-154	150	7	special	special	ADJ
aji-154	150	8	affinity	affinity	NOUN
aji-154	150	9	for	for	ADP
aji-154	150	10	the	the	DET
aji-154	150	11	cell	cell	NOUN
aji-154	150	12	junction	junction	NOUN
aji-154	151	1	[	[	X
aji-154	151	2	11	11	NUM
aji-154	151	3	]	]	PUNCT
aji-154	151	4	.	.	PUNCT
aji-154	152	1	allergic	allergic	ADJ
aji-154	152	2	contact	contact	PROPN
aji-154	152	3	dermatitis	dermatitis	NOUN
aji-154	152	4	to	to	ADP
aji-154	152	5	lanolin	lanolin	PROPN
aji-154	152	6	was	be	AUX
aji-154	152	7	first	first	ADV
aji-154	152	8	described	describe	VERB
aji-154	152	9	by	by	ADP
aji-154	152	10	ramirez	ramirez	PROPN
aji-154	152	11	and	and	CCONJ
aji-154	152	12	eller	eller	NOUN
aji-154	152	13	in	in	ADP
aji-154	152	14	1929	1929	NUM
aji-154	152	15	[	[	X
aji-154	152	16	12	12	NUM
aji-154	152	17	]	]	PUNCT
aji-154	152	18	.	.	PUNCT
aji-154	153	1	very	very	ADV
aji-154	153	2	soon	soon	ADV
aji-154	153	3	,	,	PUNCT
aji-154	153	4	several	several	ADJ
aji-154	153	5	case	case	NOUN
aji-154	153	6	reports	report	NOUN
aji-154	153	7	of	of	ADP
aji-154	153	8	hypersensitivity	hypersensitivity	NOUN
aji-154	153	9	to	to	ADP
aji-154	153	10	lanolin	lanolin	PROPN
aji-154	153	11	were	be	AUX
aji-154	153	12	published	publish	VERB
aji-154	153	13	worldwide	worldwide	ADV
aji-154	153	14	[	[	X
aji-154	153	15	13	13	NUM
aji-154	153	16	-	-	SYM
aji-154	153	17	15	15	NUM
aji-154	153	18	]	]	PUNCT
aji-154	153	19	.	.	PUNCT
aji-154	154	1	the	the	DET
aji-154	154	2	1950s	1950s	NUM
aji-154	154	3	saw	see	VERB
aji-154	154	4	the	the	DET
aji-154	154	5	beginning	beginning	NOUN
aji-154	154	6	of	of	ADP
aji-154	154	7	studies	study	NOUN
aji-154	154	8	on	on	ADP
aji-154	154	9	the	the	DET
aji-154	154	10	allergenic	allergenic	ADJ
aji-154	154	11	components	component	NOUN
aji-154	154	12	of	of	ADP
aji-154	154	13	lanolin	lanolin	NOUN
aji-154	154	14	,	,	PUNCT
aji-154	154	15	as	as	ADV
aji-154	154	16	well	well	ADV
aji-154	154	17	as	as	ADP
aji-154	154	18	on	on	ADP
aji-154	154	19	the	the	DET
aji-154	154	20	differences	difference	NOUN
aji-154	154	21	in	in	ADP
aji-154	154	22	immunoreactivity	immunoreactivity	NOUN
aji-154	154	23	between	between	ADP
aji-154	154	24	the	the	DET
aji-154	154	25	different	different	ADJ
aji-154	154	26	versions	version	NOUN
aji-154	154	27	,	,	PUNCT
aji-154	154	28	demonstrating	demonstrating	NOUN
aji-154	154	29	,	,	PUNCT
aji-154	154	30	through	through	ADP
aji-154	154	31	patch	patch	NOUN
aji-154	154	32	tests	test	NOUN
aji-154	154	33	,	,	PUNCT
aji-154	154	34	that	that	SCONJ
aji-154	154	35	the	the	DET
aji-154	154	36	main	main	ADJ
aji-154	154	37	allergenic	allergenic	ADJ
aji-154	154	38	components	component	NOUN
aji-154	154	39	could	could	AUX
aji-154	154	40	be	be	AUX
aji-154	154	41	into	into	ADP
aji-154	154	42	the	the	DET
aji-154	154	43	hydroalcoholic	hydroalcoholic	NOUN
aji-154	154	44	or	or	CCONJ
aji-154	154	45	the	the	DET
aji-154	154	46	fatty	fatty	NOUN
aji-154	154	47	lanolin	lanolin	NOUN
aji-154	154	48	components	component	NOUN
aji-154	155	1	[	[	X
aji-154	155	2	16,17	16,17	NUM
aji-154	155	3	]	]	PUNCT
aji-154	155	4	.	.	PUNCT
aji-154	156	1	allergy	allergy	PROPN
aji-154	156	2	to	to	ADP
aji-154	156	3	lanolin	lanolin	PROPN
aji-154	156	4	is	be	AUX
aji-154	156	5	more	more	ADV
aji-154	156	6	common	common	ADJ
aji-154	156	7	in	in	ADP
aji-154	156	8	children	child	NOUN
aji-154	156	9	(	(	PUNCT
aji-154	156	10	4.5	4.5	NUM
aji-154	156	11	%	%	NOUN
aji-154	156	12	)	)	PUNCT
aji-154	156	13	than	than	ADP
aji-154	156	14	in	in	ADP
aji-154	156	15	adults	adult	NOUN
aji-154	156	16	(	(	PUNCT
aji-154	156	17	3.2	3.2	NUM
aji-154	156	18	%	%	NOUN
aji-154	156	19	)	)	PUNCT
aji-154	156	20	and	and	CCONJ
aji-154	156	21	patients	patient	NOUN
aji-154	156	22	with	with	ADP
aji-154	156	23	a	a	DET
aji-154	156	24	previous	previous	ADJ
aji-154	156	25	history	history	NOUN
aji-154	156	26	of	of	ADP
aji-154	156	27	eczema	eczema	NOUN
aji-154	156	28	and	and	CCONJ
aji-154	156	29	hay	hay	NOUN
aji-154	156	30	fever	fever	NOUN
aji-154	156	31	[	[	X
aji-154	156	32	18	18	NUM
aji-154	156	33	]	]	PUNCT
aji-154	156	34	.	.	PUNCT
aji-154	157	1	although	although	SCONJ
aji-154	157	2	lanolin	lanolin	PROPN
aji-154	157	3	is	be	AUX
aji-154	157	4	considered	consider	VERB
aji-154	157	5	a	a	DET
aji-154	157	6	weak	weak	ADJ
aji-154	157	7	sensitizer	sensitizer	NOUN
aji-154	157	8	over	over	ADP
aji-154	157	9	undamaged	undamaged	ADJ
aji-154	157	10	skin	skin	NOUN
aji-154	157	11	,	,	PUNCT
aji-154	157	12	there	there	PRON
aji-154	157	13	is	be	VERB
aji-154	157	14	a	a	DET
aji-154	157	15	higher	high	ADJ
aji-154	157	16	risk	risk	NOUN
aji-154	157	17	of	of	ADP
aji-154	157	18	sensitization	sensitization	NOUN
aji-154	157	19	when	when	SCONJ
aji-154	157	20	applied	apply	VERB
aji-154	157	21	over	over	ADP
aji-154	157	22	skin	skin	NOUN
aji-154	157	23	-	-	PUNCT
aji-154	157	24	damaged	damage	VERB
aji-154	157	25	conditions	condition	NOUN
aji-154	157	26	such	such	ADJ
aji-154	157	27	as	as	ADP
aji-154	157	28	contact	contact	NOUN
aji-154	157	29	dermatitis	dermatitis	NOUN
aji-154	157	30	,	,	PUNCT
aji-154	157	31	atopic	atopic	NOUN
aji-154	157	32	dermatitis	dermatitis	NOUN
aji-154	157	33	,	,	PUNCT
aji-154	157	34	psoriasis	psoriasis	NOUN
aji-154	157	35	,	,	PUNCT
aji-154	157	36	dermatitis	dermatitis	NOUN
aji-154	157	37	herpetiformis	herpetiformis	ADV
aji-154	157	38	,	,	PUNCT
aji-154	157	39	seborrheic	seborrheic	PROPN
aji-154	157	40	dermatitis	dermatitis	NOUN
aji-154	157	41	,	,	PUNCT
aji-154	157	42	stasis	stasis	NOUN
aji-154	157	43	dermatitis	dermatitis	NOUN
aji-154	157	44	,	,	PUNCT
aji-154	157	45	leg	leg	NOUN
aji-154	157	46	ulcers	ulcer	NOUN
aji-154	157	47	,	,	PUNCT
aji-154	157	48	perineal	perineal	ADJ
aji-154	157	49	dermatitis	dermatitis	NOUN
aji-154	157	50	,	,	PUNCT
aji-154	157	51	and	and	CCONJ
aji-154	157	52	so	so	ADV
aji-154	157	53	forth	forth	ADV
aji-154	157	54	[	[	X
aji-154	157	55	19	19	NUM
aji-154	157	56	]	]	PUNCT
aji-154	157	57	.	.	PUNCT
aji-154	158	1	in	in	ADP
aji-154	158	2	the	the	DET
aji-154	158	3	eighties	eighty	NOUN
aji-154	158	4	,	,	PUNCT
aji-154	158	5	the	the	DET
aji-154	158	6	widespread	widespread	ADJ
aji-154	158	7	use	use	NOUN
aji-154	158	8	of	of	ADP
aji-154	158	9	this	this	DET
aji-154	158	10	moisturizer	moisturizer	NOUN
aji-154	158	11	exposed	expose	VERB
aji-154	158	12	a	a	DET
aji-154	158	13	lanolin	lanolin	NOUN
aji-154	158	14	allergic	allergic	ADJ
aji-154	158	15	"	"	PUNCT
aji-154	158	16	crisis	crisis	NOUN
aji-154	158	17	"	"	PUNCT
aji-154	158	18	,	,	PUNCT
aji-154	158	19	which	which	PRON
aji-154	158	20	was	be	AUX
aji-154	158	21	also	also	ADV
aji-154	158	22	described	describe	VERB
aji-154	158	23	as	as	ADP
aji-154	158	24	a	a	DET
aji-154	158	25	"	"	PUNCT
aji-154	158	26	myth	myth	NOUN
aji-154	158	27	"	"	PUNCT
aji-154	158	28	,	,	PUNCT
aji-154	158	29	and	and	CCONJ
aji-154	158	30	a	a	DET
aji-154	158	31	"	"	PUNCT
aji-154	158	32	comedy	comedy	NOUN
aji-154	158	33	"	"	PUNCT
aji-154	158	34	,	,	PUNCT
aji-154	158	35	when	when	SCONJ
aji-154	158	36	several	several	ADJ
aji-154	158	37	pharmaceutical	pharmaceutical	ADJ
aji-154	158	38	ointments	ointment	NOUN
aji-154	158	39	began	begin	VERB
aji-154	158	40	to	to	PART
aji-154	158	41	declare	declare	VERB
aji-154	158	42	on	on	ADP
aji-154	158	43	their	their	PRON
aji-154	158	44	packages	package	NOUN
aji-154	158	45	to	to	PART
aji-154	158	46	be	be	AUX
aji-154	158	47	"	"	PUNCT
aji-154	158	48	lanolin	lanolin	X
aji-154	158	49	free	free	ADJ
aji-154	158	50	"	"	PUNCT
aji-154	158	51	[	[	X
aji-154	158	52	20	20	NUM
aji-154	158	53	,	,	PUNCT
aji-154	158	54	21	21	NUM
aji-154	158	55	]	]	PUNCT
aji-154	158	56	.	.	PUNCT
aji-154	159	1	the	the	DET
aji-154	159	2	presence	presence	NOUN
aji-154	159	3	of	of	ADP
aji-154	159	4	lanolin	lanolin	PROPN
aji-154	159	5	is	be	AUX
aji-154	159	6	unanimous	unanimous	ADJ
aji-154	159	7	among	among	ADP
aji-154	159	8	the	the	DET
aji-154	159	9	diverse	diverse	ADJ
aji-154	159	10	batteries	battery	NOUN
aji-154	159	11	historically	historically	ADV
aji-154	159	12	recommended	recommend	VERB
aji-154	159	13	for	for	ADP
aji-154	159	14	making	make	VERB
aji-154	159	15	diagnostic	diagnostic	ADJ
aji-154	159	16	contact	contact	NOUN
aji-154	159	17	test	test	NOUN
aji-154	159	18	kits	kit	NOUN
aji-154	159	19	(	(	PUNCT
aji-154	159	20	patch	patch	NOUN
aji-154	159	21	tests	test	NOUN
aji-154	159	22	)	)	PUNCT
aji-154	160	1	[	[	X
aji-154	160	2	22	22	NUM
aji-154	160	3	]	]	PUNCT
aji-154	160	4	.	.	PUNCT
aji-154	161	1	the	the	DET
aji-154	161	2	biggest	big	ADJ
aji-154	161	3	obstacle	obstacle	NOUN
aji-154	161	4	to	to	ADP
aji-154	161	5	diagnosing	diagnose	VERB
aji-154	161	6	hypersensitivity	hypersensitivity	NOUN
aji-154	161	7	to	to	ADP
aji-154	161	8	lanolin	lanolin	PROPN
aji-154	161	9	is	be	AUX
aji-154	161	10	its	its	PRON
aji-154	161	11	multiple	multiple	ADJ
aji-154	161	12	varieties	variety	NOUN
aji-154	161	13	,	,	PUNCT
aji-154	161	14	components	component	NOUN
aji-154	161	15	,	,	PUNCT
aji-154	161	16	allergens	allergen	NOUN
aji-154	161	17	,	,	PUNCT
aji-154	161	18	versions	version	NOUN
aji-154	161	19	,	,	PUNCT
aji-154	161	20	contaminants	contaminant	NOUN
aji-154	161	21	,	,	PUNCT
aji-154	161	22	and	and	CCONJ
aji-154	161	23	additives	additive	NOUN
aji-154	161	24	,	,	PUNCT
aji-154	161	25	such	such	ADJ
aji-154	161	26	as	as	ADP
aji-154	161	27	preservatives	preservative	NOUN
aji-154	161	28	and	and	CCONJ
aji-154	161	29	antioxidants	antioxidant	NOUN
aji-154	161	30	[	[	X
aji-154	161	31	14	14	NUM
aji-154	161	32	]	]	PUNCT
aji-154	161	33	.	.	PUNCT
aji-154	162	1	the	the	DET
aji-154	162	2	standard	standard	ADJ
aji-154	162	3	patch	patch	ADJ
aji-154	162	4	test	test	NOUN
aji-154	162	5	agent	agent	NOUN
aji-154	162	6	for	for	ADP
aji-154	162	7	diagnosing	diagnose	VERB
aji-154	162	8	lanolin	lanolin	PROPN
aji-154	162	9	contact	contact	NOUN
aji-154	162	10	allergy	allergy	NOUN
aji-154	162	11	is	be	AUX
aji-154	162	12	lanolin	lanolin	PROPN
aji-154	162	13	alcohol	alcohol	NOUN
aji-154	162	14	30	30	NUM
aji-154	162	15	%	%	NOUN
aji-154	162	16	in	in	ADP
aji-154	162	17	petrolatum	petrolatum	NOUN
aji-154	162	18	[	[	X
aji-154	162	19	23	23	NUM
aji-154	162	20	,	,	PUNCT
aji-154	162	21	24	24	NUM
aji-154	162	22	]	]	PUNCT
aji-154	162	23	.	.	PUNCT
aji-154	163	1	however	however	ADV
aji-154	163	2	,	,	PUNCT
aji-154	163	3	this	this	DET
aji-154	163	4	method	method	NOUN
aji-154	163	5	alone	alone	ADV
aji-154	163	6	has	have	VERB
aji-154	163	7	a	a	DET
aji-154	163	8	very	very	ADV
aji-154	163	9	low	low	ADJ
aji-154	163	10	sensitivity	sensitivity	NOUN
aji-154	163	11	to	to	ADP
aji-154	163	12	diagnosis	diagnosis	NOUN
aji-154	163	13	of	of	ADP
aji-154	163	14	lanolin	lanolin	PROPN
aji-154	163	15	hypersensitivity	hypersensitivity	NOUN
aji-154	163	16	,	,	PUNCT
aji-154	163	17	a	a	DET
aji-154	163	18	fact	fact	NOUN
aji-154	163	19	that	that	PRON
aji-154	163	20	had	have	AUX
aji-154	163	21	been	be	AUX
aji-154	163	22	contributing	contribute	VERB
aji-154	163	23	to	to	ADP
aji-154	163	24	the	the	DET
aji-154	163	25	"	"	PUNCT
aji-154	163	26	lanolin	lanolin	NOUN
aji-154	163	27	paradox	paradox	NOUN
aji-154	163	28	"	"	PUNCT
aji-154	163	29	,	,	PUNCT
aji-154	163	30	leading	lead	VERB
aji-154	163	31	the	the	DET
aji-154	163	32	physicians	physician	NOUN
aji-154	163	33	to	to	PART
aji-154	163	34	use	use	VERB
aji-154	163	35	for	for	ADP
aji-154	163	36	tests	test	NOUN
aji-154	163	37	the	the	DET
aji-154	163	38	suspected	suspect	VERB
aji-154	163	39	materials	material	NOUN
aji-154	163	40	brought	bring	VERB
aji-154	163	41	in	in	ADP
aji-154	163	42	by	by	ADP
aji-154	163	43	the	the	DET
aji-154	163	44	patients	patient	NOUN
aji-154	163	45	[	[	X
aji-154	163	46	25	25	NUM
aji-154	163	47	]	]	PUNCT
aji-154	163	48	.	.	PUNCT
aji-154	164	1	several	several	ADJ
aji-154	164	2	papers	paper	NOUN
aji-154	164	3	report	report	VERB
aji-154	164	4	discrepancies	discrepancy	NOUN
aji-154	164	5	among	among	ADP
aji-154	164	6	cutaneous	cutaneous	ADJ
aji-154	164	7	tests	test	NOUN
aji-154	164	8	performed	perform	VERB
aji-154	164	9	with	with	ADP
aji-154	164	10	lanolin	lanolin	NOUN
aji-154	164	11	derivatives	derivative	NOUN
aji-154	164	12	such	such	ADJ
aji-154	164	13	as	as	ADP
aji-154	164	14	lanolin	lanolin	NOUN
aji-154	164	15	alcohols	alcohol	NOUN
aji-154	164	16	and	and	CCONJ
aji-154	164	17	amerchol	amerchol	NOUN
aji-154	164	18	l101	l101	PROPN
aji-154	164	19	(	(	PUNCT
aji-154	164	20	a	a	DET
aji-154	164	21	mixture	mixture	NOUN
aji-154	164	22	of	of	ADP
aji-154	164	23	10	10	NUM
aji-154	164	24	%	%	NOUN
aji-154	164	25	lanolin	lanolin	NOUN
aji-154	164	26	alcohols	alcohol	NOUN
aji-154	164	27	and	and	CCONJ
aji-154	164	28	mineral	mineral	NOUN
aji-154	164	29	oil	oil	NOUN
aji-154	164	30	)	)	PUNCT
aji-154	165	1	[	[	X
aji-154	165	2	26	26	NUM
aji-154	165	3	,	,	PUNCT
aji-154	165	4	27	27	NUM
aji-154	165	5	]	]	PUNCT
aji-154	165	6	.	.	PUNCT
aji-154	166	1	atopic	atopic	NOUN
aji-154	166	2	dermatitis	dermatitis	PROPN
aji-154	166	3	and	and	CCONJ
aji-154	166	4	contact	contact	NOUN
aji-154	166	5	dermatitis	dermatitis	NOUN
aji-154	166	6	are	be	AUX
aji-154	166	7	interrelated	interrelated	ADJ
aji-154	166	8	phenotypes	phenotype	NOUN
aji-154	166	9	with	with	ADP
aji-154	166	10	several	several	ADJ
aji-154	166	11	associated	associated	ADJ
aji-154	166	12	endotypes	endotype	NOUN
aji-154	166	13	[	[	X
aji-154	166	14	28	28	NUM
aji-154	166	15	]	]	PUNCT
aji-154	166	16	.	.	PUNCT
aji-154	167	1	while	while	SCONJ
aji-154	167	2	the	the	DET
aji-154	167	3	atopic	atopic	NOUN
aji-154	167	4	dermatitis	dermatitis	NOUN
aji-154	167	5	phenotypes	phenotype	NOUN
aji-154	167	6	usually	usually	ADV
aji-154	167	7	develop	develop	VERB
aji-154	167	8	in	in	ADP
aji-154	167	9	patients	patient	NOUN
aji-154	167	10	presenting	present	VERB
aji-154	167	11	hypersensitivity	hypersensitivity	NOUN
aji-154	167	12	to	to	PART
aji-154	167	13	food	food	NOUN
aji-154	167	14	allergens	allergen	NOUN
aji-154	167	15	or	or	CCONJ
aji-154	167	16	house	house	NOUN
aji-154	167	17	dust	dust	NOUN
aji-154	167	18	mites	mite	NOUN
aji-154	167	19	,	,	PUNCT
aji-154	167	20	the	the	DET
aji-154	167	21	typical	typical	ADJ
aji-154	167	22	contact	contact	NOUN
aji-154	167	23	dermatitis	dermatitis	NOUN
aji-154	167	24	phenotype	phenotype	NOUN
aji-154	167	25	develops	develop	VERB
aji-154	167	26	in	in	ADP
aji-154	167	27	patients	patient	NOUN
aji-154	167	28	presenting	present	VERB
aji-154	167	29	hypersensitivity	hypersensitivity	NOUN
aji-154	167	30	to	to	ADP
aji-154	167	31	organic	organic	ADJ
aji-154	167	32	and	and	CCONJ
aji-154	167	33	inorganic	inorganic	ADJ
aji-154	167	34	contactants	contactant	NOUN
aji-154	167	35	[	[	X
aji-154	167	36	29	29	NUM
aji-154	167	37	]	]	PUNCT
aji-154	167	38	.	.	PUNCT
aji-154	168	1	some	some	DET
aji-154	168	2	patients	patient	NOUN
aji-154	168	3	presenting	present	VERB
aji-154	168	4	predominantly	predominantly	ADV
aji-154	168	5	the	the	DET
aji-154	168	6	atopic	atopic	NOUN
aji-154	168	7	dermatitis	dermatitis	NOUN
aji-154	168	8	phenotypes	phenotype	NOUN
aji-154	168	9	may	may	AUX
aji-154	168	10	also	also	ADV
aji-154	168	11	present	present	VERB
aji-154	168	12	less	less	ADV
aji-154	168	13	evident	evident	ADJ
aji-154	168	14	contact	contact	NOUN
aji-154	168	15	dermatitis	dermatitis	NOUN
aji-154	168	16	phenotypes	phenotype	NOUN
aji-154	168	17	and	and	CCONJ
aji-154	168	18	vice	vice	NOUN
aji-154	168	19	versa	versa	NOUN
aji-154	169	1	[	[	X
aji-154	169	2	30	30	NUM
aji-154	169	3	]	]	PUNCT
aji-154	169	4	.	.	PUNCT
aji-154	170	1	there	there	PRON
aji-154	170	2	is	be	VERB
aji-154	170	3	not	not	PART
aji-154	170	4	yet	yet	ADV
aji-154	170	5	a	a	DET
aji-154	170	6	satisfactory	satisfactory	ADJ
aji-154	170	7	laboratory	laboratory	NOUN
aji-154	170	8	exam	exam	NOUN
aji-154	170	9	to	to	PART
aji-154	170	10	diagnose	diagnose	VERB
aji-154	170	11	the	the	DET
aji-154	170	12	non	non	ADJ
aji-154	170	13	-	-	ADJ
aji-154	170	14	ige	ige	ADJ
aji-154	170	15	-	-	PUNCT
aji-154	170	16	mediated	mediate	VERB
aji-154	170	17	atopic	atopic	NOUN
aji-154	170	18	dermatitis	dermatitis	NOUN
aji-154	170	19	or	or	CCONJ
aji-154	170	20	contact	contact	NOUN
aji-154	170	21	dermatitis	dermatitis	NOUN
aji-154	170	22	endotypes	endotype	NOUN
aji-154	170	23	.	.	PUNCT
aji-154	171	1	several	several	ADJ
aji-154	171	2	trial	trial	NOUN
aji-154	171	3	evaluations	evaluation	NOUN
aji-154	171	4	were	be	AUX
aji-154	171	5	conducted	conduct	VERB
aji-154	171	6	on	on	ADP
aji-154	171	7	the	the	DET
aji-154	171	8	relationship	relationship	NOUN
aji-154	171	9	between	between	ADP
aji-154	171	10	leukocytes	leukocyte	NOUN
aji-154	171	11	and	and	CCONJ
aji-154	171	12	allergy	allergy	NOUN
aji-154	171	13	tests	test	NOUN
aji-154	171	14	.	.	PUNCT
aji-154	172	1	however	however	ADV
aji-154	172	2	,	,	PUNCT
aji-154	172	3	the	the	DET
aji-154	172	4	results	result	NOUN
aji-154	172	5	did	do	AUX
aji-154	172	6	not	not	PART
aji-154	172	7	significantly	significantly	ADV
aji-154	172	8	yield	yield	VERB
aji-154	172	9	definitive	definitive	ADJ
aji-154	172	10	conclusions	conclusion	NOUN
aji-154	172	11	[	[	X
aji-154	172	12	31	31	NUM
aji-154	172	13	]	]	PUNCT
aji-154	172	14	.	.	PUNCT
aji-154	173	1	the	the	DET
aji-154	173	2	better	well	ADJ
aji-154	173	3	way	way	NOUN
aji-154	173	4	to	to	PART
aji-154	173	5	diagnose	diagnose	VERB
aji-154	173	6	lanolin	lanolin	NOUN
aji-154	173	7	hypersensitivity	hypersensitivity	NOUN
aji-154	173	8	is	be	AUX
aji-154	173	9	the	the	DET
aji-154	173	10	exclusion	exclusion	NOUN
aji-154	173	11	/	/	SYM
aji-154	173	12	provocation	provocation	NOUN
aji-154	173	13	test	test	NOUN
aji-154	173	14	when	when	SCONJ
aji-154	173	15	the	the	DET
aji-154	173	16	patient	patient	NOUN
aji-154	173	17	excludes	exclude	VERB
aji-154	173	18	the	the	DET
aji-154	173	19	use	use	NOUN
aji-154	173	20	of	of	ADP
aji-154	173	21	the	the	DET
aji-154	173	22	suspected	suspect	VERB
aji-154	173	23	allergen(s	allergen(s	NOUN
aji-154	173	24	)	)	PUNCT
aji-154	173	25	until	until	SCONJ
aji-154	173	26	the	the	DET
aji-154	173	27	symptoms	symptom	NOUN
aji-154	173	28	disappear	disappear	VERB
aji-154	173	29	,	,	PUNCT
aji-154	173	30	and	and	CCONJ
aji-154	173	31	then	then	ADV
aji-154	173	32	the	the	DET
aji-154	173	33	allergen	allergen	NOUN
aji-154	173	34	is	be	AUX
aji-154	173	35	re	re	VERB
aji-154	173	36	-	-	VERB
aji-154	173	37	introduced	introduce	VERB
aji-154	173	38	to	to	PART
aji-154	173	39	observe	observe	VERB
aji-154	173	40	reactions	reaction	NOUN
aji-154	173	41	.	.	PUNCT
aji-154	174	1	however	however	ADV
aji-154	174	2	,	,	PUNCT
aji-154	174	3	this	this	PRON
aji-154	174	4	is	be	AUX
aji-154	174	5	particularly	particularly	ADV
aji-154	174	6	difficult	difficult	ADJ
aji-154	174	7	when	when	SCONJ
aji-154	174	8	polysensitization	polysensitization	NOUN
aji-154	174	9	dominates	dominate	VERB
aji-154	174	10	the	the	DET
aji-154	174	11	clinical	clinical	ADJ
aji-154	174	12	picture	picture	NOUN
aji-154	174	13	.	.	PUNCT
aji-154	175	1	in	in	ADP
aji-154	175	2	order	order	NOUN
aji-154	175	3	to	to	PART
aji-154	175	4	shorter	shorter	VERB
aji-154	175	5	the	the	DET
aji-154	175	6	list	list	NOUN
aji-154	175	7	of	of	ADP
aji-154	175	8	suspected	suspect	VERB
aji-154	175	9	allergens	allergen	NOUN
aji-154	175	10	,	,	PUNCT
aji-154	175	11	we	we	PRON
aji-154	175	12	performed	perform	VERB
aji-154	175	13	in	in	ADP
aji-154	175	14	our	our	PRON
aji-154	175	15	facilities	facility	NOUN
aji-154	175	16	the	the	DET
aji-154	175	17	leukocyte	leukocyte	NOUN
aji-154	175	18	adherence	adherence	NOUN
aji-154	175	19	inhibition	inhibition	NOUN
aji-154	175	20	test	test	NOUN
aji-154	175	21	(	(	PUNCT
aji-154	175	22	lait	lait	NOUN
aji-154	175	23	)	)	PUNCT
aji-154	175	24	and	and	CCONJ
aji-154	175	25	the	the	DET
aji-154	175	26	tube	tube	NOUN
aji-154	175	27	titration	titration	NOUN
aji-154	175	28	of	of	ADP
aji-154	175	29	precipitins	precipitin	NOUN
aji-154	175	30	(	(	PUNCT
aji-154	175	31	ttp	ttp	NOUN
aji-154	175	32	)	)	PUNCT
aji-154	175	33	as	as	ADP
aji-154	175	34	triage	triage	NOUN
aji-154	175	35	tests	test	NOUN
aji-154	175	36	to	to	PART
aji-154	175	37	elect	elect	VERB
aji-154	175	38	the	the	DET
aji-154	175	39	allergens	allergen	NOUN
aji-154	175	40	that	that	PRON
aji-154	175	41	will	will	AUX
aji-154	175	42	be	be	AUX
aji-154	175	43	emphasized	emphasize	VERB
aji-154	175	44	in	in	ADP
aji-154	175	45	the	the	DET
aji-154	175	46	exhaustive	exhaustive	ADJ
aji-154	175	47	in	in	ADP
aji-154	175	48	vivo	vivo	ADJ
aji-154	175	49	exclusion	exclusion	NOUN
aji-154	175	50	/	/	SYM
aji-154	175	51	provocation	provocation	NOUN
aji-154	175	52	tests	test	NOUN
aji-154	175	53	[	[	X
aji-154	175	54	32	32	NUM
aji-154	175	55	-	-	SYM
aji-154	175	56	37	37	NUM
aji-154	175	57	]	]	PUNCT
aji-154	175	58	.	.	PUNCT
aji-154	176	1	the	the	DET
aji-154	176	2	present	present	ADJ
aji-154	176	3	study	study	NOUN
aji-154	176	4	hypothesizes	hypothesize	VERB
aji-154	176	5	that	that	SCONJ
aji-154	176	6	the	the	DET
aji-154	176	7	lait	lait	NOUN
aji-154	176	8	and	and	CCONJ
aji-154	176	9	the	the	DET
aji-154	176	10	ttp	ttp	NOUN
aji-154	176	11	may	may	AUX
aji-154	176	12	help	help	VERB
aji-154	176	13	differentiate	differentiate	VERB
aji-154	176	14	diverse	diverse	ADJ
aji-154	176	15	endotypes	endotype	NOUN
aji-154	176	16	and	and	CCONJ
aji-154	176	17	degrees	degree	NOUN
aji-154	176	18	of	of	ADP
aji-154	176	19	immunoreactivity	immunoreactivity	NOUN
aji-154	176	20	against	against	ADP
aji-154	176	21	lanolin	lanolin	NOUN
aji-154	176	22	among	among	ADP
aji-154	176	23	patients	patient	NOUN
aji-154	176	24	suffering	suffer	VERB
aji-154	176	25	from	from	ADP
aji-154	176	26	atopic	atopic	NOUN
aji-154	176	27	dermatitis	dermatitis	NOUN
aji-154	176	28	and/or	and/or	CCONJ
aji-154	176	29	contact	contact	NOUN
aji-154	176	30	dermatitis	dermatitis	NOUN
aji-154	176	31	.	.	PUNCT
aji-154	177	1	to	to	PART
aji-154	177	2	evaluate	evaluate	VERB
aji-154	177	3	the	the	DET
aji-154	177	4	potential	potential	NOUN
aji-154	177	5	of	of	ADP
aji-154	177	6	the	the	DET
aji-154	177	7	lait	lait	NOUN
aji-154	177	8	and	and	CCONJ
aji-154	177	9	the	the	DET
aji-154	177	10	ttp	ttp	NOUN
aji-154	177	11	to	to	ADP
aji-154	177	12	endotyping	endotype	VERB
aji-154	177	13	non	non	ADJ
aji-154	177	14	–	–	PUNCT
aji-154	177	15	ige	ige	ADJ
aji-154	177	16	-	-	PUNCT
aji-154	177	17	mediated	mediate	VERB
aji-154	177	18	immunoreactivity	immunoreactivity	NOUN
aji-154	177	19	against	against	ADP
aji-154	177	20	lanolin	lanolin	NOUN
aji-154	177	21	,	,	PUNCT
aji-154	177	22	we	we	PRON
aji-154	177	23	retrospectively	retrospectively	ADV
aji-154	177	24	compiled	compile	VERB
aji-154	177	25	the	the	DET
aji-154	177	26	electronic	electronic	ADJ
aji-154	177	27	medical	medical	ADJ
aji-154	177	28	charts	chart	NOUN
aji-154	177	29	of	of	ADP
aji-154	177	30	patients	patient	NOUN
aji-154	177	31	with	with	ADP
aji-154	177	32	these	these	DET
aji-154	177	33	conditions	condition	NOUN
aji-154	177	34	who	who	PRON
aji-154	177	35	were	be	AUX
aji-154	177	36	investigated	investigate	VERB
aji-154	177	37	with	with	ADP
aji-154	177	38	these	these	DET
aji-154	177	39	procedures	procedure	NOUN
aji-154	177	40	.	.	PUNCT
aji-154	178	1	2	2	X
aji-154	178	2	.	.	X
aji-154	178	3	materials	material	NOUN
aji-154	178	4	and	and	CCONJ
aji-154	178	5	methods	method	NOUN
aji-154	178	6	2.1	2.1	NUM
aji-154	178	7	subjects	subject	NOUN
aji-154	178	8	after	after	ADP
aji-154	178	9	receiving	receive	VERB
aji-154	178	10	institutional	institutional	ADJ
aji-154	178	11	review	review	NOUN
aji-154	178	12	board	board	NOUN
aji-154	178	13	approval	approval	NOUN
aji-154	178	14	from	from	ADP
aji-154	178	15	the	the	DET
aji-154	178	16	instituto	instituto	PROPN
aji-154	178	17	alergoimuno	alergoimuno	PROPN
aji-154	178	18	de	de	PROPN
aji-154	178	19	olivier	olivier	X
aji-154	178	20	et	et	PROPN
aji-154	178	21	al	al	PROPN
aji-154	178	22	.	.	PROPN
aji-154	178	23	;	;	PUNCT
aji-154	178	24	asian	asian	PROPN
aji-154	178	25	j.	j.	PROPN
aji-154	178	26	immunol	immunol	PROPN
aji-154	178	27	.	.	PROPN
aji-154	178	28	,	,	PUNCT
aji-154	178	29	vol	vol	NOUN
aji-154	178	30	.	.	PROPN
aji-154	178	31	7	7	NUM
aji-154	178	32	,	,	PUNCT
aji-154	178	33	no	no	INTJ
aji-154	178	34	.	.	NOUN
aji-154	178	35	1	1	NUM
aji-154	178	36	,	,	PUNCT
aji-154	178	37	pp	pp	ADJ
aji-154	178	38	.	.	PUNCT
aji-154	179	1	316	316	NUM
aji-154	179	2	-	-	SYM
aji-154	179	3	325	325	NUM
aji-154	179	4	,	,	PUNCT
aji-154	179	5	2024	2024	NUM
aji-154	179	6	;	;	PUNCT
aji-154	179	7	article	article	NOUN
aji-154	179	8	no.aji.128121	no.aji.128121	VERB
aji-154	179	9	319	319	NUM
aji-154	179	10	americana	americana	NOUN
aji-154	179	11	(	(	PUNCT
aji-154	179	12	brazil	brazil	PROPN
aji-154	179	13	;	;	PUNCT
aji-154	179	14	10/2024	10/2024	NUM
aji-154	179	15	)	)	PUNCT
aji-154	179	16	,	,	PUNCT
aji-154	179	17	we	we	PRON
aji-154	179	18	proceeded	proceed	VERB
aji-154	179	19	with	with	ADP
aji-154	179	20	the	the	DET
aji-154	179	21	electronic	electronic	ADJ
aji-154	179	22	chart	chart	NOUN
aji-154	179	23	review	review	NOUN
aji-154	179	24	of	of	ADP
aji-154	179	25	9,700	9,700	NUM
aji-154	179	26	outpatients	outpatient	NOUN
aji-154	179	27	who	who	PRON
aji-154	179	28	attended	attend	VERB
aji-154	179	29	our	our	PRON
aji-154	179	30	facility	facility	NOUN
aji-154	179	31	from	from	ADP
aji-154	179	32	january	january	PROPN
aji-154	179	33	2018	2018	NUM
aji-154	179	34	to	to	ADP
aji-154	179	35	november	november	PROPN
aji-154	179	36	2024	2024	NUM
aji-154	179	37	.	.	PUNCT
aji-154	180	1	a	a	DET
aji-154	180	2	cohort	cohort	NOUN
aji-154	180	3	of	of	ADP
aji-154	180	4	100	100	NUM
aji-154	180	5	outside	outside	ADJ
aji-154	180	6	patients	patient	NOUN
aji-154	180	7	had	have	AUX
aji-154	180	8	been	be	AUX
aji-154	180	9	submitted	submit	VERB
aji-154	180	10	to	to	ADP
aji-154	180	11	ttp	ttp	PROPN
aji-154	180	12	with	with	ADP
aji-154	180	13	lanolin	lanolin	NOUN
aji-154	180	14	solution	solution	NOUN
aji-154	180	15	for	for	ADP
aji-154	180	16	presenting	present	VERB
aji-154	180	17	non	non	ADJ
aji-154	180	18	–	–	PUNCT
aji-154	180	19	ige	ige	ADJ
aji-154	180	20	-	-	PUNCT
aji-154	180	21	mediated	mediate	VERB
aji-154	180	22	atopic	atopic	NOUN
aji-154	180	23	dermatitis	dermatitis	NOUN
aji-154	180	24	and/or	and/or	CCONJ
aji-154	180	25	contact	contact	NOUN
aji-154	180	26	dermatitis	dermatitis	NOUN
aji-154	180	27	.	.	PUNCT
aji-154	181	1	this	this	DET
aji-154	181	2	cohort	cohort	NOUN
aji-154	181	3	counted	count	VERB
aji-154	181	4	23	23	NUM
aji-154	181	5	males	male	NOUN
aji-154	181	6	;	;	PUNCT
aji-154	181	7	mean	mean	VERB
aji-154	181	8	age	age	NOUN
aji-154	181	9	38.9	38.9	NUM
aji-154	181	10	years	year	NOUN
aji-154	181	11	;	;	PUNCT
aji-154	181	12	sd	sd	NOUN
aji-154	181	13	19.9	19.9	NUM
aji-154	181	14	years	year	NOUN
aji-154	181	15	;	;	PUNCT
aji-154	181	16	range	range	VERB
aji-154	181	17	7	7	NUM
aji-154	181	18	to	to	PART
aji-154	181	19	91	91	NUM
aji-154	181	20	years	year	NOUN
aji-154	181	21	;	;	PUNCT
aji-154	181	22	median	median	NOUN
aji-154	181	23	37.5	37.5	NUM
aji-154	181	24	years	year	NOUN
aji-154	181	25	;	;	PUNCT
aji-154	181	26	modes	mode	NOUN
aji-154	181	27	:	:	PUNCT
aji-154	181	28	16	16	NUM
aji-154	181	29	;	;	PUNCT
aji-154	181	30	23	23	NUM
aji-154	181	31	;	;	PUNCT
aji-154	181	32	37	37	NUM
aji-154	181	33	;	;	PUNCT
aji-154	181	34	and	and	CCONJ
aji-154	181	35	70	70	NUM
aji-154	181	36	years	year	NOUN
aji-154	181	37	(	(	PUNCT
aji-154	181	38	each	each	PRON
aji-154	181	39	appeared	appear	VERB
aji-154	181	40	4	4	NUM
aji-154	181	41	times	time	NOUN
aji-154	181	42	)	)	PUNCT
aji-154	181	43	;	;	PUNCT
aji-154	181	44	geometric	geometric	ADJ
aji-154	181	45	mean	mean	NOUN
aji-154	181	46	=	=	SYM
aji-154	181	47	32.8	32.8	NUM
aji-154	181	48	years	year	NOUN
aji-154	181	49	.	.	PUNCT
aji-154	182	1	a	a	DET
aji-154	182	2	cohort	cohort	NOUN
aji-154	182	3	of	of	ADP
aji-154	182	4	100	100	NUM
aji-154	182	5	outside	outside	ADJ
aji-154	182	6	patients	patient	NOUN
aji-154	182	7	had	have	AUX
aji-154	182	8	been	be	AUX
aji-154	182	9	submitted	submit	VERB
aji-154	182	10	to	to	ADP
aji-154	182	11	an	an	DET
aji-154	182	12	ex	ex	X
aji-154	182	13	vivo	vivo	NOUN
aji-154	182	14	allergen	allergen	NOUN
aji-154	182	15	challenge	challenge	NOUN
aji-154	182	16	test	test	NOUN
aji-154	182	17	with	with	ADP
aji-154	182	18	lanolin	lanolin	NOUN
aji-154	182	19	solution	solution	NOUN
aji-154	182	20	monitored	monitor	VERB
aji-154	182	21	with	with	ADP
aji-154	182	22	lait	lait	NOUN
aji-154	182	23	for	for	ADP
aji-154	182	24	presenting	present	VERB
aji-154	182	25	non	non	ADJ
aji-154	182	26	–	–	PUNCT
aji-154	182	27	ige	ige	ADJ
aji-154	182	28	-	-	PUNCT
aji-154	182	29	mediated	mediate	VERB
aji-154	182	30	atopic	atopic	NOUN
aji-154	182	31	and/or	and/or	CCONJ
aji-154	182	32	contact	contact	NOUN
aji-154	182	33	dermatitis	dermatitis	NOUN
aji-154	182	34	.	.	PUNCT
aji-154	183	1	this	this	DET
aji-154	183	2	cohort	cohort	NOUN
aji-154	183	3	counted	count	VERB
aji-154	183	4	25	25	NUM
aji-154	183	5	males	male	NOUN
aji-154	183	6	;	;	PUNCT
aji-154	183	7	mean	mean	VERB
aji-154	183	8	age	age	NOUN
aji-154	183	9	40.9	40.9	NUM
aji-154	183	10	years	year	NOUN
aji-154	183	11	;	;	PUNCT
aji-154	183	12	sd	sd	ADP
aji-154	183	13	18,5	18,5	NUM
aji-154	183	14	years	year	NOUN
aji-154	183	15	;	;	PUNCT
aji-154	183	16	range	range	NOUN
aji-154	183	17	3	3	NUM
aji-154	183	18	to	to	PART
aji-154	183	19	86	86	NUM
aji-154	183	20	years	year	NOUN
aji-154	183	21	;	;	PUNCT
aji-154	183	22	median	median	NOUN
aji-154	183	23	40.5	40.5	NUM
aji-154	183	24	years	year	NOUN
aji-154	183	25	;	;	PUNCT
aji-154	183	26	mode	mode	NOUN
aji-154	183	27	=	=	SYM
aji-154	183	28	50	50	NUM
aji-154	183	29	(	(	PUNCT
aji-154	183	30	appeared	appear	VERB
aji-154	183	31	five	five	NUM
aji-154	183	32	times	time	NOUN
aji-154	183	33	)	)	PUNCT
aji-154	183	34	;	;	PUNCT
aji-154	183	35	geometric	geometric	ADJ
aji-154	183	36	mean	mean	NOUN
aji-154	183	37	=	=	NOUN
aji-154	183	38	35.0	35.0	NUM
aji-154	183	39	years	year	NOUN
aji-154	183	40	.	.	PUNCT
aji-154	184	1	this	this	DET
aji-154	184	2	study	study	NOUN
aji-154	184	3	did	do	AUX
aji-154	184	4	not	not	PART
aji-154	184	5	include	include	VERB
aji-154	184	6	patients	patient	NOUN
aji-154	184	7	under	under	ADP
aji-154	184	8	biological	biological	ADJ
aji-154	184	9	and/or	and/or	CCONJ
aji-154	184	10	systemic	systemic	ADJ
aji-154	184	11	anti	anti	ADJ
aji-154	184	12	-	-	ADJ
aji-154	184	13	inflammatory	inflammatory	ADJ
aji-154	184	14	therapy	therapy	NOUN
aji-154	184	15	.	.	PUNCT
aji-154	185	1	these	these	DET
aji-154	185	2	procedures	procedure	NOUN
aji-154	185	3	were	be	AUX
aji-154	185	4	offered	offer	VERB
aji-154	185	5	to	to	ADP
aji-154	185	6	patients	patient	NOUN
aji-154	185	7	with	with	ADP
aji-154	185	8	clinical	clinical	ADJ
aji-154	185	9	suspicion	suspicion	NOUN
aji-154	185	10	of	of	ADP
aji-154	185	11	lanolin	lanolin	NOUN
aji-154	185	12	hypersensitivity	hypersensitivity	NOUN
aji-154	185	13	who	who	PRON
aji-154	185	14	demonstrated	demonstrate	VERB
aji-154	185	15	a	a	DET
aji-154	185	16	nonreactive	nonreactive	ADJ
aji-154	185	17	or	or	CCONJ
aji-154	185	18	inconclusive	inconclusive	ADJ
aji-154	185	19	skin	skin	NOUN
aji-154	185	20	test	test	NOUN
aji-154	185	21	against	against	ADP
aji-154	185	22	lanolin	lanolin	NOUN
aji-154	185	23	solution	solution	NOUN
aji-154	185	24	[	[	X
aji-154	185	25	38	38	NUM
aji-154	185	26	]	]	PUNCT
aji-154	185	27	.	.	PUNCT
aji-154	186	1	2.2	2.2	NUM
aji-154	186	2	lanolin	lanolin	NOUN
aji-154	186	3	solution	solution	NOUN
aji-154	186	4	in	in	ADP
aji-154	186	5	a	a	DET
aji-154	186	6	becker	becker	NOUN
aji-154	186	7	flask	flask	NOUN
aji-154	186	8	,	,	PUNCT
aji-154	186	9	10	10	NUM
aji-154	186	10	ml	ml	NOUN
aji-154	186	11	of	of	ADP
aji-154	186	12	lanolin	lanolin	PROPN
aji-154	186	13	(	(	PUNCT
aji-154	186	14	farma	farma	PROPN
aji-154	186	15	norte	norte	NOUN
aji-154	186	16	™	™	NOUN
aji-154	186	17	)	)	PUNCT
aji-154	186	18	and	and	CCONJ
aji-154	186	19	10	10	NUM
aji-154	186	20	ml	ml	NOUN
aji-154	186	21	of	of	ADP
aji-154	186	22	glycerin	glycerin	NOUN
aji-154	186	23	[	[	X
aji-154	186	24	glycerin	glycerin	PROPN
aji-154	186	25	p.a	p.a	PROPN
aji-154	186	26	.	.	PROPN
aji-154	186	27	–	–	PUNCT
aji-154	186	28	acs	acs	PROPN
aji-154	186	29	,	,	PUNCT
aji-154	186	30	c3h5(oh)3	c3h5(oh)3	PROPN
aji-154	186	31	,	,	PUNCT
aji-154	186	32	dinâmica	dinâmica	PROPN
aji-154	186	33	™	™	PROPN
aji-154	186	34	]	]	PUNCT
aji-154	186	35	were	be	AUX
aji-154	186	36	homogenized	homogenize	VERB
aji-154	186	37	and	and	CCONJ
aji-154	186	38	kept	keep	VERB
aji-154	186	39	under	under	ADP
aji-154	186	40	refrigeration	refrigeration	NOUN
aji-154	186	41	(	(	PUNCT
aji-154	186	42	4	4	NUM
aji-154	186	43	°	°	NOUN
aji-154	186	44	c	c	NOUN
aji-154	186	45	)	)	PUNCT
aji-154	186	46	to	to	PART
aji-154	186	47	perform	perform	VERB
aji-154	186	48	the	the	DET
aji-154	186	49	allergic	allergic	ADJ
aji-154	186	50	skin	skin	NOUN
aji-154	186	51	tests	test	NOUN
aji-154	186	52	,	,	PUNCT
aji-154	186	53	ttp	ttp	X
aji-154	186	54	,	,	PUNCT
aji-154	186	55	and	and	CCONJ
aji-154	186	56	lait	lait	NOUN
aji-154	186	57	.	.	PUNCT
aji-154	187	1	2.3	2.3	NUM
aji-154	187	2	ex	ex	X
aji-154	187	3	vivo	vivo	ADJ
aji-154	187	4	investigation	investigation	NOUN
aji-154	187	5	:	:	PUNCT
aji-154	187	6	leukocyte	leukocyte	ADJ
aji-154	187	7	adherence	adherence	NOUN
aji-154	187	8	inhibition	inhibition	NOUN
aji-154	187	9	test	test	NOUN
aji-154	187	10	2.3.1	2.3.1	NUM
aji-154	187	11	procedure	procedure	NOUN
aji-154	187	12	for	for	ADP
aji-154	187	13	allergen	allergen	NOUN
aji-154	187	14	ex	ex	PRON
aji-154	187	15	vivo	vivo	NOUN
aji-154	187	16	challenging	challenge	VERB
aji-154	187	17	we	we	PRON
aji-154	187	18	performed	perform	VERB
aji-154	187	19	the	the	DET
aji-154	187	20	lait	lait	NOUN
aji-154	187	21	as	as	SCONJ
aji-154	187	22	previously	previously	ADV
aji-154	187	23	described	describe	VERB
aji-154	187	24	[	[	PUNCT
aji-154	187	25	39	39	NUM
aji-154	187	26	-	-	SYM
aji-154	187	27	49	49	NUM
aji-154	187	28	]	]	PUNCT
aji-154	187	29	.	.	PUNCT
aji-154	188	1	shortly	shortly	ADV
aji-154	188	2	,	,	PUNCT
aji-154	188	3	each	each	DET
aji-154	188	4	donor	donor	NOUN
aji-154	188	5	's	's	PART
aji-154	188	6	fresh	fresh	ADJ
aji-154	188	7	plasma	plasma	NOUN
aji-154	188	8	was	be	AUX
aji-154	188	9	divided	divide	VERB
aji-154	188	10	into	into	ADP
aji-154	188	11	two	two	NUM
aji-154	188	12	parts	part	NOUN
aji-154	188	13	and	and	CCONJ
aji-154	188	14	used	use	VERB
aji-154	188	15	in	in	ADP
aji-154	188	16	paralleled	parallel	VERB
aji-154	188	17	ex	ex	PRON
aji-154	188	18	vivo	vivo	ADJ
aji-154	188	19	challenging	challenge	VERB
aji-154	188	20	tests	test	NOUN
aji-154	188	21	with	with	ADP
aji-154	188	22	lanolin	lanolin	NOUN
aji-154	188	23	solution	solution	NOUN
aji-154	188	24	and	and	CCONJ
aji-154	188	25	the	the	DET
aji-154	188	26	unchallenged	unchallenged	ADJ
aji-154	188	27	plasma	plasma	NOUN
aji-154	188	28	assay	assay	VERB
aji-154	188	29	.	.	PUNCT
aji-154	189	1	we	we	PRON
aji-154	189	2	collected	collect	VERB
aji-154	189	3	plasma	plasma	NOUN
aji-154	189	4	with	with	ADP
aji-154	189	5	high	high	ADJ
aji-154	189	6	leukocyte	leukocyte	NOUN
aji-154	189	7	content	content	NOUN
aji-154	189	8	(	(	PUNCT
aji-154	189	9	buffy	buffy	PROPN
aji-154	189	10	coat	coat	PROPN
aji-154	189	11	)	)	PUNCT
aji-154	189	12	from	from	ADP
aji-154	189	13	the	the	DET
aji-154	189	14	heparinized	heparinize	VERB
aji-154	189	15	tube	tube	NOUN
aji-154	189	16	after	after	ADP
aji-154	189	17	one	one	NUM
aji-154	189	18	hour	hour	NOUN
aji-154	189	19	of	of	ADP
aji-154	189	20	sedimentation	sedimentation	NOUN
aji-154	189	21	at	at	ADP
aji-154	189	22	37	37	NUM
aji-154	189	23	°	°	NOUN
aji-154	189	24	c	c	NOUN
aji-154	189	25	.	.	PUNCT
aji-154	190	1	then	then	ADV
aji-154	190	2	,	,	PUNCT
aji-154	190	3	we	we	PRON
aji-154	190	4	distributed	distribute	VERB
aji-154	190	5	aliquots	aliquot	NOUN
aji-154	190	6	of	of	ADP
aji-154	190	7	100	100	NUM
aji-154	190	8	μl	μl	ADV
aji-154	190	9	into	into	ADP
aji-154	190	10	eppendorf	eppendorf	PROPN
aji-154	190	11	tubes	tube	NOUN
aji-154	190	12	kept	keep	VERB
aji-154	190	13	under	under	ADP
aji-154	190	14	agitation	agitation	NOUN
aji-154	190	15	for	for	ADP
aji-154	190	16	30	30	NUM
aji-154	190	17	minutes	minute	NOUN
aji-154	190	18	(	(	PUNCT
aji-154	190	19	200	200	NUM
aji-154	190	20	rpm	rpm	NOUN
aji-154	190	21	at	at	ADP
aji-154	190	22	37	37	NUM
aji-154	190	23	°	°	NOUN
aji-154	190	24	c	c	NOUN
aji-154	190	25	)	)	PUNCT
aji-154	190	26	with	with	ADP
aji-154	190	27	lanolin	lanolin	NOUN
aji-154	190	28	solution	solution	NOUN
aji-154	190	29	(	(	PUNCT
aji-154	190	30	10μl	10μl	ADV
aji-154	190	31	)	)	PUNCT
aji-154	190	32	or	or	CCONJ
aji-154	190	33	without	without	ADP
aji-154	190	34	lanolin	lanolin	NOUN
aji-154	190	35	solution	solution	NOUN
aji-154	190	36	(	(	PUNCT
aji-154	190	37	when	when	SCONJ
aji-154	190	38	used	use	VERB
aji-154	190	39	as	as	ADP
aji-154	190	40	control	control	NOUN
aji-154	190	41	)	)	PUNCT
aji-154	190	42	.	.	PUNCT
aji-154	191	1	2.3.2	2.3.2	NUM
aji-154	191	2	procedure	procedure	NOUN
aji-154	191	3	for	for	ADP
aji-154	191	4	adherence	adherence	NOUN
aji-154	191	5	assay	assay	VERB
aji-154	191	6	after	after	ADP
aji-154	191	7	incubation	incubation	NOUN
aji-154	191	8	,	,	PUNCT
aji-154	191	9	the	the	DET
aji-154	191	10	plasma	plasma	NOUN
aji-154	191	11	was	be	AUX
aji-154	191	12	allocated	allocate	VERB
aji-154	191	13	into	into	ADP
aji-154	191	14	a	a	DET
aji-154	191	15	standard	standard	ADJ
aji-154	191	16	neubauer	neubauer	PROPN
aji-154	191	17	hemocytometer	hemocytometer	PROPN
aji-154	191	18	counting	counting	PROPN
aji-154	191	19	chamber	chamber	NOUN
aji-154	191	20	with	with	ADP
aji-154	191	21	a	a	DET
aji-154	191	22	plain	plain	ADJ
aji-154	191	23	,	,	PUNCT
aji-154	191	24	non	non	ADJ
aji-154	191	25	-	-	ADJ
aji-154	191	26	metallic	metallic	ADJ
aji-154	191	27	glass	glass	NOUN
aji-154	191	28	surface	surface	NOUN
aji-154	191	29	and	and	CCONJ
aji-154	191	30	left	leave	VERB
aji-154	191	31	to	to	PART
aji-154	191	32	stand	stand	VERB
aji-154	191	33	for	for	ADP
aji-154	191	34	2	2	NUM
aji-154	191	35	hours	hour	NOUN
aji-154	191	36	at	at	ADP
aji-154	191	37	37	37	NUM
aji-154	191	38	°	°	SYM
aji-154	191	39	c	c	NOUN
aji-154	191	40	in	in	ADP
aji-154	191	41	the	the	DET
aji-154	191	42	humidified	humidified	ADJ
aji-154	191	43	atmosphere	atmosphere	NOUN
aji-154	191	44	of	of	ADP
aji-154	191	45	the	the	DET
aji-154	191	46	covered	cover	VERB
aji-154	191	47	water	water	NOUN
aji-154	191	48	bath	bath	NOUN
aji-154	191	49	to	to	PART
aji-154	191	50	allow	allow	VERB
aji-154	191	51	leukocytes	leukocyte	NOUN
aji-154	191	52	to	to	PART
aji-154	191	53	adhere	adhere	VERB
aji-154	191	54	to	to	ADP
aji-154	191	55	the	the	DET
aji-154	191	56	glass	glass	NOUN
aji-154	191	57	.	.	PUNCT
aji-154	192	1	next	next	ADV
aji-154	192	2	,	,	PUNCT
aji-154	192	3	we	we	PRON
aji-154	192	4	counted	count	VERB
aji-154	192	5	the	the	DET
aji-154	192	6	leukocytes	leukocyte	NOUN
aji-154	192	7	,	,	PUNCT
aji-154	192	8	removed	remove	VERB
aji-154	192	9	the	the	DET
aji-154	192	10	coverslip	coverslip	NOUN
aji-154	192	11	,	,	PUNCT
aji-154	192	12	and	and	CCONJ
aji-154	192	13	washed	wash	VERB
aji-154	192	14	the	the	DET
aji-154	192	15	chamber	chamber	NOUN
aji-154	192	16	by	by	ADP
aji-154	192	17	immersion	immersion	NOUN
aji-154	192	18	in	in	ADP
aji-154	192	19	a	a	DET
aji-154	192	20	beaker	beaker	NOUN
aji-154	192	21	with	with	ADP
aji-154	192	22	pbs	pbs	PROPN
aji-154	192	23	(	(	PUNCT
aji-154	192	24	phosphatebuffered	phosphatebuffere	VERB
aji-154	192	25	saline	saline	NOUN
aji-154	192	26	)	)	PUNCT
aji-154	192	27	at	at	ADP
aji-154	192	28	37	37	NUM
aji-154	192	29	°	°	NOUN
aji-154	192	30	c	c	NOUN
aji-154	192	31	.	.	PUNCT
aji-154	193	1	then	then	ADV
aji-154	193	2	,	,	PUNCT
aji-154	193	3	we	we	PRON
aji-154	193	4	added	add	VERB
aji-154	193	5	a	a	DET
aji-154	193	6	drop	drop	NOUN
aji-154	193	7	of	of	ADP
aji-154	193	8	pbs	pbs	PROPN
aji-154	193	9	to	to	ADP
aji-154	193	10	the	the	DET
aji-154	193	11	hemocytometer	hemocytometer	NOUN
aji-154	193	12	's	's	PART
aji-154	193	13	chamber	chamber	NOUN
aji-154	193	14	and	and	CCONJ
aji-154	193	15	allocated	allocate	VERB
aji-154	193	16	a	a	DET
aji-154	193	17	clean	clean	ADJ
aji-154	193	18	coverslip	coverslip	NOUN
aji-154	193	19	over	over	ADP
aji-154	193	20	it	it	PRON
aji-154	193	21	.	.	PUNCT
aji-154	194	1	the	the	DET
aji-154	194	2	remaining	remain	VERB
aji-154	194	3	cells	cell	NOUN
aji-154	194	4	were	be	AUX
aji-154	194	5	counted	count	VERB
aji-154	194	6	in	in	ADP
aji-154	194	7	the	the	DET
aji-154	194	8	same	same	ADJ
aji-154	194	9	squares	square	NOUN
aji-154	194	10	as	as	SCONJ
aji-154	194	11	previously	previously	ADV
aji-154	194	12	examined	examine	VERB
aji-154	194	13	.	.	PUNCT
aji-154	195	1	2.3.3	2.3.3	NUM
aji-154	195	2	procedure	procedure	NOUN
aji-154	195	3	for	for	ADP
aji-154	195	4	calculation	calculation	NOUN
aji-154	195	5	the	the	DET
aji-154	195	6	percentage	percentage	NOUN
aji-154	195	7	of	of	ADP
aji-154	195	8	leukocyte	leukocyte	NOUN
aji-154	195	9	adherence	adherence	NOUN
aji-154	195	10	(	(	PUNCT
aji-154	195	11	la	la	NOUN
aji-154	195	12	)	)	PUNCT
aji-154	195	13	of	of	ADP
aji-154	195	14	each	each	DET
aji-154	195	15	assay	assay	NOUN
aji-154	195	16	was	be	AUX
aji-154	195	17	estimated	estimate	VERB
aji-154	195	18	as	as	ADP
aji-154	195	19	:	:	PUNCT
aji-154	195	20	(	(	PUNCT
aji-154	195	21	the	the	DET
aji-154	195	22	number	number	NOUN
aji-154	195	23	of	of	ADP
aji-154	195	24	leukocytes	leukocyte	NOUN
aji-154	195	25	observed	observe	VERB
aji-154	195	26	on	on	ADP
aji-154	195	27	the	the	DET
aji-154	195	28	hemocytometry	hemocytometry	PROPN
aji-154	195	29	chamber	chamber	PROPN
aji-154	195	30	after	after	ADP
aji-154	195	31	washing	wash	VERB
aji-154	195	32	divided	divide	VERB
aji-154	195	33	by	by	ADP
aji-154	195	34	the	the	DET
aji-154	195	35	number	number	NOUN
aji-154	195	36	of	of	ADP
aji-154	195	37	leukocytes	leukocyte	NOUN
aji-154	195	38	observed	observe	VERB
aji-154	195	39	on	on	ADP
aji-154	195	40	the	the	DET
aji-154	195	41	hemocytometry	hemocytometry	PROPN
aji-154	195	42	chamber	chamber	PROPN
aji-154	195	43	before	before	ADP
aji-154	195	44	washing	washing	NOUN
aji-154	195	45	)	)	PUNCT
aji-154	195	46	and	and	CCONJ
aji-154	195	47	multiplied	multiply	VERB
aji-154	195	48	by	by	ADP
aji-154	195	49	100	100	NUM
aji-154	195	50	(	(	PUNCT
aji-154	195	51	%	%	NOUN
aji-154	195	52	)	)	PUNCT
aji-154	195	53	.	.	PUNCT
aji-154	196	1	the	the	DET
aji-154	196	2	leukocyte	leukocyte	NOUN
aji-154	196	3	adherence	adherence	NOUN
aji-154	196	4	ratio	ratio	NOUN
aji-154	196	5	(	(	PUNCT
aji-154	196	6	lar	lar	ADJ
aji-154	196	7	)	)	PUNCT
aji-154	196	8	was	be	AUX
aji-154	196	9	estimated	estimate	VERB
aji-154	196	10	based	base	VERB
aji-154	196	11	on	on	ADP
aji-154	196	12	the	the	DET
aji-154	196	13	ratio	ratio	NOUN
aji-154	196	14	between	between	ADP
aji-154	196	15	the	the	DET
aji-154	196	16	la	la	NOUN
aji-154	196	17	from	from	ADP
aji-154	196	18	the	the	DET
aji-154	196	19	antigen	antigen	NOUN
aji-154	196	20	-	-	PUNCT
aji-154	196	21	specific	specific	ADJ
aji-154	196	22	challenged	challenge	VERB
aji-154	196	23	plasma	plasma	NOUN
aji-154	196	24	and	and	CCONJ
aji-154	196	25	the	the	DET
aji-154	196	26	la	la	PROPN
aji-154	196	27	from	from	ADP
aji-154	196	28	the	the	DET
aji-154	196	29	unchallenged	unchallenged	ADJ
aji-154	196	30	control	control	NOUN
aji-154	196	31	plasma	plasma	NOUN
aji-154	196	32	:	:	PUNCT
aji-154	196	33	lar	lar	PROPN
aji-154	196	34	=	=	PUNCT
aji-154	196	35	la	la	PROPN
aji-154	196	36	of	of	ADP
aji-154	196	37	the	the	DET
aji-154	196	38	challenged	challenge	VERB
aji-154	196	39	sample	sample	NOUN
aji-154	196	40	divided	divide	VERB
aji-154	196	41	by	by	ADP
aji-154	196	42	la	la	PROPN
aji-154	196	43	of	of	ADP
aji-154	196	44	unchallenged	unchallenged	ADJ
aji-154	196	45	control	control	NOUN
aji-154	196	46	plasma	plasma	NOUN
aji-154	196	47	multiplied	multiply	VERB
aji-154	196	48	by	by	ADP
aji-154	196	49	100	100	NUM
aji-154	196	50	(	(	PUNCT
aji-154	196	51	%	%	NOUN
aji-154	196	52	)	)	PUNCT
aji-154	196	53	.	.	PUNCT
aji-154	197	1	to	to	PART
aji-154	197	2	further	far	ADV
aji-154	197	3	calculate	calculate	VERB
aji-154	197	4	the	the	DET
aji-154	197	5	leukocyte	leukocyte	NOUN
aji-154	197	6	adherence	adherence	NOUN
aji-154	197	7	inhibition	inhibition	NOUN
aji-154	197	8	(	(	PUNCT
aji-154	197	9	lai	lai	PROPN
aji-154	197	10	)	)	PUNCT
aji-154	197	11	,	,	PUNCT
aji-154	197	12	we	we	PRON
aji-154	197	13	subtracted	subtract	VERB
aji-154	197	14	the	the	DET
aji-154	197	15	lar	lar	NOUN
aji-154	197	16	from	from	ADP
aji-154	197	17	100	100	NUM
aji-154	197	18	(	(	PUNCT
aji-154	197	19	%	%	NOUN
aji-154	197	20	)	)	PUNCT
aji-154	197	21	.	.	PUNCT
aji-154	198	1	we	we	PRON
aji-154	198	2	employed	employ	VERB
aji-154	198	3	the	the	DET
aji-154	198	4	lai	lai	PROPN
aji-154	198	5	results	result	NOUN
aji-154	198	6	for	for	ADP
aji-154	198	7	the	the	DET
aji-154	198	8	cascade	cascade	NOUN
aji-154	198	9	distribution	distribution	NOUN
aji-154	198	10	chart	chart	NOUN
aji-154	198	11	and	and	CCONJ
aji-154	198	12	the	the	DET
aji-154	198	13	statistics	statistic	NOUN
aji-154	198	14	calculations	calculation	NOUN
aji-154	198	15	,	,	PUNCT
aji-154	198	16	both	both	PRON
aji-154	198	17	performed	perform	VERB
aji-154	198	18	with	with	ADP
aji-154	198	19	the	the	DET
aji-154	198	20	help	help	NOUN
aji-154	198	21	of	of	ADP
aji-154	198	22	the	the	DET
aji-154	198	23	microsoft	microsoft	PROPN
aji-154	198	24	excel	excel	PROPN
aji-154	198	25	®	®	NOUN
aji-154	198	26	statistical	statistical	ADJ
aji-154	198	27	package	package	NOUN
aji-154	198	28	.	.	PUNCT
aji-154	199	1	2.4	2.4	NUM
aji-154	199	2	in	in	ADP
aji-154	199	3	vitro	vitro	X
aji-154	199	4	investigation	investigation	NOUN
aji-154	199	5	:	:	PUNCT
aji-154	199	6	tube	tube	NOUN
aji-154	199	7	titration	titration	NOUN
aji-154	199	8	of	of	ADP
aji-154	199	9	precipitins	precipitin	NOUN
aji-154	199	10	(	(	PUNCT
aji-154	199	11	ttp	ttp	NOUN
aji-154	199	12	)	)	PUNCT
aji-154	199	13	as	as	SCONJ
aji-154	199	14	previously	previously	ADV
aji-154	199	15	reported	report	VERB
aji-154	199	16	,	,	PUNCT
aji-154	199	17	a	a	DET
aji-154	199	18	transparent	transparent	ADJ
aji-154	199	19	vitreous	vitreous	ADJ
aji-154	199	20	tube	tube	NOUN
aji-154	199	21	array	array	NOUN
aji-154	199	22	performed	perform	VERB
aji-154	199	23	the	the	DET
aji-154	199	24	semi	semi	ADJ
aji-154	199	25	-	-	ADJ
aji-154	199	26	quantitative	quantitative	ADJ
aji-154	199	27	ttp	ttp	NOUN
aji-154	199	28	against	against	ADP
aji-154	199	29	the	the	DET
aji-154	199	30	lanolin	lanolin	NOUN
aji-154	199	31	solution	solution	NOUN
aji-154	199	32	[	[	X
aji-154	199	33	50	50	NUM
aji-154	199	34	-	-	SYM
aji-154	199	35	54	54	NUM
aji-154	199	36	]	]	PUNCT
aji-154	199	37	.	.	PUNCT
aji-154	200	1	shortly	shortly	ADV
aji-154	200	2	,	,	PUNCT
aji-154	200	3	the	the	DET
aji-154	200	4	patient	patient	NOUN
aji-154	200	5	's	's	PART
aji-154	200	6	blood	blood	NOUN
aji-154	200	7	was	be	AUX
aji-154	200	8	collected	collect	VERB
aji-154	200	9	in	in	ADP
aji-154	200	10	a	a	DET
aji-154	200	11	clot	clot	NOUN
aji-154	200	12	-	-	PUNCT
aji-154	200	13	activator	activator	NOUN
aji-154	200	14	collecting	collect	VERB
aji-154	200	15	tube	tube	NOUN
aji-154	200	16	.	.	PUNCT
aji-154	201	1	after	after	ADP
aji-154	201	2	separation	separation	NOUN
aji-154	201	3	,	,	PUNCT
aji-154	201	4	the	the	DET
aji-154	201	5	serum	serum	NOUN
aji-154	201	6	was	be	AUX
aji-154	201	7	centrifugated	centrifugate	VERB
aji-154	201	8	at	at	ADP
aji-154	201	9	2,000	2,000	NUM
aji-154	201	10	rpm	rpm	NOUN
aji-154	201	11	for	for	ADP
aji-154	201	12	10	10	NUM
aji-154	201	13	minutes	minute	NOUN
aji-154	201	14	.	.	PUNCT
aji-154	202	1	the	the	DET
aji-154	202	2	allergen	allergen	NOUN
aji-154	202	3	extracts	extract	NOUN
aji-154	202	4	were	be	AUX
aji-154	202	5	allocated	allocate	VERB
aji-154	202	6	in	in	ADP
aji-154	202	7	sets	set	NOUN
aji-154	202	8	of	of	ADP
aji-154	202	9	eleven	eleven	NUM
aji-154	202	10	glass	glass	NOUN
aji-154	202	11	tubes	tube	NOUN
aji-154	202	12	at	at	ADP
aji-154	202	13	progressive	progressive	ADJ
aji-154	202	14	duplicated	duplicate	VERB
aji-154	202	15	serum	serum	NOUN
aji-154	202	16	dilutions	dilution	NOUN
aji-154	202	17	.	.	PUNCT
aji-154	203	1	the	the	DET
aji-154	203	2	progressive	progressive	ADJ
aji-154	203	3	dilutions	dilution	NOUN
aji-154	203	4	were	be	AUX
aji-154	203	5	combined	combine	VERB
aji-154	203	6	with	with	ADP
aji-154	203	7	the	the	DET
aji-154	203	8	15	15	NUM
aji-154	203	9	μl	μl	NUM
aji-154	203	10	of	of	ADP
aji-154	203	11	the	the	DET
aji-154	203	12	antigen	antigen	ADJ
aji-154	203	13	solution	solution	NOUN
aji-154	203	14	with	with	ADP
aji-154	203	15	250	250	NUM
aji-154	203	16	μl	μl	ADP
aji-154	203	17	of	of	ADP
aji-154	203	18	the	the	DET
aji-154	203	19	patient	patient	NOUN
aji-154	203	20	's	's	PART
aji-154	203	21	serum	serum	NOUN
aji-154	203	22	,	,	PUNCT
aji-154	203	23	progressively	progressively	ADV
aji-154	203	24	diluted	dilute	VERB
aji-154	203	25	into	into	ADP
aji-154	203	26	physiological	physiological	ADJ
aji-154	203	27	saline	saline	NOUN
aji-154	203	28	solution	solution	NOUN
aji-154	203	29	(	(	PUNCT
aji-154	203	30	nacl	nacl	NOUN
aji-154	203	31	0,9	0,9	NUM
aji-154	203	32	%	%	NOUN
aji-154	203	33	)	)	PUNCT
aji-154	203	34	in	in	ADP
aji-154	203	35	the	the	DET
aji-154	203	36	dilution	dilution	NOUN
aji-154	203	37	ratios	ratio	NOUN
aji-154	203	38	of	of	ADP
aji-154	203	39	1:1	1:1	NUM
aji-154	203	40	;	;	PUNCT
aji-154	203	41	1:2	1:2	NUM
aji-154	203	42	;	;	PUNCT
aji-154	203	43	1:4	1:4	NUM
aji-154	203	44	;	;	PUNCT
aji-154	203	45	1:8	1:8	NUM
aji-154	203	46	;	;	PUNCT
aji-154	203	47	olivier	olivier	PROPN
aji-154	203	48	et	et	PROPN
aji-154	203	49	al	al	PROPN
aji-154	203	50	.	.	PROPN
aji-154	203	51	;	;	PUNCT
aji-154	203	52	asian	asian	PROPN
aji-154	203	53	j.	j.	PROPN
aji-154	203	54	immunol	immunol	PROPN
aji-154	203	55	.	.	PROPN
aji-154	203	56	,	,	PUNCT
aji-154	203	57	vol	vol	NOUN
aji-154	203	58	.	.	PROPN
aji-154	204	1	7	7	NUM
aji-154	204	2	,	,	PUNCT
aji-154	204	3	no	no	INTJ
aji-154	204	4	.	.	NOUN
aji-154	204	5	1	1	NUM
aji-154	204	6	,	,	PUNCT
aji-154	204	7	pp	pp	ADJ
aji-154	204	8	.	.	PUNCT
aji-154	205	1	316	316	NUM
aji-154	205	2	-	-	SYM
aji-154	205	3	325	325	NUM
aji-154	205	4	,	,	PUNCT
aji-154	205	5	2024	2024	NUM
aji-154	205	6	;	;	PUNCT
aji-154	205	7	article	article	NOUN
aji-154	205	8	no.aji.128121	no.aji.128121	ADV
aji-154	205	9	320	320	NUM
aji-154	205	10	1:16	1:16	NUM
aji-154	205	11	;	;	PUNCT
aji-154	205	12	1:32	1:32	NUM
aji-154	205	13	;	;	PUNCT
aji-154	205	14	1:64	1:64	NUM
aji-154	205	15	;	;	PUNCT
aji-154	205	16	1:128	1:128	NUM
aji-154	205	17	;	;	PUNCT
aji-154	205	18	1:256	1:256	NUM
aji-154	205	19	;	;	PUNCT
aji-154	205	20	and	and	CCONJ
aji-154	205	21	1:512	1:512	NUM
aji-154	205	22	.	.	PUNCT
aji-154	206	1	one	one	NUM
aji-154	206	2	tube	tube	NOUN
aji-154	206	3	was	be	AUX
aji-154	206	4	a	a	DET
aji-154	206	5	blank	blank	ADJ
aji-154	206	6	control	control	NOUN
aji-154	206	7	done	do	VERB
aji-154	206	8	with	with	ADP
aji-154	206	9	the	the	DET
aji-154	206	10	water	water	NOUN
aji-154	206	11	and	and	CCONJ
aji-154	206	12	serum	serum	NOUN
aji-154	206	13	to	to	PART
aji-154	206	14	observe	observe	VERB
aji-154	206	15	occasional	occasional	ADJ
aji-154	206	16	spontaneous	spontaneous	ADJ
aji-154	206	17	precipitation	precipitation	NOUN
aji-154	206	18	(	(	PUNCT
aji-154	206	19	sia	sia	PROPN
aji-154	206	20	test	test	NOUN
aji-154	206	21	)	)	PUNCT
aji-154	206	22	.	.	PUNCT
aji-154	207	1	after	after	ADP
aji-154	207	2	24	24	NUM
aji-154	207	3	hours	hour	NOUN
aji-154	207	4	,	,	PUNCT
aji-154	207	5	the	the	DET
aji-154	207	6	tubes	tube	NOUN
aji-154	207	7	were	be	AUX
aji-154	207	8	examined	examine	VERB
aji-154	207	9	,	,	PUNCT
aji-154	207	10	and	and	CCONJ
aji-154	207	11	the	the	DET
aji-154	207	12	titers	titer	NOUN
aji-154	207	13	(	(	PUNCT
aji-154	207	14	the	the	DET
aji-154	207	15	highest	high	ADJ
aji-154	207	16	dilution	dilution	NOUN
aji-154	207	17	factor	factor	NOUN
aji-154	207	18	that	that	PRON
aji-154	207	19	yields	yield	VERB
aji-154	207	20	a	a	DET
aji-154	207	21	positive	positive	ADJ
aji-154	207	22	reading	reading	NOUN
aji-154	207	23	)	)	PUNCT
aji-154	207	24	were	be	AUX
aji-154	207	25	recorded	record	VERB
aji-154	207	26	[	[	X
aji-154	207	27	55	55	NUM
aji-154	207	28	]	]	PUNCT
aji-154	207	29	.	.	PUNCT
aji-154	208	1	3	3	X
aji-154	208	2	.	.	X
aji-154	208	3	results	result	NOUN
aji-154	208	4	as	as	ADP
aji-154	208	5	a	a	DET
aji-154	208	6	retrospective	retrospective	ADJ
aji-154	208	7	survey	survey	NOUN
aji-154	208	8	,	,	PUNCT
aji-154	208	9	there	there	PRON
aji-154	208	10	was	be	VERB
aji-154	208	11	no	no	DET
aji-154	208	12	research	research	NOUN
aji-154	208	13	protocol	protocol	NOUN
aji-154	208	14	;	;	PUNCT
aji-154	208	15	therefore	therefore	ADV
aji-154	208	16	,	,	PUNCT
aji-154	208	17	we	we	PRON
aji-154	208	18	report	report	VERB
aji-154	208	19	the	the	DET
aji-154	208	20	incidental	incidental	ADJ
aji-154	208	21	immune	immune	ADJ
aji-154	208	22	investigation	investigation	NOUN
aji-154	208	23	as	as	SCONJ
aji-154	208	24	registered	register	VERB
aji-154	208	25	in	in	ADP
aji-154	208	26	the	the	DET
aji-154	208	27	digital	digital	ADJ
aji-154	208	28	medical	medical	ADJ
aji-154	208	29	charts	chart	NOUN
aji-154	208	30	.	.	PUNCT
aji-154	209	1	fig	fig	NOUN
aji-154	209	2	.	.	PUNCT
aji-154	210	1	1	1	NUM
aji-154	210	2	.	.	X
aji-154	210	3	cascade	cascade	NOUN
aji-154	210	4	distribution	distribution	NOUN
aji-154	210	5	chart	chart	NOUN
aji-154	210	6	of	of	ADP
aji-154	210	7	the	the	DET
aji-154	210	8	tube	tube	NOUN
aji-154	210	9	titration	titration	NOUN
aji-154	210	10	of	of	ADP
aji-154	210	11	precipitins	precipitin	NOUN
aji-154	210	12	(	(	PUNCT
aji-154	210	13	x	x	NOUN
aji-154	210	14	-	-	ADJ
aji-154	210	15	axis	axis	ADJ
aji-154	210	16	%	%	NOUN
aji-154	210	17	)	)	PUNCT
aji-154	210	18	resulting	result	VERB
aji-154	210	19	from	from	ADP
aji-154	210	20	the	the	DET
aji-154	210	21	lanolin	lanolin	NOUN
aji-154	210	22	solution	solution	NOUN
aji-154	210	23	against	against	ADP
aji-154	210	24	the	the	DET
aji-154	210	25	serum	serum	NOUN
aji-154	210	26	of	of	ADP
aji-154	210	27	a	a	DET
aji-154	210	28	cohort	cohort	NOUN
aji-154	210	29	of	of	ADP
aji-154	210	30	100	100	NUM
aji-154	210	31	tests	test	NOUN
aji-154	210	32	/	/	SYM
aji-154	210	33	subjects	subject	NOUN
aji-154	210	34	(	(	PUNCT
aji-154	210	35	y	y	NOUN
aji-154	210	36	-	-	PUNCT
aji-154	210	37	axis	axis	ADJ
aji-154	210	38	)	)	PUNCT
aji-154	210	39	fig	fig	NOUN
aji-154	210	40	.	.	PUNCT
aji-154	211	1	2	2	NUM
aji-154	211	2	.	.	NOUN
aji-154	211	3	cascade	cascade	NOUN
aji-154	211	4	distribution	distribution	NOUN
aji-154	211	5	chart	chart	NOUN
aji-154	211	6	of	of	ADP
aji-154	211	7	the	the	DET
aji-154	211	8	range	range	NOUN
aji-154	211	9	groups	group	NOUN
aji-154	211	10	of	of	ADP
aji-154	211	11	leukocyte	leukocyte	NOUN
aji-154	211	12	adherence	adherence	NOUN
aji-154	211	13	inhibition	inhibition	NOUN
aji-154	211	14	(	(	PUNCT
aji-154	211	15	lai	lai	NOUN
aji-154	211	16	)	)	PUNCT
aji-154	211	17	results	result	NOUN
aji-154	211	18	(	(	PUNCT
aji-154	211	19	x	x	NOUN
aji-154	211	20	-	-	ADJ
aji-154	211	21	axis	axis	ADJ
aji-154	211	22	%	%	NOUN
aji-154	211	23	)	)	PUNCT
aji-154	211	24	of	of	ADP
aji-154	211	25	ex	ex	PRON
aji-154	211	26	vivo	vivo	ADJ
aji-154	211	27	lanolin	lanolin	NOUN
aji-154	211	28	solution	solution	NOUN
aji-154	211	29	monitored	monitor	VERB
aji-154	211	30	by	by	ADP
aji-154	211	31	the	the	DET
aji-154	211	32	leukocyte	leukocyte	NOUN
aji-154	211	33	adherence	adherence	NOUN
aji-154	211	34	inhibition	inhibition	NOUN
aji-154	211	35	test	test	NOUN
aji-154	211	36	(	(	PUNCT
aji-154	211	37	lait	lait	NOUN
aji-154	211	38	)	)	PUNCT
aji-154	211	39	,	,	PUNCT
aji-154	211	40	according	accord	VERB
aji-154	211	41	to	to	ADP
aji-154	211	42	the	the	DET
aji-154	211	43	respective	respective	ADJ
aji-154	211	44	number	number	NOUN
aji-154	211	45	of	of	ADP
aji-154	211	46	outcomes	outcome	NOUN
aji-154	211	47	over	over	ADP
aji-154	211	48	a	a	DET
aji-154	211	49	cohort	cohort	NOUN
aji-154	211	50	with	with	ADP
aji-154	211	51	100	100	NUM
aji-154	211	52	tests	test	NOUN
aji-154	211	53	/	/	SYM
aji-154	211	54	subjects	subject	NOUN
aji-154	211	55	(	(	PUNCT
aji-154	211	56	y	y	NOUN
aji-154	211	57	-	-	PUNCT
aji-154	211	58	axis	axis	NOUN
aji-154	211	59	)	)	PUNCT
aji-154	211	60	olivier	olivier	NOUN
aji-154	211	61	et	et	PROPN
aji-154	211	62	al	al	PROPN
aji-154	211	63	.	.	PROPN
aji-154	211	64	;	;	PUNCT
aji-154	211	65	asian	asian	PROPN
aji-154	211	66	j.	j.	PROPN
aji-154	211	67	immunol	immunol	PROPN
aji-154	211	68	.	.	PROPN
aji-154	211	69	,	,	PUNCT
aji-154	211	70	vol	vol	NOUN
aji-154	211	71	.	.	PROPN
aji-154	212	1	7	7	NUM
aji-154	212	2	,	,	PUNCT
aji-154	212	3	no	no	INTJ
aji-154	212	4	.	.	NOUN
aji-154	212	5	1	1	NUM
aji-154	212	6	,	,	PUNCT
aji-154	212	7	pp	pp	ADJ
aji-154	212	8	.	.	PUNCT
aji-154	213	1	316	316	NUM
aji-154	213	2	-	-	SYM
aji-154	213	3	325	325	NUM
aji-154	213	4	,	,	PUNCT
aji-154	213	5	2024	2024	NUM
aji-154	213	6	;	;	PUNCT
aji-154	213	7	article	article	NOUN
aji-154	213	8	no.aji.128121	no.aji.128121	ADV
aji-154	213	9	321	321	NUM
aji-154	213	10	the	the	DET
aji-154	213	11	ttp	ttp	NOUN
aji-154	213	12	showed	show	VERB
aji-154	213	13	a	a	DET
aji-154	213	14	distribution	distribution	NOUN
aji-154	213	15	concentrated	concentrate	VERB
aji-154	213	16	over	over	ADP
aji-154	213	17	the	the	DET
aji-154	213	18	more	more	ADV
aji-154	213	19	diluted	diluted	ADJ
aji-154	213	20	titrations	titration	NOUN
aji-154	213	21	(	(	PUNCT
aji-154	213	22	fig	fig	NOUN
aji-154	213	23	.	.	PUNCT
aji-154	213	24	1	1	NUM
aji-154	213	25	)	)	PUNCT
aji-154	213	26	.	.	PUNCT
aji-154	214	1	there	there	PRON
aji-154	214	2	was	be	VERB
aji-154	214	3	no	no	DET
aji-154	214	4	negative	negative	ADJ
aji-154	214	5	result	result	NOUN
aji-154	214	6	.	.	PUNCT
aji-154	215	1	the	the	DET
aji-154	215	2	mean	mean	NOUN
aji-154	215	3	was	be	AUX
aji-154	215	4	estimated	estimate	VERB
aji-154	215	5	at	at	ADP
aji-154	215	6	1:343	1:343	NUM
aji-154	215	7	;	;	PUNCT
aji-154	215	8	the	the	DET
aji-154	215	9	median	median	NOUN
aji-154	215	10	was	be	AUX
aji-154	215	11	1:512	1:512	NUM
aji-154	215	12	;	;	PUNCT
aji-154	215	13	the	the	DET
aji-154	215	14	standard	standard	ADJ
aji-154	215	15	deviation	deviation	NOUN
aji-154	215	16	was	be	AUX
aji-154	215	17	estimated	estimate	VERB
aji-154	215	18	at	at	ADP
aji-154	215	19	1:187	1:187	NUM
aji-154	215	20	;	;	PUNCT
aji-154	215	21	the	the	DET
aji-154	215	22	mode	mode	NOUN
aji-154	215	23	was	be	AUX
aji-154	215	24	1:512	1:512	NUM
aji-154	215	25	(	(	PUNCT
aji-154	215	26	appeared	appear	VERB
aji-154	215	27	53	53	NUM
aji-154	215	28	times	time	NOUN
aji-154	215	29	)	)	PUNCT
aji-154	215	30	.	.	PUNCT
aji-154	216	1	all	all	PRON
aji-154	216	2	sia	sia	PROPN
aji-154	216	3	tests	test	NOUN
aji-154	216	4	were	be	AUX
aji-154	216	5	negative	negative	ADJ
aji-154	216	6	.	.	PUNCT
aji-154	217	1	the	the	DET
aji-154	217	2	lait	lait	NOUN
aji-154	217	3	showed	show	VERB
aji-154	217	4	a	a	DET
aji-154	217	5	wide	wide	ADJ
aji-154	217	6	distribution	distribution	NOUN
aji-154	217	7	range	range	NOUN
aji-154	217	8	of	of	ADP
aji-154	217	9	results	result	NOUN
aji-154	217	10	.	.	PUNCT
aji-154	218	1	the	the	DET
aji-154	218	2	lai	lai	PROPN
aji-154	218	3	ranged	range	VERB
aji-154	218	4	from	from	ADP
aji-154	218	5	0	0	NUM
aji-154	218	6	%	%	NOUN
aji-154	218	7	to	to	PART
aji-154	218	8	95	95	NUM
aji-154	218	9	%	%	NOUN
aji-154	218	10	.	.	PUNCT
aji-154	219	1	the	the	DET
aji-154	219	2	mean	mean	NOUN
aji-154	219	3	was	be	AUX
aji-154	219	4	41.5	41.5	NUM
aji-154	219	5	%	%	NOUN
aji-154	219	6	;	;	PUNCT
aji-154	219	7	the	the	DET
aji-154	219	8	median	median	NOUN
aji-154	219	9	was	be	AUX
aji-154	219	10	41.5	41.5	NUM
aji-154	219	11	%	%	NOUN
aji-154	219	12	;	;	PUNCT
aji-154	219	13	the	the	DET
aji-154	219	14	standard	standard	ADJ
aji-154	219	15	deviation	deviation	NOUN
aji-154	219	16	was	be	AUX
aji-154	219	17	27.3	27.3	NUM
aji-154	219	18	%	%	NOUN
aji-154	219	19	;	;	PUNCT
aji-154	219	20	the	the	DET
aji-154	219	21	mode	mode	NOUN
aji-154	219	22	was	be	AUX
aji-154	219	23	0	0	NUM
aji-154	219	24	%	%	NOUN
aji-154	219	25	(	(	PUNCT
aji-154	219	26	appeared	appear	VERB
aji-154	219	27	sixteen	sixteen	NUM
aji-154	219	28	times	time	NOUN
aji-154	219	29	)	)	PUNCT
aji-154	219	30	.	.	PUNCT
aji-154	220	1	the	the	DET
aji-154	220	2	cascade	cascade	NOUN
aji-154	220	3	distribution	distribution	NOUN
aji-154	220	4	demonstrates	demonstrate	VERB
aji-154	220	5	a	a	DET
aji-154	220	6	wide	wide	ADJ
aji-154	220	7	range	range	NOUN
aji-154	220	8	spread	spread	NOUN
aji-154	220	9	of	of	ADP
aji-154	220	10	lai	lai	PROPN
aji-154	220	11	results	result	NOUN
aji-154	220	12	(	(	PUNCT
aji-154	220	13	fig	fig	NOUN
aji-154	220	14	.	.	PUNCT
aji-154	221	1	2	2	NUM
aji-154	221	2	)	)	PUNCT
aji-154	221	3	.	.	PUNCT
aji-154	222	1	half	half	NOUN
aji-154	222	2	of	of	ADP
aji-154	222	3	the	the	DET
aji-154	222	4	patients	patient	NOUN
aji-154	222	5	presented	present	VERB
aji-154	222	6	moderate	moderate	ADJ
aji-154	222	7	immunoreactivity	immunoreactivity	NOUN
aji-154	222	8	during	during	ADP
aji-154	222	9	the	the	DET
aji-154	222	10	ex	ex	ADJ
aji-154	222	11	vivo	vivo	NOUN
aji-154	222	12	challenge	challenge	NOUN
aji-154	222	13	test	test	NOUN
aji-154	222	14	(	(	PUNCT
aji-154	222	15	lai	lai	NOUN
aji-154	222	16	=	=	PUNCT
aji-154	222	17	22	22	NUM
aji-154	222	18	to	to	PART
aji-154	222	19	60	60	NUM
aji-154	222	20	%	%	NOUN
aji-154	222	21	)	)	PUNCT
aji-154	222	22	.	.	PUNCT
aji-154	223	1	at	at	ADP
aji-154	223	2	the	the	DET
aji-154	223	3	same	same	ADJ
aji-154	223	4	time	time	NOUN
aji-154	223	5	,	,	PUNCT
aji-154	223	6	one	one	NUM
aji-154	223	7	quarter	quarter	NOUN
aji-154	223	8	displayed	display	VERB
aji-154	223	9	strong	strong	ADJ
aji-154	223	10	immunoreactivity	immunoreactivity	NOUN
aji-154	223	11	,	,	PUNCT
aji-154	223	12	while	while	SCONJ
aji-154	223	13	the	the	DET
aji-154	223	14	other	other	ADJ
aji-154	223	15	quarter	quarter	NOUN
aji-154	223	16	displayed	display	VERB
aji-154	223	17	low	low	ADJ
aji-154	223	18	or	or	CCONJ
aji-154	223	19	no	no	DET
aji-154	223	20	immunoreactivity	immunoreactivity	NOUN
aji-154	223	21	.	.	PUNCT
aji-154	224	1	4	4	X
aji-154	224	2	.	.	X
aji-154	224	3	discussion	discussion	NOUN
aji-154	224	4	lanolin	lanolin	NOUN
aji-154	224	5	-	-	PUNCT
aji-154	224	6	based	base	VERB
aji-154	224	7	creams	cream	NOUN
aji-154	224	8	are	be	AUX
aji-154	224	9	frequently	frequently	ADV
aji-154	224	10	prescribed	prescribe	VERB
aji-154	224	11	for	for	ADP
aji-154	224	12	patients	patient	NOUN
aji-154	224	13	with	with	ADP
aji-154	224	14	atopic	atopic	NOUN
aji-154	224	15	and/or	and/or	CCONJ
aji-154	224	16	contact	contact	NOUN
aji-154	224	17	dermatitis	dermatitis	NOUN
aji-154	224	18	due	due	ADP
aji-154	224	19	to	to	ADP
aji-154	224	20	their	their	PRON
aji-154	224	21	emollient	emollient	NOUN
aji-154	224	22	properties	property	NOUN
aji-154	224	23	[	[	X
aji-154	224	24	54	54	NUM
aji-154	224	25	]	]	PUNCT
aji-154	224	26	.	.	PUNCT
aji-154	225	1	the	the	DET
aji-154	225	2	american	american	PROPN
aji-154	225	3	contact	contact	PROPN
aji-154	225	4	dermatitis	dermatitis	PROPN
aji-154	225	5	society	society	NOUN
aji-154	225	6	elected	elect	VERB
aji-154	225	7	lanolin	lanolin	PROPN
aji-154	225	8	as	as	ADP
aji-154	225	9	the	the	DET
aji-154	225	10	"	"	PUNCT
aji-154	225	11	allergen	allergen	NOUN
aji-154	225	12	of	of	ADP
aji-154	225	13	the	the	DET
aji-154	225	14	year	year	NOUN
aji-154	225	15	2023	2023	NUM
aji-154	225	16	"	"	PUNCT
aji-154	226	1	[	[	X
aji-154	226	2	55	55	NUM
aji-154	226	3	]	]	PUNCT
aji-154	226	4	.	.	PUNCT
aji-154	227	1	despite	despite	SCONJ
aji-154	227	2	the	the	DET
aji-154	227	3	emphasis	emphasis	NOUN
aji-154	227	4	borrowed	borrow	VERB
aji-154	227	5	by	by	ADP
aji-154	227	6	this	this	DET
aji-154	227	7	title	title	NOUN
aji-154	227	8	,	,	PUNCT
aji-154	227	9	there	there	PRON
aji-154	227	10	is	be	VERB
aji-154	227	11	a	a	DET
aji-154	227	12	total	total	ADJ
aji-154	227	13	lack	lack	NOUN
aji-154	227	14	of	of	ADP
aji-154	227	15	scientific	scientific	ADJ
aji-154	227	16	studies	study	NOUN
aji-154	227	17	about	about	ADP
aji-154	227	18	the	the	DET
aji-154	227	19	physiopathology	physiopathology	NOUN
aji-154	227	20	of	of	ADP
aji-154	227	21	the	the	DET
aji-154	227	22	hypersensitivity	hypersensitivity	NOUN
aji-154	227	23	(	(	PUNCT
aji-154	227	24	or	or	CCONJ
aji-154	227	25	hypersensitivities	hypersensitivity	NOUN
aji-154	227	26	)	)	PUNCT
aji-154	227	27	against	against	ADP
aji-154	227	28	lanolin	lanolin	NOUN
aji-154	227	29	.	.	PUNCT
aji-154	228	1	the	the	DET
aji-154	228	2	only	only	ADJ
aji-154	228	3	tools	tool	NOUN
aji-154	228	4	to	to	PART
aji-154	228	5	verify	verify	VERB
aji-154	228	6	hypersensitivity	hypersensitivity	NOUN
aji-154	228	7	against	against	ADP
aji-154	228	8	lanolin	lanolin	PROPN
aji-154	228	9	are	be	AUX
aji-154	228	10	the	the	DET
aji-154	228	11	cutaneous	cutaneous	ADJ
aji-154	228	12	tests	test	NOUN
aji-154	228	13	.	.	PUNCT
aji-154	229	1	there	there	PRON
aji-154	229	2	is	be	VERB
aji-154	229	3	no	no	DET
aji-154	229	4	record	record	NOUN
aji-154	229	5	in	in	ADP
aji-154	229	6	the	the	DET
aji-154	229	7	literature	literature	NOUN
aji-154	229	8	of	of	ADP
aji-154	229	9	any	any	DET
aji-154	229	10	standardized	standardized	ADJ
aji-154	229	11	lab	lab	NOUN
aji-154	229	12	examination	examination	NOUN
aji-154	229	13	(	(	PUNCT
aji-154	229	14	such	such	ADJ
aji-154	229	15	as	as	ADP
aji-154	229	16	specific	specific	ADJ
aji-154	229	17	ige	ige	NOUN
aji-154	229	18	,	,	PUNCT
aji-154	229	19	associated	associate	VERB
aji-154	229	20	cytokines	cytokine	NOUN
aji-154	229	21	,	,	PUNCT
aji-154	229	22	or	or	CCONJ
aji-154	229	23	any	any	DET
aji-154	229	24	serologic	serologic	ADJ
aji-154	229	25	technique	technique	NOUN
aji-154	229	26	)	)	PUNCT
aji-154	229	27	to	to	PART
aji-154	229	28	diagnose	diagnose	VERB
aji-154	229	29	lanolin	lanolin	NOUN
aji-154	229	30	hypersensitivity	hypersensitivity	NOUN
aji-154	229	31	or	or	CCONJ
aji-154	229	32	suggest	suggest	VERB
aji-154	229	33	lanolin	lanolin	PROPN
aji-154	229	34	immunoreactivity	immunoreactivity	NOUN
aji-154	229	35	.	.	PUNCT
aji-154	230	1	endotyping	endotype	VERB
aji-154	230	2	the	the	DET
aji-154	230	3	mechanisms	mechanism	NOUN
aji-154	230	4	responsible	responsible	ADJ
aji-154	230	5	for	for	ADP
aji-154	230	6	allergic	allergic	ADJ
aji-154	230	7	phenotypes	phenotype	NOUN
aji-154	230	8	is	be	AUX
aji-154	230	9	crucial	crucial	ADJ
aji-154	230	10	,	,	PUNCT
aji-154	230	11	not	not	PART
aji-154	230	12	only	only	ADV
aji-154	230	13	for	for	ADP
aji-154	230	14	diagnosis	diagnosis	NOUN
aji-154	230	15	but	but	CCONJ
aji-154	230	16	also	also	ADV
aji-154	230	17	for	for	ADP
aji-154	230	18	supervising	supervise	VERB
aji-154	230	19	treatments	treatment	NOUN
aji-154	230	20	under	under	ADP
aji-154	230	21	the	the	DET
aji-154	230	22	perspective	perspective	NOUN
aji-154	230	23	of	of	ADP
aji-154	230	24	personalized	personalized	ADJ
aji-154	230	25	medicine	medicine	NOUN
aji-154	230	26	and	and	CCONJ
aji-154	230	27	recognizing	recognize	VERB
aji-154	230	28	differential	differential	ADJ
aji-154	230	29	diagnosis	diagnosis	NOUN
aji-154	230	30	among	among	ADP
aji-154	230	31	phenotypes	phenotype	NOUN
aji-154	230	32	[	[	X
aji-154	230	33	56	56	NUM
aji-154	230	34	]	]	PUNCT
aji-154	230	35	.	.	PUNCT
aji-154	231	1	as	as	ADP
aji-154	231	2	a	a	DET
aji-154	231	3	proof	proof	NOUN
aji-154	231	4	of	of	ADP
aji-154	231	5	concept	concept	NOUN
aji-154	231	6	,	,	PUNCT
aji-154	231	7	we	we	PRON
aji-154	231	8	submitted	submit	VERB
aji-154	231	9	lanolin	lanolin	NOUN
aji-154	231	10	to	to	ADP
aji-154	231	11	an	an	DET
aji-154	231	12	ex	ex	X
aji-154	231	13	vivo	vivo	NOUN
aji-154	231	14	challenge	challenge	NOUN
aji-154	231	15	monitored	monitor	VERB
aji-154	231	16	by	by	ADP
aji-154	231	17	the	the	DET
aji-154	231	18	lait	lait	NOUN
aji-154	231	19	to	to	PART
aji-154	231	20	testify	testify	VERB
aji-154	231	21	to	to	ADP
aji-154	231	22	cellular	cellular	ADJ
aji-154	231	23	immunoreactivity	immunoreactivity	NOUN
aji-154	231	24	.	.	PUNCT
aji-154	232	1	in	in	ADP
aji-154	232	2	the	the	DET
aji-154	232	3	same	same	ADJ
aji-154	232	4	proofof	proofof	ADJ
aji-154	232	5	-	-	PUNCT
aji-154	232	6	concept	concept	NOUN
aji-154	232	7	mentality	mentality	NOUN
aji-154	232	8	,	,	PUNCT
aji-154	232	9	we	we	PRON
aji-154	232	10	research	research	VERB
aji-154	232	11	precipitins	precipitin	NOUN
aji-154	232	12	against	against	ADP
aji-154	232	13	lanolin	lanolin	NOUN
aji-154	232	14	to	to	PART
aji-154	232	15	testify	testify	VERB
aji-154	232	16	to	to	ADP
aji-154	232	17	humoral	humoral	ADJ
aji-154	232	18	immunoreactivity	immunoreactivity	NOUN
aji-154	232	19	through	through	ADP
aji-154	232	20	the	the	DET
aji-154	232	21	ttp	ttp	NOUN
aji-154	232	22	.	.	PUNCT
aji-154	233	1	despite	despite	SCONJ
aji-154	233	2	nonreactive	nonreactive	ADJ
aji-154	233	3	or	or	CCONJ
aji-154	233	4	inconclusive	inconclusive	ADJ
aji-154	233	5	skin	skin	NOUN
aji-154	233	6	tests	test	NOUN
aji-154	233	7	,	,	PUNCT
aji-154	233	8	we	we	PRON
aji-154	233	9	propose	propose	VERB
aji-154	233	10	these	these	DET
aji-154	233	11	procedures	procedure	NOUN
aji-154	233	12	to	to	ADP
aji-154	233	13	patients	patient	NOUN
aji-154	233	14	with	with	ADP
aji-154	233	15	atopic	atopic	NOUN
aji-154	233	16	dermatitis	dermatitis	NOUN
aji-154	233	17	and/or	and/or	CCONJ
aji-154	233	18	contact	contact	NOUN
aji-154	233	19	dermatitis	dermatitis	NOUN
aji-154	233	20	with	with	ADP
aji-154	233	21	a	a	DET
aji-154	233	22	strong	strong	ADJ
aji-154	233	23	clinical	clinical	ADJ
aji-154	233	24	suspicion	suspicion	NOUN
aji-154	233	25	of	of	ADP
aji-154	233	26	hypersensitivity	hypersensitivity	NOUN
aji-154	233	27	against	against	ADP
aji-154	233	28	lanolin	lanolin	NOUN
aji-154	233	29	.	.	PUNCT
aji-154	234	1	the	the	DET
aji-154	234	2	clinical	clinical	ADJ
aji-154	234	3	reasoning	reasoning	NOUN
aji-154	234	4	to	to	PART
aji-154	234	5	indicate	indicate	VERB
aji-154	234	6	these	these	DET
aji-154	234	7	tests	test	NOUN
aji-154	234	8	is	be	AUX
aji-154	234	9	in	in	ADP
aji-154	234	10	the	the	DET
aji-154	234	11	assumption	assumption	NOUN
aji-154	234	12	that	that	SCONJ
aji-154	234	13	they	they	PRON
aji-154	234	14	may	may	AUX
aji-154	234	15	function	function	VERB
aji-154	234	16	as	as	ADP
aji-154	234	17	triage	triage	NOUN
aji-154	234	18	tests	test	NOUN
aji-154	234	19	to	to	PART
aji-154	234	20	reinforce	reinforce	VERB
aji-154	234	21	the	the	DET
aji-154	234	22	need	need	NOUN
aji-154	234	23	for	for	ADP
aji-154	234	24	a	a	DET
aji-154	234	25	more	more	ADV
aji-154	234	26	exhaustive	exhaustive	ADJ
aji-154	234	27	exclusion	exclusion	NOUN
aji-154	234	28	-	-	PUNCT
aji-154	234	29	provocative	provocative	ADJ
aji-154	234	30	test	test	NOUN
aji-154	234	31	(	(	PUNCT
aji-154	234	32	when	when	SCONJ
aji-154	234	33	the	the	DET
aji-154	234	34	patients	patient	NOUN
aji-154	234	35	exclude	exclude	VERB
aji-154	234	36	the	the	DET
aji-154	234	37	suspected	suspect	VERB
aji-154	234	38	allergen	allergen	NOUN
aji-154	234	39	until	until	SCONJ
aji-154	234	40	the	the	DET
aji-154	234	41	symptoms	symptom	NOUN
aji-154	234	42	disappear	disappear	VERB
aji-154	234	43	and	and	CCONJ
aji-154	234	44	then	then	ADV
aji-154	234	45	re	re	VERB
aji-154	234	46	-	-	NOUN
aji-154	234	47	introduces	introduce	VERB
aji-154	234	48	the	the	DET
aji-154	234	49	allergen	allergen	NOUN
aji-154	234	50	to	to	PART
aji-154	234	51	observe	observe	VERB
aji-154	234	52	the	the	DET
aji-154	234	53	reactions	reaction	NOUN
aji-154	234	54	)	)	PUNCT
aji-154	234	55	.	.	PUNCT
aji-154	235	1	there	there	PRON
aji-154	235	2	was	be	VERB
aji-154	235	3	no	no	DET
aji-154	235	4	prospective	prospective	ADJ
aji-154	235	5	plan	plan	NOUN
aji-154	235	6	.	.	PUNCT
aji-154	236	1	we	we	PRON
aji-154	236	2	spreadsheeted	spreadsheete	VERB
aji-154	236	3	the	the	DET
aji-154	236	4	results	result	NOUN
aji-154	236	5	of	of	ADP
aji-154	236	6	a	a	DET
aji-154	236	7	retrospective	retrospective	ADJ
aji-154	236	8	compilation	compilation	NOUN
aji-154	236	9	of	of	ADP
aji-154	236	10	data	datum	NOUN
aji-154	236	11	produced	produce	VERB
aji-154	236	12	by	by	ADP
aji-154	236	13	ttp	ttp	PROPN
aji-154	236	14	and	and	CCONJ
aji-154	236	15	tial	tial	ADJ
aji-154	236	16	,	,	PUNCT
aji-154	236	17	exploring	explore	VERB
aji-154	236	18	humoral	humoral	ADJ
aji-154	236	19	and	and	CCONJ
aji-154	236	20	cellular	cellular	ADJ
aji-154	236	21	immunoreactivity	immunoreactivity	NOUN
aji-154	236	22	against	against	ADP
aji-154	236	23	lanolin	lanolin	NOUN
aji-154	236	24	.	.	PUNCT
aji-154	237	1	these	these	DET
aji-154	237	2	assays	assay	NOUN
aji-154	237	3	provide	provide	VERB
aji-154	237	4	clues	clue	NOUN
aji-154	237	5	about	about	ADP
aji-154	237	6	humoral	humoral	ADJ
aji-154	237	7	and	and	CCONJ
aji-154	237	8	cellular	cellular	ADJ
aji-154	237	9	immunoreactivity	immunoreactivity	NOUN
aji-154	237	10	,	,	PUNCT
aji-154	237	11	and	and	CCONJ
aji-154	237	12	the	the	DET
aji-154	237	13	results	result	NOUN
aji-154	237	14	distribute	distribute	VERB
aji-154	237	15	themselves	themselves	PRON
aji-154	237	16	in	in	ADP
aji-154	237	17	an	an	DET
aji-154	237	18	extensive	extensive	ADJ
aji-154	237	19	spectral	spectral	ADJ
aji-154	237	20	range	range	NOUN
aji-154	237	21	between	between	ADP
aji-154	237	22	immune	immune	ADJ
aji-154	237	23	tolerance	tolerance	NOUN
aji-154	237	24	and	and	CCONJ
aji-154	237	25	symptomatic	symptomatic	ADJ
aji-154	237	26	hypersensitivity	hypersensitivity	NOUN
aji-154	237	27	.	.	PUNCT
aji-154	238	1	results	result	NOUN
aji-154	238	2	provided	provide	VERB
aji-154	238	3	by	by	ADP
aji-154	238	4	lait	lait	NOUN
aji-154	238	5	and	and	CCONJ
aji-154	238	6	ttp	ttp	PROPN
aji-154	238	7	were	be	AUX
aji-154	238	8	interpreted	interpret	VERB
aji-154	238	9	as	as	ADP
aji-154	238	10	markers	marker	NOUN
aji-154	238	11	of	of	ADP
aji-154	238	12	the	the	DET
aji-154	238	13	immune	immune	ADJ
aji-154	238	14	response	response	NOUN
aji-154	238	15	after	after	ADP
aji-154	238	16	contact	contact	NOUN
aji-154	238	17	with	with	ADP
aji-154	238	18	the	the	DET
aji-154	238	19	specific	specific	ADJ
aji-154	238	20	antigen	antigen	NOUN
aji-154	238	21	,	,	PUNCT
aji-154	238	22	configuring	configure	VERB
aji-154	238	23	themselves	themselves	PRON
aji-154	238	24	as	as	ADP
aji-154	238	25	techniques	technique	NOUN
aji-154	238	26	to	to	PART
aji-154	238	27	identify	identify	VERB
aji-154	238	28	exposition	exposition	NOUN
aji-154	238	29	to	to	ADP
aji-154	238	30	the	the	DET
aji-154	238	31	antigen	antigen	NOUN
aji-154	238	32	,	,	PUNCT
aji-154	238	33	as	as	SCONJ
aji-154	238	34	proposed	propose	VERB
aji-154	238	35	by	by	ADP
aji-154	238	36	the	the	DET
aji-154	238	37	exposome	exposome	NOUN
aji-154	238	38	-	-	PUNCT
aji-154	238	39	wide	wide	ADJ
aji-154	238	40	association	association	NOUN
aji-154	238	41	study	study	NOUN
aji-154	238	42	[	[	X
aji-154	238	43	57	57	NUM
aji-154	238	44	]	]	PUNCT
aji-154	238	45	.	.	PUNCT
aji-154	239	1	this	this	DET
aji-154	239	2	retrospective	retrospective	ADJ
aji-154	239	3	survey	survey	NOUN
aji-154	239	4	demonstrated	demonstrate	VERB
aji-154	239	5	significative	significative	ADJ
aji-154	239	6	cellular	cellular	ADJ
aji-154	239	7	and	and	CCONJ
aji-154	239	8	humoral	humoral	ADJ
aji-154	239	9	immunoreactivity	immunoreactivity	NOUN
aji-154	239	10	demonstrated	demonstrate	VERB
aji-154	239	11	by	by	ADP
aji-154	239	12	the	the	DET
aji-154	239	13	ttp	ttp	NOUN
aji-154	239	14	and	and	CCONJ
aji-154	239	15	the	the	DET
aji-154	239	16	ex	ex	X
aji-154	239	17	vivo	vivo	NOUN
aji-154	239	18	challenge	challenge	NOUN
aji-154	239	19	test	test	NOUN
aji-154	239	20	monitored	monitor	VERB
aji-154	239	21	by	by	ADP
aji-154	239	22	lait	lait	NOUN
aji-154	239	23	against	against	ADP
aji-154	239	24	lanolin	lanolin	NOUN
aji-154	239	25	in	in	ADP
aji-154	239	26	two	two	NUM
aji-154	239	27	cohorts	cohort	NOUN
aji-154	239	28	of	of	ADP
aji-154	239	29	patients	patient	NOUN
aji-154	239	30	with	with	ADP
aji-154	239	31	atopic	atopic	NOUN
aji-154	239	32	and/or	and/or	CCONJ
aji-154	239	33	contact	contact	NOUN
aji-154	239	34	dermatitis	dermatitis	NOUN
aji-154	239	35	.	.	PUNCT
aji-154	240	1	all	all	DET
aji-154	240	2	patients	patient	NOUN
aji-154	240	3	evaluated	evaluate	VERB
aji-154	240	4	with	with	ADP
aji-154	240	5	ttp	ttp	PROPN
aji-154	240	6	demonstrated	demonstrate	VERB
aji-154	240	7	some	some	DET
aji-154	240	8	degree	degree	NOUN
aji-154	240	9	of	of	ADP
aji-154	240	10	humoral	humoral	ADJ
aji-154	240	11	immunoreactivity	immunoreactivity	NOUN
aji-154	240	12	(	(	PUNCT
aji-154	240	13	there	there	PRON
aji-154	240	14	was	be	VERB
aji-154	240	15	no	no	DET
aji-154	240	16	negative	negative	ADJ
aji-154	240	17	result	result	NOUN
aji-154	240	18	)	)	PUNCT
aji-154	240	19	,	,	PUNCT
aji-154	240	20	and	and	CCONJ
aji-154	240	21	most	most	ADV
aji-154	240	22	presented	present	VERB
aji-154	240	23	positivity	positivity	NOUN
aji-154	240	24	by	by	ADP
aji-154	240	25	the	the	DET
aji-154	240	26	more	more	ADV
aji-154	240	27	diluted	diluted	ADJ
aji-154	240	28	titrations	titration	NOUN
aji-154	240	29	,	,	PUNCT
aji-154	240	30	demonstrating	demonstrate	VERB
aji-154	240	31	that	that	SCONJ
aji-154	240	32	lanolin	lanolin	NOUN
aji-154	240	33	allergens	allergen	NOUN
aji-154	240	34	are	be	AUX
aji-154	240	35	widespread	widespread	ADJ
aji-154	240	36	among	among	ADP
aji-154	240	37	patients	patient	NOUN
aji-154	240	38	with	with	ADP
aji-154	240	39	dermatitis	dermatitis	NOUN
aji-154	240	40	and	and	CCONJ
aji-154	240	41	are	be	AUX
aji-154	240	42	highly	highly	ADV
aji-154	240	43	immunogenic	immunogenic	ADJ
aji-154	240	44	.	.	PUNCT
aji-154	241	1	sixteen	sixteen	NUM
aji-154	241	2	patients	patient	NOUN
aji-154	241	3	did	do	AUX
aji-154	241	4	not	not	PART
aji-154	241	5	present	present	VERB
aji-154	241	6	cellular	cellular	ADJ
aji-154	241	7	immunoreactivity	immunoreactivity	NOUN
aji-154	241	8	against	against	ADP
aji-154	241	9	lanolin	lanolin	PROPN
aji-154	241	10	(	(	PUNCT
aji-154	241	11	lai	lai	NOUN
aji-154	241	12	=	=	PUNCT
aji-154	241	13	zero%	zero%	NUM
aji-154	241	14	)	)	PUNCT
aji-154	241	15	.	.	PUNCT
aji-154	242	1	in	in	ADP
aji-154	242	2	contrast	contrast	NOUN
aji-154	242	3	,	,	PUNCT
aji-154	242	4	others	other	NOUN
aji-154	242	5	presented	present	VERB
aji-154	242	6	an	an	DET
aji-154	242	7	extensive	extensive	ADJ
aji-154	242	8	range	range	NOUN
aji-154	242	9	of	of	ADP
aji-154	242	10	inhibition	inhibition	NOUN
aji-154	242	11	of	of	ADP
aji-154	242	12	the	the	DET
aji-154	242	13	leukocyte	leukocyte	NOUN
aji-154	242	14	adherence	adherence	NOUN
aji-154	242	15	after	after	ADP
aji-154	242	16	the	the	DET
aji-154	242	17	ex	ex	ADJ
aji-154	242	18	vivo	vivo	ADJ
aji-154	242	19	provocation	provocation	NOUN
aji-154	242	20	test	test	NOUN
aji-154	242	21	,	,	PUNCT
aji-154	242	22	suggesting	suggest	VERB
aji-154	242	23	that	that	SCONJ
aji-154	242	24	cellular	cellular	ADJ
aji-154	242	25	immunoreactivity	immunoreactivity	NOUN
aji-154	242	26	must	must	AUX
aji-154	242	27	be	be	AUX
aji-154	242	28	a	a	DET
aji-154	242	29	better	well	ADJ
aji-154	242	30	parameter	parameter	NOUN
aji-154	242	31	to	to	PART
aji-154	242	32	differentiate	differentiate	VERB
aji-154	242	33	hypersensitivity	hypersensitivity	NOUN
aji-154	242	34	reactions	reaction	NOUN
aji-154	242	35	among	among	ADP
aji-154	242	36	patients	patient	NOUN
aji-154	242	37	.	.	PUNCT
aji-154	243	1	none	none	NOUN
aji-154	243	2	of	of	ADP
aji-154	243	3	our	our	PRON
aji-154	243	4	patients	patient	NOUN
aji-154	243	5	presented	present	VERB
aji-154	243	6	an	an	DET
aji-154	243	7	exclusive	exclusive	ADJ
aji-154	243	8	reaction	reaction	NOUN
aji-154	243	9	to	to	ADP
aji-154	243	10	lanolin	lanolin	NOUN
aji-154	243	11	.	.	PUNCT
aji-154	244	1	we	we	PRON
aji-154	244	2	assessed	assess	VERB
aji-154	244	3	every	every	DET
aji-154	244	4	patient	patient	NOUN
aji-154	244	5	simultaneously	simultaneously	ADV
aji-154	244	6	with	with	ADP
aji-154	244	7	several	several	ADJ
aji-154	244	8	chemical	chemical	ADJ
aji-154	244	9	and	and	CCONJ
aji-154	244	10	biological	biological	ADJ
aji-154	244	11	allergens	allergen	NOUN
aji-154	244	12	,	,	PUNCT
aji-154	244	13	demonstrating	demonstrate	VERB
aji-154	244	14	positive	positive	ADJ
aji-154	244	15	results	result	NOUN
aji-154	244	16	for	for	ADP
aji-154	244	17	some	some	PRON
aji-154	244	18	of	of	ADP
aji-154	244	19	them	they	PRON
aji-154	244	20	,	,	PUNCT
aji-154	244	21	according	accord	VERB
aji-154	244	22	to	to	ADP
aji-154	244	23	the	the	DET
aji-154	244	24	clinical	clinical	ADJ
aji-154	244	25	suspicions	suspicion	NOUN
aji-154	244	26	.	.	PUNCT
aji-154	245	1	the	the	DET
aji-154	245	2	most	most	ADV
aji-154	245	3	vital	vital	ADJ
aji-154	245	4	suggestion	suggestion	NOUN
aji-154	245	5	driven	drive	VERB
aji-154	245	6	by	by	ADP
aji-154	245	7	the	the	DET
aji-154	245	8	results	result	NOUN
aji-154	245	9	is	be	AUX
aji-154	245	10	that	that	SCONJ
aji-154	245	11	allergic	allergic	ADJ
aji-154	245	12	patients	patient	NOUN
aji-154	245	13	may	may	AUX
aji-154	245	14	impair	impair	VERB
aji-154	245	15	their	their	PRON
aji-154	245	16	symptoms	symptom	NOUN
aji-154	245	17	by	by	ADP
aji-154	245	18	using	use	VERB
aji-154	245	19	creams	cream	NOUN
aji-154	245	20	or	or	CCONJ
aji-154	245	21	cosmetics	cosmetic	NOUN
aji-154	245	22	produced	produce	VERB
aji-154	245	23	with	with	ADP
aji-154	245	24	lanolin	lanolin	PROPN
aji-154	245	25	.	.	PUNCT
aji-154	246	1	in	in	ADP
aji-154	246	2	our	our	PRON
aji-154	246	3	practice	practice	NOUN
aji-154	246	4	,	,	PUNCT
aji-154	246	5	we	we	PRON
aji-154	246	6	have	have	AUX
aji-154	246	7	observed	observe	VERB
aji-154	246	8	immediate	immediate	ADJ
aji-154	246	9	cutaneous	cutaneous	ADJ
aji-154	246	10	reactions	reaction	NOUN
aji-154	246	11	(	(	PUNCT
aji-154	246	12	obtained	obtain	VERB
aji-154	246	13	by	by	ADP
aji-154	246	14	the	the	DET
aji-154	246	15	skin	skin	NOUN
aji-154	246	16	scrape	scrape	NOUN
aji-154	246	17	olivier	olivier	NOUN
aji-154	246	18	et	et	PROPN
aji-154	246	19	al	al	PROPN
aji-154	246	20	.	.	PROPN
aji-154	246	21	;	;	PUNCT
aji-154	247	1	asian	asian	PROPN
aji-154	247	2	j.	j.	PROPN
aji-154	247	3	immunol	immunol	PROPN
aji-154	247	4	.	.	PROPN
aji-154	247	5	,	,	PUNCT
aji-154	247	6	vol	vol	NOUN
aji-154	247	7	.	.	PROPN
aji-154	247	8	7	7	NUM
aji-154	247	9	,	,	PUNCT
aji-154	247	10	no	no	INTJ
aji-154	247	11	.	.	NOUN
aji-154	247	12	1	1	NUM
aji-154	247	13	,	,	PUNCT
aji-154	247	14	pp	pp	ADJ
aji-154	247	15	.	.	PUNCT
aji-154	248	1	316	316	NUM
aji-154	248	2	-	-	SYM
aji-154	248	3	325	325	NUM
aji-154	248	4	,	,	PUNCT
aji-154	248	5	2024	2024	NUM
aji-154	248	6	;	;	PUNCT
aji-154	248	7	article	article	NOUN
aji-154	248	8	no.aji.128121	no.aji.128121	VERB
aji-154	248	9	322	322	NUM
aji-154	248	10	test	test	NOUN
aji-154	248	11	)	)	PUNCT
aji-154	248	12	and	and	CCONJ
aji-154	248	13	delayed	delay	VERB
aji-154	248	14	reactions	reaction	NOUN
aji-154	248	15	obtained	obtain	VERB
aji-154	248	16	by	by	ADP
aji-154	248	17	a	a	DET
aji-154	248	18	fortyeight	fortyeight	ADJ
aji-154	248	19	-	-	PUNCT
aji-154	248	20	hour	hour	NOUN
aji-154	248	21	contact	contact	NOUN
aji-154	248	22	test	test	NOUN
aji-154	248	23	or	or	CCONJ
aji-154	248	24	a	a	DET
aji-154	248	25	photosensitized	photosensitized	ADJ
aji-154	248	26	ninety	ninety	NUM
aji-154	248	27	-	-	PUNCT
aji-154	248	28	six	six	NUM
aji-154	248	29	-	-	PUNCT
aji-154	248	30	hour	hour	NOUN
aji-154	248	31	contact	contact	NOUN
aji-154	248	32	test	test	NOUN
aji-154	248	33	(	(	PUNCT
aji-154	248	34	patch	patch	NOUN
aji-154	248	35	test	test	NOUN
aji-154	248	36	)	)	PUNCT
aji-154	248	37	.	.	PUNCT
aji-154	249	1	based	base	VERB
aji-154	249	2	on	on	ADP
aji-154	249	3	this	this	DET
aji-154	249	4	clinical	clinical	ADJ
aji-154	249	5	experience	experience	NOUN
aji-154	249	6	,	,	PUNCT
aji-154	249	7	we	we	PRON
aji-154	249	8	can	can	AUX
aji-154	249	9	hypothesize	hypothesize	VERB
aji-154	249	10	that	that	SCONJ
aji-154	249	11	at	at	ADV
aji-154	249	12	least	least	ADV
aji-154	249	13	three	three	NUM
aji-154	249	14	endotypes	endotype	NOUN
aji-154	249	15	are	be	AUX
aji-154	249	16	associated	associate	VERB
aji-154	249	17	with	with	ADP
aji-154	249	18	lanolin	lanolin	PROPN
aji-154	249	19	hypersensitivity	hypersensitivity	NOUN
aji-154	249	20	.	.	PUNCT
aji-154	250	1	the	the	DET
aji-154	250	2	results	result	NOUN
aji-154	250	3	presented	present	VERB
aji-154	250	4	by	by	ADP
aji-154	250	5	this	this	DET
aji-154	250	6	work	work	NOUN
aji-154	250	7	demonstrated	demonstrate	VERB
aji-154	250	8	that	that	SCONJ
aji-154	250	9	there	there	PRON
aji-154	250	10	is	be	VERB
aji-154	250	11	yet	yet	ADV
aji-154	250	12	a	a	DET
aji-154	250	13	lot	lot	NOUN
aji-154	250	14	unknown	unknown	ADJ
aji-154	250	15	about	about	ADP
aji-154	250	16	the	the	DET
aji-154	250	17	endotypes	endotype	NOUN
aji-154	250	18	responsible	responsible	ADJ
aji-154	250	19	for	for	ADP
aji-154	250	20	lanolin	lanolin	NOUN
aji-154	250	21	hypersensitivity	hypersensitivity	NOUN
aji-154	250	22	,	,	PUNCT
aji-154	250	23	which	which	PRON
aji-154	250	24	may	may	AUX
aji-154	250	25	be	be	AUX
aji-154	250	26	produced	produce	VERB
aji-154	250	27	by	by	ADP
aji-154	250	28	at	at	ADV
aji-154	250	29	least	least	ADV
aji-154	250	30	three	three	NUM
aji-154	250	31	mechanisms	mechanism	NOUN
aji-154	250	32	:	:	PUNCT
aji-154	250	33	a	a	DET
aji-154	250	34	predominantly	predominantly	ADV
aji-154	250	35	humoral	humoral	ADJ
aji-154	250	36	,	,	PUNCT
aji-154	250	37	a	a	DET
aji-154	250	38	predominantly	predominantly	ADV
aji-154	250	39	cellular	cellular	ADJ
aji-154	250	40	,	,	PUNCT
aji-154	250	41	and	and	CCONJ
aji-154	250	42	a	a	DET
aji-154	250	43	compound	compound	NOUN
aji-154	250	44	of	of	ADP
aji-154	250	45	both	both	PRON
aji-154	250	46	.	.	PUNCT
aji-154	251	1	5	5	X
aji-154	251	2	.	.	X
aji-154	251	3	limitations	limitation	NOUN
aji-154	251	4	this	this	DET
aji-154	251	5	study	study	NOUN
aji-154	251	6	is	be	AUX
aji-154	251	7	a	a	DET
aji-154	251	8	retrospective	retrospective	ADJ
aji-154	251	9	analysis	analysis	NOUN
aji-154	251	10	of	of	ADP
aji-154	251	11	data	datum	NOUN
aji-154	251	12	collected	collect	VERB
aji-154	251	13	over	over	ADP
aji-154	251	14	six	six	NUM
aji-154	251	15	years	year	NOUN
aji-154	251	16	.	.	PUNCT
aji-154	252	1	there	there	PRON
aji-154	252	2	was	be	VERB
aji-154	252	3	no	no	DET
aji-154	252	4	protocol	protocol	NOUN
aji-154	252	5	research	research	NOUN
aji-154	252	6	,	,	PUNCT
aji-154	252	7	and	and	CCONJ
aji-154	252	8	the	the	DET
aji-154	252	9	subject	subject	NOUN
aji-154	252	10	's	's	PART
aji-154	252	11	data	datum	NOUN
aji-154	252	12	was	be	AUX
aji-154	252	13	limited	limit	VERB
aji-154	252	14	to	to	ADP
aji-154	252	15	the	the	DET
aji-154	252	16	essentials	essential	NOUN
aji-154	252	17	available	available	ADJ
aji-154	252	18	on	on	ADP
aji-154	252	19	our	our	PRON
aji-154	252	20	electronic	electronic	ADJ
aji-154	252	21	sheets	sheet	NOUN
aji-154	252	22	.	.	PUNCT
aji-154	253	1	therefore	therefore	ADV
aji-154	253	2	,	,	PUNCT
aji-154	253	3	we	we	PRON
aji-154	253	4	could	could	AUX
aji-154	253	5	not	not	PART
aji-154	253	6	establish	establish	VERB
aji-154	253	7	a	a	DET
aji-154	253	8	crosscomparison	crosscomparison	NOUN
aji-154	253	9	between	between	ADP
aji-154	253	10	positive	positive	ADJ
aji-154	253	11	and	and	CCONJ
aji-154	253	12	negative	negative	ADJ
aji-154	253	13	controls	control	NOUN
aji-154	253	14	to	to	PART
aji-154	253	15	validate	validate	VERB
aji-154	253	16	the	the	DET
aji-154	253	17	results	result	NOUN
aji-154	253	18	.	.	PUNCT
aji-154	254	1	the	the	DET
aji-154	254	2	number	number	NOUN
aji-154	254	3	of	of	ADP
aji-154	254	4	subjects	subject	NOUN
aji-154	254	5	is	be	AUX
aji-154	254	6	appropriate	appropriate	ADJ
aji-154	254	7	for	for	ADP
aji-154	254	8	a	a	DET
aji-154	254	9	preliminary	preliminary	ADJ
aji-154	254	10	study	study	NOUN
aji-154	254	11	;	;	PUNCT
aji-154	254	12	however	however	ADV
aji-154	254	13	,	,	PUNCT
aji-154	254	14	future	future	ADJ
aji-154	254	15	studies	study	NOUN
aji-154	254	16	must	must	AUX
aji-154	254	17	be	be	AUX
aji-154	254	18	more	more	ADV
aji-154	254	19	comprehensive	comprehensive	ADJ
aji-154	254	20	.	.	PUNCT
aji-154	255	1	the	the	DET
aji-154	255	2	lack	lack	NOUN
aji-154	255	3	of	of	ADP
aji-154	255	4	a	a	DET
aji-154	255	5	research	research	NOUN
aji-154	255	6	protocol	protocol	NOUN
aji-154	255	7	implies	imply	VERB
aji-154	255	8	the	the	DET
aji-154	255	9	possibility	possibility	NOUN
aji-154	255	10	of	of	ADP
aji-154	255	11	a	a	DET
aji-154	255	12	bias	bias	NOUN
aji-154	255	13	produced	produce	VERB
aji-154	255	14	by	by	ADP
aji-154	255	15	the	the	DET
aji-154	255	16	physician	physician	NOUN
aji-154	255	17	's	's	PART
aji-154	255	18	point	point	NOUN
aji-154	255	19	of	of	ADP
aji-154	255	20	view	view	NOUN
aji-154	255	21	,	,	PUNCT
aji-154	255	22	who	who	PRON
aji-154	255	23	suggested	suggest	VERB
aji-154	255	24	the	the	DET
aji-154	255	25	exam	exam	NOUN
aji-154	255	26	barely	barely	ADV
aji-154	255	27	on	on	ADP
aji-154	255	28	clinical	clinical	ADJ
aji-154	255	29	suspicion	suspicion	NOUN
aji-154	255	30	led	lead	VERB
aji-154	255	31	purely	purely	ADV
aji-154	255	32	by	by	ADP
aji-154	255	33	the	the	DET
aji-154	255	34	anamnesis	anamnesis	NOUN
aji-154	255	35	and	and	CCONJ
aji-154	255	36	physical	physical	ADJ
aji-154	255	37	examination	examination	NOUN
aji-154	255	38	.	.	PUNCT
aji-154	256	1	the	the	DET
aji-154	256	2	study	study	NOUN
aji-154	256	3	lost	lose	VERB
aji-154	256	4	many	many	ADJ
aji-154	256	5	of	of	ADP
aji-154	256	6	these	these	DET
aji-154	256	7	patients	patient	NOUN
aji-154	256	8	to	to	PART
aji-154	256	9	follow	follow	VERB
aji-154	256	10	-	-	PUNCT
aji-154	256	11	up	up	NOUN
aji-154	256	12	,	,	PUNCT
aji-154	256	13	so	so	ADV
aji-154	256	14	assuring	assure	VERB
aji-154	256	15	the	the	DET
aji-154	256	16	relationship	relationship	NOUN
aji-154	256	17	between	between	ADP
aji-154	256	18	the	the	DET
aji-154	256	19	immunoassays	immunoassay	NOUN
aji-154	256	20	'	'	PART
aji-154	256	21	results	result	NOUN
aji-154	256	22	and	and	CCONJ
aji-154	256	23	the	the	DET
aji-154	256	24	patient	patient	NOUN
aji-154	256	25	's	's	PART
aji-154	256	26	clinical	clinical	ADJ
aji-154	256	27	outcome	outcome	NOUN
aji-154	256	28	is	be	AUX
aji-154	256	29	impossible	impossible	ADJ
aji-154	256	30	.	.	PUNCT
aji-154	257	1	6	6	X
aji-154	257	2	.	.	X
aji-154	257	3	conclusion	conclusion	NOUN
aji-154	257	4	our	our	PRON
aji-154	257	5	preliminary	preliminary	ADJ
aji-154	257	6	results	result	NOUN
aji-154	257	7	show	show	VERB
aji-154	257	8	that	that	SCONJ
aji-154	257	9	the	the	DET
aji-154	257	10	lait	lait	NOUN
aji-154	257	11	and	and	CCONJ
aji-154	257	12	ttp	ttp	PROPN
aji-154	257	13	may	may	AUX
aji-154	257	14	differentiate	differentiate	VERB
aji-154	257	15	diverse	diverse	ADJ
aji-154	257	16	cellular	cellular	ADJ
aji-154	257	17	and	and	CCONJ
aji-154	257	18	humoral	humoral	ADJ
aji-154	257	19	immunoreactivity	immunoreactivity	NOUN
aji-154	257	20	degrees	degree	NOUN
aji-154	257	21	against	against	ADP
aji-154	257	22	lanolin	lanolin	NOUN
aji-154	257	23	in	in	ADP
aji-154	257	24	patients	patient	NOUN
aji-154	257	25	clinically	clinically	ADV
aji-154	257	26	diagnosed	diagnose	VERB
aji-154	257	27	with	with	ADP
aji-154	257	28	non	non	ADJ
aji-154	257	29	–	–	PUNCT
aji-154	257	30	ige	ige	ADJ
aji-154	257	31	-	-	PUNCT
aji-154	257	32	mediated	mediate	VERB
aji-154	257	33	allergies	allergy	NOUN
aji-154	257	34	.	.	PUNCT
aji-154	258	1	this	this	DET
aji-154	258	2	methodology	methodology	NOUN
aji-154	258	3	can	can	AUX
aji-154	258	4	provide	provide	VERB
aji-154	258	5	a	a	DET
aji-154	258	6	socioeconomic	socioeconomic	ADJ
aji-154	258	7	impact	impact	NOUN
aji-154	258	8	since	since	SCONJ
aji-154	258	9	the	the	DET
aji-154	258	10	technologies	technology	NOUN
aji-154	258	11	to	to	PART
aji-154	258	12	perform	perform	VERB
aji-154	258	13	tial	tial	ADJ
aji-154	258	14	and	and	CCONJ
aji-154	258	15	ttp	ttp	NOUN
aji-154	258	16	are	be	AUX
aji-154	258	17	inexpensive	inexpensive	ADJ
aji-154	258	18	and	and	CCONJ
aji-154	258	19	can	can	AUX
aji-154	258	20	be	be	AUX
aji-154	258	21	performed	perform	VERB
aji-154	258	22	in	in	ADP
aji-154	258	23	a	a	DET
aji-154	258	24	single	single	ADJ
aji-154	258	25	lab	lab	NOUN
aji-154	258	26	room	room	NOUN
aji-154	258	27	attached	attach	VERB
aji-154	258	28	to	to	ADP
aji-154	258	29	the	the	DET
aji-154	258	30	facilities	facility	NOUN
aji-154	258	31	with	with	ADP
aji-154	258	32	minimum	minimum	ADJ
aji-154	258	33	laboratory	laboratory	NOUN
aji-154	258	34	equipment	equipment	NOUN
aji-154	258	35	.	.	PUNCT
aji-154	259	1	however	however	ADV
aji-154	259	2	,	,	PUNCT
aji-154	259	3	the	the	DET
aji-154	259	4	propaedeutic	propaedeutic	ADJ
aji-154	259	5	meaning	meaning	NOUN
aji-154	259	6	of	of	ADP
aji-154	259	7	these	these	DET
aji-154	259	8	results	result	NOUN
aji-154	259	9	and	and	CCONJ
aji-154	259	10	the	the	DET
aji-154	259	11	possibility	possibility	NOUN
aji-154	259	12	of	of	ADP
aji-154	259	13	interferents	interferent	NOUN
aji-154	259	14	must	must	AUX
aji-154	259	15	be	be	AUX
aji-154	259	16	better	well	ADV
aji-154	259	17	established	establish	VERB
aji-154	259	18	[	[	X
aji-154	259	19	58	58	NUM
aji-154	259	20	]	]	PUNCT
aji-154	259	21	.	.	PUNCT
aji-154	260	1	more	more	ADJ
aji-154	260	2	studies	study	NOUN
aji-154	260	3	focused	focus	VERB
aji-154	260	4	on	on	ADP
aji-154	260	5	the	the	DET
aji-154	260	6	quality	quality	NOUN
aji-154	260	7	-	-	PUNCT
aji-154	260	8	by	by	ADP
aji-154	260	9	-	-	PUNCT
aji-154	260	10	design	design	NOUN
aji-154	260	11	approach	approach	NOUN
aji-154	260	12	with	with	ADP
aji-154	260	13	prospective	prospective	ADJ
aji-154	260	14	larger	large	ADJ
aji-154	260	15	double	double	ADJ
aji-154	260	16	-	-	PUNCT
aji-154	260	17	blind	blind	ADJ
aji-154	260	18	cohorts	cohort	NOUN
aji-154	260	19	need	need	VERB
aji-154	260	20	to	to	PART
aji-154	260	21	evaluate	evaluate	VERB
aji-154	260	22	the	the	DET
aji-154	260	23	potential	potential	ADJ
aji-154	260	24	contribution	contribution	NOUN
aji-154	260	25	of	of	ADP
aji-154	260	26	lait	lait	NOUN
aji-154	260	27	and	and	CCONJ
aji-154	260	28	ttp	ttp	NOUN
aji-154	260	29	for	for	ADP
aji-154	260	30	endotyping	endotype	VERB
aji-154	260	31	immunoreactivity	immunoreactivity	NOUN
aji-154	260	32	of	of	ADP
aji-154	260	33	patients	patient	NOUN
aji-154	260	34	suspected	suspect	VERB
aji-154	260	35	of	of	ADP
aji-154	260	36	symptomatic	symptomatic	ADJ
aji-154	260	37	hypersensitivity	hypersensitivity	NOUN
aji-154	260	38	against	against	ADP
aji-154	260	39	lanolin	lanolin	NOUN
aji-154	260	40	and	and	CCONJ
aji-154	260	41	other	other	ADJ
aji-154	260	42	similar	similar	ADJ
aji-154	260	43	food	food	NOUN
aji-154	260	44	processing	processing	NOUN
aji-154	260	45	additives	additive	NOUN
aji-154	261	1	[	[	X
aji-154	261	2	59	59	NUM
aji-154	261	3	]	]	PUNCT
aji-154	261	4	.	.	PUNCT
aji-154	262	1	we	we	PRON
aji-154	262	2	are	be	AUX
aji-154	262	3	planning	plan	VERB
aji-154	262	4	future	future	ADJ
aji-154	262	5	work	work	NOUN
aji-154	262	6	with	with	ADP
aji-154	262	7	control	control	NOUN
aji-154	262	8	groups	group	NOUN
aji-154	262	9	to	to	PART
aji-154	262	10	draw	draw	VERB
aji-154	262	11	more	more	ADV
aji-154	262	12	substantiated	substantiated	ADJ
aji-154	262	13	conclusions	conclusion	NOUN
aji-154	262	14	.	.	PUNCT
aji-154	263	1	7	7	X
aji-154	263	2	.	.	X
aji-154	263	3	future	future	ADJ
aji-154	263	4	directions	direction	NOUN
aji-154	263	5	and	and	CCONJ
aji-154	263	6	recommendations	recommendation	NOUN
aji-154	263	7	for	for	ADP
aji-154	263	8	clinical	clinical	ADJ
aji-154	263	9	practice	practice	NOUN
aji-154	263	10	the	the	DET
aji-154	263	11	primary	primary	ADJ
aji-154	263	12	intended	intend	VERB
aji-154	263	13	use	use	NOUN
aji-154	263	14	of	of	ADP
aji-154	263	15	in	in	ADP
aji-154	263	16	vitro	vitro	X
aji-154	263	17	or	or	CCONJ
aji-154	263	18	ex	ex	PRON
aji-154	263	19	vivo	vivo	NOUN
aji-154	263	20	allergen	allergen	NOUN
aji-154	263	21	challenge	challenge	NOUN
aji-154	263	22	tests	test	NOUN
aji-154	263	23	is	be	AUX
aji-154	263	24	to	to	PART
aji-154	263	25	spare	spare	VERB
aji-154	263	26	the	the	DET
aji-154	263	27	patients	patient	NOUN
aji-154	263	28	from	from	ADP
aji-154	263	29	being	be	AUX
aji-154	263	30	submitted	submit	VERB
aji-154	263	31	to	to	ADP
aji-154	263	32	unnecessary	unnecessary	ADJ
aji-154	263	33	,	,	PUNCT
aji-154	263	34	exhaustive	exhaustive	ADJ
aji-154	263	35	,	,	PUNCT
aji-154	263	36	and	and	CCONJ
aji-154	263	37	dangerous	dangerous	ADJ
aji-154	263	38	in	in	ADP
aji-154	263	39	vivo	vivo	ADJ
aji-154	263	40	challenge	challenge	NOUN
aji-154	263	41	tests	test	NOUN
aji-154	263	42	.	.	PUNCT
aji-154	264	1	exploring	explore	VERB
aji-154	264	2	the	the	DET
aji-154	264	3	humoral	humoral	ADJ
aji-154	264	4	and	and	CCONJ
aji-154	264	5	the	the	DET
aji-154	264	6	cellular	cellular	ADJ
aji-154	264	7	arms	arm	NOUN
aji-154	264	8	of	of	ADP
aji-154	264	9	immune	immune	ADJ
aji-154	264	10	systems	system	NOUN
aji-154	264	11	,	,	PUNCT
aji-154	264	12	the	the	DET
aji-154	264	13	ttp	ttp	NOUN
aji-154	264	14	and	and	CCONJ
aji-154	264	15	tial	tial	NOUN
aji-154	264	16	alone	alone	ADV
aji-154	264	17	or	or	CCONJ
aji-154	264	18	combined	combine	VERB
aji-154	264	19	may	may	AUX
aji-154	264	20	represent	represent	VERB
aji-154	264	21	,	,	PUNCT
aji-154	264	22	in	in	ADP
aji-154	264	23	the	the	DET
aji-154	264	24	near	near	ADJ
aji-154	264	25	future	future	NOUN
aji-154	264	26	,	,	PUNCT
aji-154	264	27	a	a	DET
aji-154	264	28	tool	tool	NOUN
aji-154	264	29	for	for	ADP
aji-154	264	30	allergists	allergist	NOUN
aji-154	264	31	to	to	PART
aji-154	264	32	construct	construct	VERB
aji-154	264	33	an	an	DET
aji-154	264	34	etiologic	etiologic	ADJ
aji-154	264	35	diagnosis	diagnosis	NOUN
aji-154	264	36	from	from	ADP
aji-154	264	37	their	their	PRON
aji-154	264	38	patients	patient	NOUN
aji-154	264	39	,	,	PUNCT
aji-154	264	40	as	as	ADV
aji-154	264	41	well	well	ADV
aji-154	264	42	as	as	ADP
aji-154	264	43	determine	determine	VERB
aji-154	264	44	the	the	DET
aji-154	264	45	endotypes	endotype	NOUN
aji-154	264	46	(	(	PUNCT
aji-154	264	47	mechanisms	mechanism	NOUN
aji-154	264	48	)	)	PUNCT
aji-154	264	49	of	of	ADP
aji-154	264	50	hypersensitivity	hypersensitivity	NOUN
aji-154	264	51	,	,	PUNCT
aji-154	264	52	in	in	ADP
aji-154	264	53	order	order	NOUN
aji-154	264	54	to	to	PART
aji-154	264	55	choose	choose	VERB
aji-154	264	56	more	more	ADV
aji-154	264	57	convenient	convenient	ADJ
aji-154	264	58	and	and	CCONJ
aji-154	264	59	personalized	personalized	ADJ
aji-154	264	60	therapies	therapy	NOUN
aji-154	264	61	for	for	ADP
aji-154	264	62	them	they	PRON
aji-154	264	63	.	.	PUNCT
aji-154	265	1	disclaimer	disclaimer	NOUN
aji-154	265	2	(	(	PUNCT
aji-154	265	3	artificial	artificial	ADJ
aji-154	265	4	intelligence	intelligence	NOUN
aji-154	265	5	)	)	PUNCT
aji-154	265	6	author(s	author(s	NOUN
aji-154	265	7	)	)	PUNCT
aji-154	265	8	hereby	hereby	ADV
aji-154	265	9	declare	declare	VERB
aji-154	265	10	that	that	SCONJ
aji-154	265	11	no	no	DET
aji-154	265	12	generative	generative	NOUN
aji-154	265	13	ai	ai	VERB
aji-154	265	14	technologies	technology	NOUN
aji-154	265	15	such	such	ADJ
aji-154	265	16	as	as	ADP
aji-154	265	17	large	large	ADJ
aji-154	265	18	language	language	NOUN
aji-154	265	19	models	model	NOUN
aji-154	265	20	(	(	PUNCT
aji-154	265	21	chatgpt	chatgpt	NOUN
aji-154	265	22	,	,	PUNCT
aji-154	265	23	copilot	copilot	NOUN
aji-154	265	24	,	,	PUNCT
aji-154	265	25	etc	etc	X
aji-154	265	26	.	.	X
aji-154	265	27	)	)	PUNCT
aji-154	265	28	and	and	CCONJ
aji-154	265	29	text	text	NOUN
aji-154	265	30	-	-	PUNCT
aji-154	265	31	to	to	ADP
aji-154	265	32	-	-	PUNCT
aji-154	265	33	image	image	NOUN
aji-154	265	34	generators	generator	NOUN
aji-154	265	35	have	have	AUX
aji-154	265	36	been	be	AUX
aji-154	265	37	used	use	VERB
aji-154	265	38	during	during	ADP
aji-154	265	39	the	the	DET
aji-154	265	40	writing	writing	NOUN
aji-154	265	41	or	or	CCONJ
aji-154	265	42	editing	editing	NOUN
aji-154	265	43	of	of	ADP
aji-154	265	44	this	this	DET
aji-154	265	45	manuscript	manuscript	NOUN
aji-154	265	46	.	.	PUNCT
aji-154	266	1	ethical	ethical	ADJ
aji-154	266	2	approval	approval	NOUN
aji-154	266	3	as	as	ADP
aji-154	266	4	a	a	DET
aji-154	266	5	retrospective	retrospective	ADJ
aji-154	266	6	survey	survey	NOUN
aji-154	266	7	of	of	ADP
aji-154	266	8	results	result	NOUN
aji-154	266	9	recorded	record	VERB
aji-154	266	10	in	in	ADP
aji-154	266	11	cognito	cognito	PROPN
aji-154	266	12	,	,	PUNCT
aji-154	266	13	consent	consent	NOUN
aji-154	266	14	was	be	AUX
aji-154	266	15	given	give	VERB
aji-154	266	16	collectively	collectively	ADV
aji-154	266	17	by	by	ADP
aji-154	266	18	the	the	DET
aji-154	266	19	institution	institution	NOUN
aji-154	266	20	's	's	PART
aji-154	266	21	ethics	ethic	NOUN
aji-154	266	22	committee	committee	NOUN
aji-154	266	23	following	follow	VERB
aji-154	266	24	the	the	DET
aji-154	266	25	principles	principle	NOUN
aji-154	266	26	of	of	ADP
aji-154	266	27	the	the	DET
aji-154	266	28	declaration	declaration	NOUN
aji-154	266	29	of	of	ADP
aji-154	266	30	helsinki	helsinki	PROPN
aji-154	267	1	[	[	X
aji-154	267	2	60	60	NUM
aji-154	267	3	]	]	PUNCT
aji-154	267	4	.	.	PUNCT
aji-154	268	1	acknowledgements	acknowledgement	VERB
aji-154	268	2	the	the	DET
aji-154	268	3	instituto	instituto	PROPN
aji-154	268	4	alergoimuno	alergoimuno	PROPN
aji-154	268	5	de	de	PROPN
aji-154	268	6	americana	americana	PROPN
aji-154	268	7	funded	fund	VERB
aji-154	268	8	this	this	DET
aji-154	268	9	work	work	NOUN
aji-154	268	10	.	.	PUNCT
aji-154	269	1	we	we	PRON
aji-154	269	2	want	want	VERB
aji-154	269	3	to	to	PART
aji-154	269	4	thank	thank	VERB
aji-154	269	5	the	the	DET
aji-154	269	6	laboratory	laboratory	NOUN
aji-154	269	7	technicians	technician	NOUN
aji-154	269	8	alessandra	alessandra	PROPN
aji-154	269	9	vieira	vieira	PROPN
aji-154	269	10	de	de	PROPN
aji-154	269	11	oliveira	oliveira	PROPN
aji-154	269	12	and	and	CCONJ
aji-154	269	13	luciana	luciana	PROPN
aji-154	269	14	sacilotto	sacilotto	PROPN
aji-154	269	15	carvalho	carvalho	PROPN
aji-154	269	16	for	for	ADP
aji-154	269	17	their	their	PRON
aji-154	269	18	help	help	NOUN
aji-154	269	19	with	with	ADP
aji-154	269	20	the	the	DET
aji-154	269	21	exams	exam	NOUN
aji-154	269	22	.	.	PUNCT
aji-154	270	1	competing	compete	VERB
aji-154	270	2	interests	interest	NOUN
aji-154	270	3	authors	author	NOUN
aji-154	270	4	have	have	AUX
aji-154	270	5	declared	declare	VERB
aji-154	270	6	that	that	SCONJ
aji-154	270	7	no	no	DET
aji-154	270	8	competing	compete	VERB
aji-154	270	9	interests	interest	NOUN
aji-154	270	10	exist	exist	VERB
aji-154	270	11	.	.	PUNCT
aji-154	271	1	references	reference	NOUN
aji-154	271	2	1	1	NUM
aji-154	271	3	.	.	PUNCT
aji-154	272	1	osborne	osborne	PROPN
aji-154	272	2	ed	ed	PROPN
aji-154	272	3	,	,	PUNCT
aji-154	272	4	murray	murray	PROPN
aji-154	272	5	pf	pf	PROPN
aji-154	272	6	.	.	PROPN
aji-154	272	7	atopic	atopic	PROPN
aji-154	272	8	dermatitis	dermatitis	PROPN
aji-154	272	9	;	;	PUNCT
aji-154	272	10	a	a	DET
aji-154	272	11	study	study	NOUN
aji-154	272	12	of	of	ADP
aji-154	272	13	its	its	PRON
aji-154	272	14	natural	natural	ADJ
aji-154	272	15	course	course	NOUN
aji-154	272	16	and	and	CCONJ
aji-154	272	17	of	of	ADP
aji-154	272	18	wool	wool	NOUN
aji-154	272	19	as	as	ADP
aji-154	272	20	a	a	DET
aji-154	272	21	dominant	dominant	ADJ
aji-154	272	22	allergenic	allergenic	ADJ
aji-154	272	23	factor	factor	NOUN
aji-154	272	24	.	.	PUNCT
aji-154	273	1	arch	arch	ADJ
aji-154	273	2	dermatol	dermatol	NOUN
aji-154	273	3	syphilol	syphilol	NOUN
aji-154	273	4	.	.	PUNCT
aji-154	274	1	1953;68(6):619	1953;68(6):619	NUM
aji-154	274	2	-	-	SYM
aji-154	274	3	630	630	NUM
aji-154	274	4	.	.	NOUN
aji-154	275	1	2	2	NUM
aji-154	275	2	.	.	NOUN
aji-154	275	3	hill	hill	PROPN
aji-154	275	4	lw	lw	PROPN
aji-154	275	5	.	.	PUNCT
aji-154	275	6	wool	wool	NOUN
aji-154	275	7	as	as	ADP
aji-154	275	8	a	a	DET
aji-154	275	9	cause	cause	NOUN
aji-154	275	10	of	of	ADP
aji-154	275	11	eczema	eczema	NOUN
aji-154	275	12	in	in	ADP
aji-154	275	13	children	child	NOUN
aji-154	275	14	.	.	PUNCT
aji-154	276	1	n	n	PROPN
aji-154	276	2	engl	engl	PROPN
aji-154	276	3	j	j	PROPN
aji-154	276	4	med	med	PROPN
aji-154	276	5	.	.	PUNCT
aji-154	277	1	1951;245(11):407409	1951;245(11):407409	NUM
aji-154	277	2	.	.	NOUN
aji-154	277	3	3	3	X
aji-154	277	4	.	.	X
aji-154	277	5	lord	lord	PROPN
aji-154	277	6	lw	lw	PROPN
aji-154	277	7	.	.	PUNCT
aji-154	278	1	cutaneous	cutaneous	ADJ
aji-154	278	2	sensitization	sensitization	NOUN
aji-154	278	3	to	to	ADP
aji-154	278	4	wool	wool	NOUN
aji-154	278	5	.	.	PUNCT
aji-154	279	1	arch	arch	ADJ
aji-154	279	2	dermatol	dermatol	NOUN
aji-154	279	3	syphilol	syphilol	NOUN
aji-154	279	4	.	.	PUNCT
aji-154	280	1	1932;26(4):707709	1932;26(4):707709	NOUN
aji-154	280	2	.	.	PUNCT
aji-154	281	1	olivier	olivier	PROPN
aji-154	281	2	et	et	PROPN
aji-154	281	3	al	al	PROPN
aji-154	281	4	.	.	PROPN
aji-154	281	5	;	;	PUNCT
aji-154	281	6	asian	asian	PROPN
aji-154	281	7	j.	j.	PROPN
aji-154	281	8	immunol	immunol	PROPN
aji-154	281	9	.	.	PROPN
aji-154	281	10	,	,	PUNCT
aji-154	281	11	vol	vol	NOUN
aji-154	281	12	.	.	PROPN
aji-154	282	1	7	7	NUM
aji-154	282	2	,	,	PUNCT
aji-154	282	3	no	no	INTJ
aji-154	282	4	.	.	NOUN
aji-154	282	5	1	1	NUM
aji-154	282	6	,	,	PUNCT
aji-154	282	7	pp	pp	ADJ
aji-154	282	8	.	.	PUNCT
aji-154	283	1	316	316	NUM
aji-154	283	2	-	-	SYM
aji-154	283	3	325	325	NUM
aji-154	283	4	,	,	PUNCT
aji-154	283	5	2024	2024	NUM
aji-154	283	6	;	;	PUNCT
aji-154	283	7	article	article	NOUN
aji-154	283	8	no.aji.128121	no.aji.128121	ADV
aji-154	283	9	323	323	NUM
aji-154	283	10	4	4	NUM
aji-154	283	11	.	.	PUNCT
aji-154	283	12	sulzberger	sulzberger	NOUN
aji-154	283	13	mb	mb	PROPN
aji-154	283	14	,	,	PUNCT
aji-154	283	15	morse	morse	PROPN
aji-154	283	16	jl	jl	PROPN
aji-154	283	17	.	.	PUNCT
aji-154	283	18	hypersensitivity	hypersensitivity	NOUN
aji-154	283	19	to	to	PART
aji-154	283	20	wool	wool	VERB
aji-154	283	21	fat	fat	ADJ
aji-154	283	22	:	:	PUNCT
aji-154	283	23	report	report	NOUN
aji-154	283	24	of	of	ADP
aji-154	283	25	two	two	NUM
aji-154	283	26	cases	case	NOUN
aji-154	283	27	.	.	PUNCT
aji-154	284	1	jama	jama	PROPN
aji-154	284	2	.	.	PUNCT
aji-154	285	1	1931;96(25):2099	1931;96(25):2099	NUM
aji-154	285	2	-	-	SYM
aji-154	285	3	2100	2100	NUM
aji-154	285	4	.	.	PUNCT
aji-154	286	1	5	5	NUM
aji-154	286	2	.	.	X
aji-154	286	3	information	information	NOUN
aji-154	286	4	.	.	PUNCT
aji-154	287	1	ncfb	ncfb	PROPN
aji-154	287	2	.	.	PUNCT
aji-154	288	1	pubchem	pubchem	PROPN
aji-154	288	2	compound	compound	NOUN
aji-154	288	3	summary	summary	NOUN
aji-154	288	4	for	for	ADP
aji-154	288	5	lanolin	lanolin	PROPN
aji-154	288	6	.	.	PUNCT
aji-154	289	1	retrieved	retrieve	VERB
aji-154	289	2	july	july	PROPN
aji-154	289	3	27	27	NUM
aji-154	289	4	,	,	PUNCT
aji-154	289	5	2024	2024	NUM
aji-154	289	6	from	from	ADP
aji-154	289	7	https://pubchem.ncbi.nlm.nih.gov/compoun	https://pubchem.ncbi.nlm.nih.gov/compoun	PROPN
aji-154	289	8	d	d	PROPN
aji-154	289	9	/	/	SYM
aji-154	289	10	lanolin	lanolin	NOUN
aji-154	289	11	.	.	PUNCT
aji-154	290	1	2024	2024	NUM
aji-154	290	2	.	.	PUNCT
aji-154	291	1	6	6	NUM
aji-154	291	2	.	.	X
aji-154	292	1	hoppe	hoppe	PROPN
aji-154	292	2	u.	u.	VERB
aji-154	292	3	the	the	DET
aji-154	292	4	lanolin	lanolin	PROPN
aji-154	292	5	book	book	NOUN
aji-154	292	6	.	.	PUNCT
aji-154	293	1	beiersdorf	beiersdorf	PROPN
aji-154	293	2	;	;	PUNCT
aji-154	293	3	1999	1999	NUM
aji-154	293	4	.	.	PUNCT
aji-154	294	1	7	7	X
aji-154	294	2	.	.	X
aji-154	294	3	lee	lee	PROPN
aji-154	294	4	b	b	PROPN
aji-154	294	5	,	,	PUNCT
aji-154	294	6	warshaw	warshaw	PROPN
aji-154	294	7	e.	e.	PROPN
aji-154	294	8	lanolin	lanolin	PROPN
aji-154	294	9	allergy	allergy	PROPN
aji-154	294	10	:	:	PUNCT
aji-154	294	11	history	history	NOUN
aji-154	294	12	,	,	PUNCT
aji-154	294	13	epidemiology	epidemiology	NOUN
aji-154	294	14	,	,	PUNCT
aji-154	294	15	responsible	responsible	ADJ
aji-154	294	16	allergens	allergen	NOUN
aji-154	294	17	,	,	PUNCT
aji-154	294	18	and	and	CCONJ
aji-154	294	19	management	management	NOUN
aji-154	294	20	.	.	PUNCT
aji-154	295	1	dermatitis	dermatitis	NOUN
aji-154	295	2	.	.	PUNCT
aji-154	296	1	2008;19(2):63	2008;19(2):63	NUM
aji-154	296	2	-	-	SYM
aji-154	296	3	72	72	NUM
aji-154	296	4	.	.	NOUN
aji-154	296	5	8	8	NUM
aji-154	296	6	.	.	PUNCT
aji-154	296	7	braun	braun	PROPN
aji-154	296	8	o	o	PROPN
aji-154	296	9	,	,	PUNCT
aji-154	296	10	liebreice	liebreice	PROPN
aji-154	296	11	o	o	NOUN
aji-154	296	12	,	,	PUNCT
aji-154	296	13	inventors	inventor	NOUN
aji-154	296	14	.	.	PUNCT
aji-154	297	1	method	method	NOUN
aji-154	297	2	of	of	ADP
aji-154	297	3	treating	treat	VERB
aji-154	297	4	wool	wool	NOUN
aji-154	297	5	-	-	PUNCT
aji-154	297	6	oil	oil	NOUN
aji-154	297	7	to	to	PART
aji-154	297	8	produce	produce	VERB
aji-154	297	9	lanolin	lanolin	NOUN
aji-154	297	10	.	.	PUNCT
aji-154	298	1	1883	1883	NUM
aji-154	298	2	.	.	PUNCT
aji-154	299	1	9	9	X
aji-154	299	2	.	.	X
aji-154	299	3	schlossman	schlossman	NOUN
aji-154	299	4	ml	ml	PROPN
aji-154	299	5	,	,	PUNCT
aji-154	299	6	mccarthy	mccarthy	PROPN
aji-154	299	7	jp	jp	PROPN
aji-154	299	8	.	.	PUNCT
aji-154	300	1	lanolin	lanolin	PROPN
aji-154	300	2	and	and	CCONJ
aji-154	300	3	derivatives	derivative	NOUN
aji-154	300	4	chemistry	chemistry	NOUN
aji-154	300	5	:	:	PUNCT
aji-154	300	6	relationship	relationship	NOUN
aji-154	300	7	to	to	ADP
aji-154	300	8	allergic	allergic	ADJ
aji-154	300	9	contact	contact	NOUN
aji-154	300	10	dermatitis	dermatitis	NOUN
aji-154	300	11	.	.	PUNCT
aji-154	301	1	contact	contact	PROPN
aji-154	301	2	dermatitis	dermatitis	PROPN
aji-154	301	3	.	.	PUNCT
aji-154	302	1	1979;5(2):65	1979;5(2):65	NUM
aji-154	302	2	-	-	SYM
aji-154	302	3	72	72	NUM
aji-154	302	4	.	.	PUNCT
aji-154	303	1	10	10	NUM
aji-154	303	2	.	.	PUNCT
aji-154	304	1	sengupta	sengupta	NOUN
aji-154	304	2	a	a	PRON
aji-154	304	3	,	,	PUNCT
aji-154	304	4	behera	behera	PROPN
aji-154	304	5	j.	j.	PROPN
aji-154	304	6	comprehensive	comprehensive	PROPN
aji-154	304	7	view	view	NOUN
aji-154	304	8	on	on	ADP
aji-154	304	9	chemistry	chemistry	NOUN
aji-154	304	10	,	,	PUNCT
aji-154	304	11	manufacturing	manufacturing	NOUN
aji-154	304	12	and	and	CCONJ
aji-154	304	13	applications	application	NOUN
aji-154	304	14	of	of	ADP
aji-154	304	15	lanolin	lanolin	PROPN
aji-154	304	16	extracted	extract	VERB
aji-154	304	17	from	from	ADP
aji-154	304	18	wool	wool	NOUN
aji-154	304	19	pretreatment	pretreatment	NOUN
aji-154	304	20	.	.	PUNCT
aji-154	305	1	amer	amer	PROPN
aji-154	305	2	j	j	PROPN
aji-154	305	3	engin	engin	PROPN
aji-154	305	4	res	res	PROPN
aji-154	305	5	.	.	PUNCT
aji-154	306	1	2014;3(7):33	2014;3(7):33	NUM
aji-154	306	2	-	-	SYM
aji-154	306	3	43	43	NUM
aji-154	306	4	.	.	PUNCT
aji-154	307	1	11	11	NUM
aji-154	307	2	.	.	PUNCT
aji-154	308	1	clark	clark	PROPN
aji-154	308	2	ew	ew	PROPN
aji-154	308	3	,	,	PUNCT
aji-154	308	4	steel	steel	NOUN
aji-154	308	5	i.	i.	NOUN
aji-154	308	6	investigations	investigation	NOUN
aji-154	308	7	into	into	ADP
aji-154	308	8	biomechanisms	biomechanism	NOUN
aji-154	308	9	of	of	ADP
aji-154	308	10	the	the	DET
aji-154	308	11	moisturizing	moisturize	VERB
aji-154	308	12	function	function	NOUN
aji-154	308	13	of	of	ADP
aji-154	308	14	lanolin	lanolin	PROPN
aji-154	308	15	.	.	PUNCT
aji-154	309	1	j	j	PROPN
aji-154	309	2	soc	soc	PROPN
aji-154	309	3	cosmetic	cosmetic	PROPN
aji-154	309	4	chemists	chemist	NOUN
aji-154	309	5	.	.	PUNCT
aji-154	310	1	1993;44:181	1993;44:181	X
aji-154	310	2	-	-	SYM
aji-154	310	3	195	195	NUM
aji-154	310	4	.	.	NOUN
aji-154	310	5	12	12	NUM
aji-154	310	6	.	.	PUNCT
aji-154	311	1	cronin	cronin	PROPN
aji-154	311	2	e.	e.	PROPN
aji-154	311	3	lanolin	lanolin	PROPN
aji-154	311	4	dermatitis	dermatitis	PROPN
aji-154	311	5	.	.	PUNCT
aji-154	312	1	brit	brit	PROPN
aji-154	312	2	j	j	PROPN
aji-154	312	3	dermatol	dermatol	NOUN
aji-154	312	4	.	.	PUNCT
aji-154	313	1	1966;78(3):167	1966;78(3):167	NUM
aji-154	313	2	-	-	PUNCT
aji-154	313	3	174	174	NUM
aji-154	313	4	.	.	PUNCT
aji-154	314	1	13	13	NUM
aji-154	314	2	.	.	PUNCT
aji-154	315	1	sulzberger	sulzberger	NOUN
aji-154	315	2	mb	mb	PROPN
aji-154	315	3	,	,	PUNCT
aji-154	315	4	morse	morse	PROPN
aji-154	315	5	jl	jl	PROPN
aji-154	315	6	.	.	PUNCT
aji-154	316	1	hypersensitiviness	hypersensitiviness	ADV
aji-154	316	2	to	to	PART
aji-154	316	3	wool	wool	VERB
aji-154	316	4	fat	fat	ADJ
aji-154	316	5	:	:	PUNCT
aji-154	316	6	report	report	NOUN
aji-154	316	7	of	of	ADP
aji-154	316	8	two	two	NUM
aji-154	316	9	cases	case	NOUN
aji-154	316	10	.	.	PUNCT
aji-154	317	1	jama	jama	PROPN
aji-154	317	2	.	.	PUNCT
aji-154	318	1	1931;96(25):2099	1931;96(25):2099	NUM
aji-154	318	2	-	-	SYM
aji-154	318	3	2100	2100	NUM
aji-154	318	4	.	.	PUNCT
aji-154	319	1	14	14	NUM
aji-154	319	2	.	.	PUNCT
aji-154	320	1	mortensen	mortensen	PROPN
aji-154	320	2	t.	t.	PROPN
aji-154	320	3	allergy	allergy	PROPN
aji-154	320	4	to	to	ADP
aji-154	320	5	lanolin	lanolin	PROPN
aji-154	320	6	.	.	PUNCT
aji-154	321	1	contact	contact	PROPN
aji-154	321	2	dermatitis	dermatitis	PROPN
aji-154	321	3	.	.	PUNCT
aji-154	322	1	1979;5(3):137	1979;5(3):137	NUM
aji-154	322	2	-	-	SYM
aji-154	322	3	139	139	NUM
aji-154	322	4	.	.	PUNCT
aji-154	323	1	15	15	NUM
aji-154	323	2	.	.	PUNCT
aji-154	323	3	thune	thune	PROPN
aji-154	323	4	p.	p.	PROPN
aji-154	323	5	allergy	allergy	PROPN
aji-154	323	6	to	to	PART
aji-154	323	7	wool	wool	VERB
aji-154	323	8	fat	fat	ADJ
aji-154	323	9	.	.	PUNCT
aji-154	324	1	the	the	DET
aji-154	324	2	addition	addition	NOUN
aji-154	324	3	of	of	ADP
aji-154	324	4	salicylic	salicylic	ADJ
aji-154	324	5	acid	acid	NOUN
aji-154	324	6	for	for	ADP
aji-154	324	7	patch	patch	NOUN
aji-154	324	8	test	test	NOUN
aji-154	324	9	purposes	purpose	NOUN
aji-154	324	10	.	.	PUNCT
aji-154	325	1	acta	acta	PROPN
aji-154	325	2	derm	derm	PROPN
aji-154	325	3	venereol	venereol	NOUN
aji-154	325	4	.	.	PUNCT
aji-154	326	1	1969;49(3):282	1969;49(3):282	PROPN
aji-154	326	2	-	-	SYM
aji-154	326	3	287	287	NUM
aji-154	326	4	.	.	PUNCT
aji-154	327	1	16	16	NUM
aji-154	327	2	.	.	PUNCT
aji-154	328	1	sulzberger	sulzberger	NOUN
aji-154	328	2	mb	mb	PROPN
aji-154	328	3	,	,	PUNCT
aji-154	328	4	lazar	lazar	PROPN
aji-154	328	5	mp	mp	PROPN
aji-154	328	6	,	,	PUNCT
aji-154	328	7	furman	furman	PROPN
aji-154	328	8	d.	d.	PROPN
aji-154	328	9	a	a	DET
aji-154	328	10	study	study	NOUN
aji-154	328	11	of	of	ADP
aji-154	328	12	the	the	DET
aji-154	328	13	allergenic	allergenic	ADJ
aji-154	328	14	constituents	constituent	NOUN
aji-154	328	15	of	of	ADP
aji-154	328	16	lanolin	lanolin	PROPN
aji-154	328	17	(	(	PUNCT
aji-154	328	18	wool	wool	NOUN
aji-154	328	19	fat	fat	PROPN
aji-154	328	20	)	)	PUNCT
aji-154	328	21	.	.	PUNCT
aji-154	329	1	j	j	PROPN
aji-154	329	2	invest	invest	VERB
aji-154	329	3	dermatol	dermatol	NOUN
aji-154	329	4	.	.	PUNCT
aji-154	330	1	1950;15(6):453	1950;15(6):453	NUM
aji-154	330	2	-	-	SYM
aji-154	330	3	458	458	NUM
aji-154	330	4	.	.	PUNCT
aji-154	331	1	17	17	NUM
aji-154	331	2	.	.	PUNCT
aji-154	331	3	everall	everall	PROPN
aji-154	331	4	j	j	PROPN
aji-154	331	5	,	,	PUNCT
aji-154	331	6	truter	truter	ADV
aji-154	331	7	ev	ev	INTJ
aji-154	331	8	.	.	PROPN
aji-154	331	9	cutaneous	cutaneous	ADJ
aji-154	331	10	hypersensitivity	hypersensitivity	NOUN
aji-154	331	11	to	to	ADP
aji-154	331	12	lanolin	lanolin	NOUN
aji-154	331	13	;	;	PUNCT
aji-154	331	14	investigation	investigation	NOUN
aji-154	331	15	of	of	ADP
aji-154	331	16	one	one	NUM
aji-154	331	17	case	case	NOUN
aji-154	331	18	.	.	PUNCT
aji-154	332	1	j	j	PROPN
aji-154	332	2	invest	invest	VERB
aji-154	332	3	dermatol	dermatol	NOUN
aji-154	332	4	.	.	PUNCT
aji-154	333	1	1954	1954	NUM
aji-154	333	2	;	;	PUNCT
aji-154	334	1	22(6):493	22(6):493	NUM
aji-154	334	2	-	-	SYM
aji-154	334	3	496	496	NUM
aji-154	334	4	.	.	PUNCT
aji-154	335	1	18	18	NUM
aji-154	335	2	.	.	PUNCT
aji-154	336	1	silverberg	silverberg	PROPN
aji-154	336	2	ji	ji	PROPN
aji-154	336	3	,	,	PUNCT
aji-154	336	4	patel	patel	PROPN
aji-154	336	5	n	n	CCONJ
aji-154	336	6	,	,	PUNCT
aji-154	336	7	warshaw	warshaw	VERB
aji-154	336	8	em	em	PRON
aji-154	336	9	,	,	PUNCT
aji-154	336	10	et	et	PROPN
aji-154	336	11	al	al	PROPN
aji-154	336	12	.	.	PUNCT
aji-154	337	1	lanolin	lanolin	PROPN
aji-154	337	2	allergic	allergic	ADJ
aji-154	337	3	reactions	reaction	NOUN
aji-154	337	4	:	:	PUNCT
aji-154	337	5	north	north	ADJ
aji-154	337	6	american	american	ADJ
aji-154	337	7	contact	contact	PROPN
aji-154	337	8	dermatitis	dermatitis	PROPN
aji-154	337	9	group	group	NOUN
aji-154	337	10	experience	experience	NOUN
aji-154	337	11	,	,	PUNCT
aji-154	337	12	2001	2001	NUM
aji-154	337	13	to	to	ADP
aji-154	337	14	2018	2018	NUM
aji-154	337	15	.	.	PUNCT
aji-154	338	1	dermatitis	dermatitis	NOUN
aji-154	338	2	.	.	PUNCT
aji-154	339	1	2022;33(3):193199	2022;33(3):193199	PROPN
aji-154	339	2	.	.	PROPN
aji-154	339	3	19	19	NUM
aji-154	339	4	.	.	PUNCT
aji-154	339	5	jenkins	jenkins	PROPN
aji-154	339	6	ba	ba	PROPN
aji-154	339	7	,	,	PUNCT
aji-154	339	8	belsito	belsito	PROPN
aji-154	340	1	dv	dv	PROPN
aji-154	340	2	.	.	PROPN
aji-154	340	3	lanolin	lanolin	PROPN
aji-154	340	4	.	.	PUNCT
aji-154	341	1	dermatitis	dermatitis	NOUN
aji-154	341	2	.	.	PUNCT
aji-154	342	1	2023;34(1):4	2023;34(1):4	NUM
aji-154	342	2	-	-	SYM
aji-154	342	3	12	12	NUM
aji-154	342	4	.	.	PUNCT
aji-154	343	1	20	20	NUM
aji-154	343	2	.	.	X
aji-154	344	1	kligman	kligman	PROPN
aji-154	344	2	am	am	PROPN
aji-154	344	3	.	.	PUNCT
aji-154	345	1	lanolin	lanolin	PROPN
aji-154	345	2	allergy	allergy	PROPN
aji-154	345	3	:	:	PUNCT
aji-154	345	4	crisis	crisis	NOUN
aji-154	345	5	or	or	CCONJ
aji-154	345	6	comedy	comedy	NOUN
aji-154	345	7	.	.	PUNCT
aji-154	346	1	contact	contact	NOUN
aji-154	346	2	dermatitis	dermatitis	NOUN
aji-154	346	3	.	.	PUNCT
aji-154	347	1	1983;9(2):99107	1983;9(2):99107	X
aji-154	347	2	.	.	NOUN
aji-154	347	3	21	21	NUM
aji-154	347	4	.	.	X
aji-154	348	1	kligman	kligman	PROPN
aji-154	348	2	am	be	AUX
aji-154	348	3	.	.	PUNCT
aji-154	349	1	the	the	DET
aji-154	349	2	myth	myth	NOUN
aji-154	349	3	of	of	ADP
aji-154	349	4	lanolin	lanolin	PROPN
aji-154	349	5	allergy	allergy	PROPN
aji-154	349	6	.	.	PUNCT
aji-154	350	1	contact	contact	PROPN
aji-154	350	2	dermatitis	dermatitis	NOUN
aji-154	350	3	.	.	PUNCT
aji-154	351	1	1998;39(3):103	1998;39(3):103	NUM
aji-154	351	2	-	-	SYM
aji-154	351	3	107	107	NUM
aji-154	351	4	.	.	PUNCT
aji-154	352	1	22	22	NUM
aji-154	352	2	.	.	PUNCT
aji-154	353	1	bruynzeel	bruynzeel	PROPN
aji-154	353	2	dp	dp	PROPN
aji-154	353	3	,	,	PUNCT
aji-154	353	4	andersen	andersen	PROPN
aji-154	353	5	ke	ke	PROPN
aji-154	353	6	,	,	PUNCT
aji-154	353	7	camarasa	camarasa	VERB
aji-154	353	8	jg	jg	PROPN
aji-154	353	9	,	,	PUNCT
aji-154	353	10	lachapelle	lachapelle	PROPN
aji-154	353	11	j	j	PROPN
aji-154	353	12	-	-	PROPN
aji-154	353	13	m	m	PROPN
aji-154	353	14	,	,	PUNCT
aji-154	353	15	menné	menné	PROPN
aji-154	353	16	t	t	PROPN
aji-154	353	17	,	,	PUNCT
aji-154	353	18	white	white	PROPN
aji-154	353	19	ir	ir	PROPN
aji-154	353	20	.	.	PUNCT
aji-154	354	1	the	the	DET
aji-154	354	2	european	european	PROPN
aji-154	354	3	standard	standard	PROPN
aji-154	354	4	series	series	PROPN
aji-154	354	5	.	.	PUNCT
aji-154	354	6	1995	1995	NUM
aji-154	354	7	;	;	PUNCT
aji-154	354	8	33(3):145	33(3):145	NUM
aji-154	354	9	-	-	SYM
aji-154	354	10	148	148	NUM
aji-154	354	11	.	.	PUNCT
aji-154	355	1	23	23	NUM
aji-154	355	2	.	.	PUNCT
aji-154	356	1	miest	mi	ADJ
aji-154	356	2	ry	ry	NOUN
aji-154	356	3	,	,	PUNCT
aji-154	356	4	yiannias	yiannias	PROPN
aji-154	356	5	ja	ja	PROPN
aji-154	356	6	,	,	PUNCT
aji-154	356	7	chang	chang	PROPN
aji-154	356	8	yh	yh	PROPN
aji-154	356	9	,	,	PUNCT
aji-154	356	10	singh	singh	ADJ
aji-154	356	11	n.	n.	NOUN
aji-154	356	12	diagnosis	diagnosis	NOUN
aji-154	356	13	and	and	CCONJ
aji-154	356	14	prevalence	prevalence	NOUN
aji-154	356	15	of	of	ADP
aji-154	356	16	lanolin	lanolin	PROPN
aji-154	356	17	allergy	allergy	NOUN
aji-154	356	18	.	.	PUNCT
aji-154	357	1	dermatitis	dermatitis	NOUN
aji-154	357	2	.	.	PUNCT
aji-154	358	1	2013;24(3):119	2013;24(3):119	NUM
aji-154	358	2	-	-	SYM
aji-154	358	3	123	123	NUM
aji-154	358	4	.	.	PUNCT
aji-154	359	1	24	24	NUM
aji-154	359	2	.	.	PUNCT
aji-154	359	3	warshaw	warshaw	PROPN
aji-154	359	4	em	em	PRON
aji-154	359	5	,	,	PUNCT
aji-154	359	6	nelsen	nelsen	PROPN
aji-154	359	7	dd	dd	PROPN
aji-154	359	8	,	,	PUNCT
aji-154	359	9	maibach	maibach	PROPN
aji-154	359	10	hi	hi	PROPN
aji-154	359	11	,	,	PUNCT
aji-154	359	12	marks	mark	VERB
aji-154	359	13	jg	jg	PROPN
aji-154	359	14	,	,	PUNCT
aji-154	359	15	zug	zug	PROPN
aji-154	359	16	ka	ka	PROPN
aji-154	359	17	,	,	PUNCT
aji-154	359	18	taylor	taylor	PROPN
aji-154	359	19	js	js	PROPN
aji-154	359	20	et	et	PROPN
aji-154	359	21	al	al	PROPN
aji-154	359	22	.	.	PROPN
aji-154	360	1	positive	positive	ADJ
aji-154	360	2	patch	patch	ADJ
aji-154	360	3	test	test	NOUN
aji-154	360	4	reactions	reaction	NOUN
aji-154	360	5	to	to	ADP
aji-154	360	6	lanolin	lanolin	NOUN
aji-154	360	7	:	:	PUNCT
aji-154	360	8	cross	cross	ADJ
aji-154	360	9	-	-	ADJ
aji-154	360	10	sectional	sectional	ADJ
aji-154	360	11	data	datum	NOUN
aji-154	360	12	from	from	ADP
aji-154	360	13	the	the	DET
aji-154	360	14	north	north	ADJ
aji-154	360	15	american	american	ADJ
aji-154	360	16	contact	contact	PROPN
aji-154	360	17	dermatitis	dermatitis	PROPN
aji-154	360	18	group	group	NOUN
aji-154	360	19	,	,	PUNCT
aji-154	360	20	1994	1994	NUM
aji-154	360	21	to	to	ADP
aji-154	360	22	2006	2006	NUM
aji-154	360	23	.	.	PUNCT
aji-154	361	1	dermatitis	dermatitis	NOUN
aji-154	361	2	.	.	PUNCT
aji-154	362	1	2009;20(2):79	2009;20(2):79	NOUN
aji-154	362	2	-	-	SYM
aji-154	362	3	88	88	NUM
aji-154	362	4	.	.	PUNCT
aji-154	363	1	25	25	NUM
aji-154	363	2	.	.	PUNCT
aji-154	364	1	wolf	wolf	PROPN
aji-154	364	2	r.	r.	PROPN
aji-154	364	3	the	the	DET
aji-154	364	4	lanolin	lanolin	PROPN
aji-154	364	5	paradox	paradox	NOUN
aji-154	364	6	.	.	PUNCT
aji-154	365	1	dermatology	dermatology	NOUN
aji-154	365	2	1996;192(3):198	1996;192(3):198	PROPN
aji-154	365	3	-	-	SYM
aji-154	365	4	202	202	NUM
aji-154	365	5	.	.	NOUN
aji-154	365	6	26	26	NUM
aji-154	365	7	.	.	PUNCT
aji-154	366	1	knijp	knijp	PROPN
aji-154	366	2	j	j	PROPN
aji-154	366	3	,	,	PUNCT
aji-154	366	4	bruynzeel	bruynzeel	PROPN
aji-154	366	5	dp	dp	NOUN
aji-154	366	6	,	,	PUNCT
aji-154	366	7	rustemeyer	rustemeyer	NOUN
aji-154	366	8	t.	t.	NOUN
aji-154	366	9	diagnosing	diagnose	VERB
aji-154	366	10	lanolin	lanolin	PROPN
aji-154	366	11	contact	contact	NOUN
aji-154	366	12	allergy	allergy	NOUN
aji-154	366	13	with	with	ADP
aji-154	366	14	lanolin	lanolin	PROPN
aji-154	366	15	alcohol	alcohol	NOUN
aji-154	366	16	and	and	CCONJ
aji-154	366	17	amerchol	amerchol	NOUN
aji-154	366	18	l101	l101	PROPN
aji-154	366	19	.	.	PUNCT
aji-154	367	1	contact	contact	PROPN
aji-154	367	2	dermatitis	dermatitis	NOUN
aji-154	367	3	.	.	PUNCT
aji-154	368	1	2019;80(5):298	2019;80(5):298	NUM
aji-154	368	2	303	303	NUM
aji-154	368	3	.	.	PUNCT
aji-154	369	1	27	27	NUM
aji-154	369	2	.	.	PUNCT
aji-154	370	1	matthieu	matthieu	PROPN
aji-154	370	2	l	l	PROPN
aji-154	370	3	,	,	PUNCT
aji-154	370	4	dockx	dockx	PROPN
aji-154	370	5	p.	p.	NOUN
aji-154	370	6	discrepancy	discrepancy	NOUN
aji-154	370	7	in	in	ADP
aji-154	370	8	patch	patch	NOUN
aji-154	370	9	test	test	NOUN
aji-154	370	10	results	result	NOUN
aji-154	370	11	with	with	ADP
aji-154	370	12	wool	wool	NOUN
aji-154	370	13	wax	wax	NOUN
aji-154	370	14	alcohols	alcohol	NOUN
aji-154	370	15	and	and	CCONJ
aji-154	370	16	amerchol	amerchol	PROPN
aji-154	370	17	l-101	l-101	PROPN
aji-154	370	18	.	.	PUNCT
aji-154	371	1	contact	contact	PROPN
aji-154	371	2	dermatitis	dermatitis	PROPN
aji-154	371	3	.	.	PUNCT
aji-154	372	1	1997	1997	NUM
aji-154	372	2	;	;	PUNCT
aji-154	373	1	36(3):150	36(3):150	NUM
aji-154	373	2	-	-	SYM
aji-154	373	3	151	151	NUM
aji-154	373	4	.	.	PUNCT
aji-154	373	5	28	28	NUM
aji-154	373	6	.	.	PUNCT
aji-154	374	1	czarnowicki	czarnowicki	PROPN
aji-154	374	2	t	t	PROPN
aji-154	374	3	,	,	PUNCT
aji-154	374	4	he	he	PRON
aji-154	374	5	h	h	VERB
aji-154	374	6	,	,	PUNCT
aji-154	374	7	krueger	krueger	PROPN
aji-154	374	8	jg	jg	PROPN
aji-154	374	9	,	,	PUNCT
aji-154	374	10	guttman	guttman	ADJ
aji-154	374	11	-	-	PUNCT
aji-154	374	12	yassky	yassky	ADJ
aji-154	374	13	e.	e.	PROPN
aji-154	374	14	atopic	atopic	PROPN
aji-154	374	15	dermatitis	dermatitis	PROPN
aji-154	374	16	endotypes	endotype	NOUN
aji-154	374	17	and	and	CCONJ
aji-154	374	18	implications	implication	NOUN
aji-154	374	19	for	for	ADP
aji-154	374	20	targeted	target	VERB
aji-154	374	21	therapeutics	therapeutic	NOUN
aji-154	374	22	.	.	PUNCT
aji-154	375	1	jaci	jaci	PROPN
aji-154	375	2	.	.	PUNCT
aji-154	376	1	2018;143(1):1	2018;143(1):1	NUM
aji-154	376	2	-	-	SYM
aji-154	376	3	11	11	NUM
aji-154	376	4	.	.	PUNCT
aji-154	376	5	29	29	NUM
aji-154	376	6	.	.	PUNCT
aji-154	377	1	olivier	olivier	PROPN
aji-154	377	2	ce	ce	PROPN
aji-154	377	3	,	,	PUNCT
aji-154	377	4	pinto	pinto	NOUN
aji-154	377	5	dg	dg	PROPN
aji-154	377	6	,	,	PUNCT
aji-154	377	7	teixeira	teixeira	PROPN
aji-154	377	8	apm	apm	PROPN
aji-154	377	9	,	,	PUNCT
aji-154	377	10	santana	santana	PROPN
aji-154	377	11	jls	jls	PROPN
aji-154	377	12	,	,	PUNCT
aji-154	377	13	santos	santos	PROPN
aji-154	377	14	rapgs	rapgs	PROPN
aji-154	377	15	,	,	PUNCT
aji-154	377	16	lima	lima	PROPN
aji-154	377	17	rps	rps	PROPN
aji-154	377	18	.	.	PUNCT
aji-154	378	1	immunoreactivity	immunoreactivity	NOUN
aji-154	378	2	against	against	ADP
aji-154	378	3	dermatophagoides	dermatophagoide	NOUN
aji-154	378	4	pteronyssinus	pteronyssinus	NOUN
aji-154	378	5	assessed	assess	VERB
aji-154	378	6	by	by	ADP
aji-154	378	7	the	the	DET
aji-154	378	8	leukocyte	leukocyte	NOUN
aji-154	378	9	adherence	adherence	NOUN
aji-154	378	10	inhibition	inhibition	NOUN
aji-154	378	11	test	test	NOUN
aji-154	378	12	in	in	ADP
aji-154	378	13	patients	patient	NOUN
aji-154	378	14	with	with	ADP
aji-154	378	15	intrinsic	intrinsic	ADJ
aji-154	378	16	atopic	atopic	NOUN
aji-154	378	17	dermatitis	dermatitis	NOUN
aji-154	378	18	and	and	CCONJ
aji-154	378	19	correlated	correlate	VERB
aji-154	378	20	"	"	PUNCT
aji-154	378	21	intrinsic	intrinsic	ADJ
aji-154	378	22	"	"	PUNCT
aji-154	378	23	non	non	ADJ
aji-154	378	24	–	–	PUNCT
aji-154	378	25	ige	ige	ADJ
aji-154	378	26	-	-	PUNCT
aji-154	378	27	mediated	mediate	VERB
aji-154	378	28	allergic	allergic	ADJ
aji-154	378	29	conditions	condition	NOUN
aji-154	378	30	.	.	PUNCT
aji-154	379	1	european	european	ADJ
aji-154	379	2	journal	journal	PROPN
aji-154	379	3	of	of	ADP
aji-154	379	4	clinical	clinical	ADJ
aji-154	379	5	medicine	medicine	NOUN
aji-154	379	6	.	.	PUNCT
aji-154	380	1	2021;2(6):45	2021;2(6):45	NUM
aji-154	380	2	-	-	SYM
aji-154	380	3	50	50	NUM
aji-154	380	4	.	.	PUNCT
aji-154	380	5	30	30	NUM
aji-154	380	6	.	.	PUNCT
aji-154	381	1	olivier	olivier	PROPN
aji-154	381	2	ce	ce	PROPN
aji-154	381	3	,	,	PUNCT
aji-154	381	4	pinto	pinto	NOUN
aji-154	381	5	dg	dg	PROPN
aji-154	381	6	,	,	PUNCT
aji-154	381	7	teixeira	teixeira	PROPN
aji-154	381	8	apm	apm	PROPN
aji-154	381	9	,	,	PUNCT
aji-154	381	10	santana	santana	PROPN
aji-154	381	11	jls	jls	PROPN
aji-154	381	12	,	,	PUNCT
aji-154	381	13	santos	santos	PROPN
aji-154	381	14	rapgs	rapgs	PROPN
aji-154	381	15	,	,	PUNCT
aji-154	382	1	lima	lima	PROPN
aji-154	382	2	rps	rps	PROPN
aji-154	382	3	et	et	PROPN
aji-154	382	4	al	al	PROPN
aji-154	382	5	.	.	PROPN
aji-154	382	6	contribution	contribution	NOUN
aji-154	382	7	of	of	ADP
aji-154	382	8	the	the	DET
aji-154	382	9	leukocyte	leukocyte	NOUN
aji-154	382	10	adherence	adherence	NOUN
aji-154	382	11	inhibition	inhibition	NOUN
aji-154	382	12	test	test	NOUN
aji-154	382	13	to	to	ADP
aji-154	382	14	the	the	DET
aji-154	382	15	diagnosis	diagnosis	NOUN
aji-154	382	16	of	of	ADP
aji-154	382	17	non	non	ADJ
aji-154	382	18	–	–	PUNCT
aji-154	382	19	ige	ige	ADJ
aji-154	382	20	-	-	PUNCT
aji-154	382	21	mediated	mediate	VERB
aji-154	382	22	immunoreactivity	immunoreactivity	NOUN
aji-154	382	23	against	against	ADP
aji-154	382	24	candida	candida	NOUN
aji-154	382	25	albicans	albican	NOUN
aji-154	382	26	in	in	ADP
aji-154	382	27	patients	patient	NOUN
aji-154	382	28	with	with	ADP
aji-154	382	29	atopic	atopic	NOUN
aji-154	382	30	dermatitis	dermatitis	NOUN
aji-154	382	31	.	.	PUNCT
aji-154	383	1	asian	asian	PROPN
aji-154	383	2	j	j	PROPN
aji-154	383	3	immunol	immunol	NOUN
aji-154	383	4	.	.	PUNCT
aji-154	384	1	2023;6(1):268	2023;6(1):268	NUM
aji-154	384	2	-	-	SYM
aji-154	384	3	276	276	NUM
aji-154	384	4	.	.	PUNCT
aji-154	385	1	31	31	NUM
aji-154	385	2	.	.	PUNCT
aji-154	386	1	altaş	altaş	PROPN
aji-154	386	2	u	u	PROPN
aji-154	386	3	,	,	PUNCT
aji-154	386	4	ünlü	ünlü	NOUN
aji-154	386	5	ad	ad	NOUN
aji-154	386	6	,	,	PUNCT
aji-154	386	7	güllüce	güllüce	NOUN
aji-154	386	8	h	h	NOUN
aji-154	386	9	,	,	PUNCT
aji-154	386	10	tunce	tunce	NOUN
aji-154	386	11	e	e	NOUN
aji-154	386	12	,	,	PUNCT
aji-154	386	13	altaş	altaş	PROPN
aji-154	386	14	zm	zm	PROPN
aji-154	386	15	,	,	PUNCT
aji-154	386	16	söğütlü	söğütlü	PROPN
aji-154	386	17	y	y	PROPN
aji-154	386	18	,	,	PUNCT
aji-154	386	19	et	et	PROPN
aji-154	386	20	al	al	PROPN
aji-154	386	21	.	.	PUNCT
aji-154	386	22	evaluation	evaluation	NOUN
aji-154	386	23	of	of	ADP
aji-154	386	24	the	the	DET
aji-154	386	25	relationship	relationship	NOUN
aji-154	386	26	between	between	ADP
aji-154	386	27	laboratory	laboratory	NOUN
aji-154	386	28	parameters	parameter	NOUN
aji-154	386	29	and	and	CCONJ
aji-154	386	30	allergy	allergy	NOUN
aji-154	386	31	tests	test	VERB
aji-154	386	32	in	in	ADP
aji-154	386	33	children	child	NOUN
aji-154	386	34	with	with	ADP
aji-154	386	35	atopic	atopic	NOUN
aji-154	386	36	dermatitis	dermatitis	NOUN
aji-154	386	37	:	:	PUNCT
aji-154	386	38	laboratory	laboratory	NOUN
aji-154	386	39	parameters	parameter	NOUN
aji-154	386	40	and	and	CCONJ
aji-154	386	41	allergy	allergy	NOUN
aji-154	386	42	tests	test	VERB
aji-154	386	43	in	in	ADP
aji-154	386	44	children	child	NOUN
aji-154	386	45	with	with	ADP
aji-154	386	46	atopic	atopic	NOUN
aji-154	386	47	dermatitis	dermatitis	NOUN
aji-154	386	48	.	.	PUNCT
aji-154	387	1	chronicles	chronicle	NOUN
aji-154	387	2	of	of	ADP
aji-154	387	3	precision	precision	NOUN
aji-154	387	4	medical	medical	ADJ
aji-154	387	5	researchers	researcher	NOUN
aji-154	387	6	.	.	PUNCT
aji-154	388	1	2023	2023	NUM
aji-154	388	2	;	;	PUNCT
aji-154	388	3	4(2):168	4(2):168	NUM
aji-154	388	4	-	-	SYM
aji-154	388	5	171	171	NUM
aji-154	388	6	.	.	PUNCT
aji-154	389	1	olivier	olivier	PROPN
aji-154	389	2	et	et	PROPN
aji-154	389	3	al	al	PROPN
aji-154	389	4	.	.	PROPN
aji-154	389	5	;	;	PUNCT
aji-154	389	6	asian	asian	PROPN
aji-154	389	7	j.	j.	PROPN
aji-154	389	8	immunol	immunol	PROPN
aji-154	389	9	.	.	PROPN
aji-154	389	10	,	,	PUNCT
aji-154	389	11	vol	vol	NOUN
aji-154	389	12	.	.	PROPN
aji-154	390	1	7	7	NUM
aji-154	390	2	,	,	PUNCT
aji-154	390	3	no	no	INTJ
aji-154	390	4	.	.	NOUN
aji-154	390	5	1	1	NUM
aji-154	390	6	,	,	PUNCT
aji-154	390	7	pp	pp	ADJ
aji-154	390	8	.	.	PUNCT
aji-154	391	1	316	316	NUM
aji-154	391	2	-	-	SYM
aji-154	391	3	325	325	NUM
aji-154	391	4	,	,	PUNCT
aji-154	391	5	2024	2024	NUM
aji-154	391	6	;	;	PUNCT
aji-154	391	7	article	article	NOUN
aji-154	391	8	no.aji.128121	no.aji.128121	VERB
aji-154	391	9	324	324	NUM
aji-154	391	10	32	32	NUM
aji-154	391	11	.	.	PUNCT
aji-154	392	1	kuratsuji	kuratsuji	PROPN
aji-154	392	2	t.	t.	PROPN
aji-154	392	3	studies	study	NOUN
aji-154	392	4	on	on	ADP
aji-154	392	5	leukocyte	leukocyte	ADJ
aji-154	392	6	adherence	adherence	NOUN
aji-154	392	7	inhibition	inhibition	NOUN
aji-154	392	8	test	test	NOUN
aji-154	392	9	.	.	PUNCT
aji-154	393	1	part	part	PROPN
aji-154	393	2	ii	ii	PROPN
aji-154	393	3	.	.	PUNCT
aji-154	394	1	clinical	clinical	ADJ
aji-154	394	2	applications	application	NOUN
aji-154	394	3	of	of	ADP
aji-154	394	4	lai	lai	PROPN
aji-154	394	5	test	test	PROPN
aji-154	394	6	to	to	PART
aji-154	394	7	detect	detect	VERB
aji-154	394	8	delayed	delay	VERB
aji-154	394	9	type	type	NOUN
aji-154	394	10	hypersensitivity	hypersensitivity	NOUN
aji-154	394	11	in	in	ADP
aji-154	394	12	infants	infant	NOUN
aji-154	394	13	and	and	CCONJ
aji-154	394	14	children	child	NOUN
aji-154	394	15	.	.	PUNCT
aji-154	395	1	keio	keio	PROPN
aji-154	395	2	j	j	PROPN
aji-154	395	3	med	med	PROPN
aji-154	395	4	.	.	PUNCT
aji-154	396	1	1981;30(2):65	1981;30(2):65	NUM
aji-154	396	2	-	-	PUNCT
aji-154	396	3	69	69	NUM
aji-154	396	4	.	.	PUNCT
aji-154	397	1	33	33	NUM
aji-154	397	2	.	.	PUNCT
aji-154	398	1	olivier	olivier	PROPN
aji-154	398	2	ce	ce	PROPN
aji-154	398	3	,	,	PUNCT
aji-154	398	4	pinto	pinto	NOUN
aji-154	398	5	dg	dg	PROPN
aji-154	398	6	,	,	PUNCT
aji-154	398	7	teixeira	teixeira	PROPN
aji-154	398	8	apm	apm	PROPN
aji-154	398	9	,	,	PUNCT
aji-154	398	10	et	et	PROPN
aji-154	398	11	al	al	PROPN
aji-154	398	12	.	.	PUNCT
aji-154	398	13	evaluating	evaluate	VERB
aji-154	398	14	non	non	ADJ
aji-154	398	15	-	-	ADJ
aji-154	398	16	ige	ige	ADJ
aji-154	398	17	-	-	PUNCT
aji-154	398	18	mediated	mediate	VERB
aji-154	398	19	allergens	allergen	NOUN
aji-154	398	20	'	'	PART
aji-154	398	21	immunoreactivity	immunoreactivity	NOUN
aji-154	398	22	in	in	ADP
aji-154	398	23	patients	patient	NOUN
aji-154	398	24	with	with	ADP
aji-154	398	25	"	"	PUNCT
aji-154	398	26	intrinsic	intrinsic	ADJ
aji-154	398	27	"	"	PUNCT
aji-154	398	28	persistent	persistent	ADJ
aji-154	398	29	rhinitis	rhinitis	NOUN
aji-154	398	30	with	with	ADP
aji-154	398	31	help	help	NOUN
aji-154	398	32	of	of	ADP
aji-154	398	33	the	the	DET
aji-154	398	34	leukocyte	leukocyte	NOUN
aji-154	398	35	adherence	adherence	NOUN
aji-154	398	36	inhibition	inhibition	NOUN
aji-154	398	37	test	test	NOUN
aji-154	398	38	.	.	PUNCT
aji-154	399	1	eur	eur	PROPN
aji-154	399	2	j	j	PROPN
aji-154	399	3	med	med	PROPN
aji-154	399	4	health	health	PROPN
aji-154	399	5	sci	sci	PROPN
aji-154	399	6	.	.	PUNCT
aji-154	400	1	2023;5(1):17	2023;5(1):17	NUM
aji-154	400	2	-	-	SYM
aji-154	400	3	22	22	NUM
aji-154	400	4	.	.	PUNCT
aji-154	401	1	34	34	NUM
aji-154	401	2	.	.	PUNCT
aji-154	402	1	olivier	olivier	PROPN
aji-154	402	2	ce	ce	PROPN
aji-154	402	3	,	,	PUNCT
aji-154	402	4	pinto	pinto	NOUN
aji-154	402	5	dg	dg	PROPN
aji-154	402	6	,	,	PUNCT
aji-154	402	7	teixeira	teixeira	PROPN
aji-154	402	8	apm	apm	PROPN
aji-154	402	9	,	,	PUNCT
aji-154	402	10	santana	santana	PROPN
aji-154	402	11	jls	jls	PROPN
aji-154	402	12	,	,	PUNCT
aji-154	402	13	santos	santos	PROPN
aji-154	402	14	rapgs	rapgs	PROPN
aji-154	402	15	,	,	PUNCT
aji-154	402	16	lima	lima	PROPN
aji-154	402	17	rps	rps	PROPN
aji-154	402	18	.	.	PUNCT
aji-154	403	1	evaluating	evaluate	VERB
aji-154	403	2	non	non	ADJ
aji-154	403	3	-	-	ADJ
aji-154	403	4	ige	ige	ADJ
aji-154	403	5	-	-	PUNCT
aji-154	403	6	mediated	mediate	VERB
aji-154	403	7	allergens	allergen	NOUN
aji-154	403	8	'	'	PART
aji-154	403	9	immunoreactivity	immunoreactivity	NOUN
aji-154	403	10	in	in	ADP
aji-154	403	11	patients	patient	NOUN
aji-154	403	12	formerly	formerly	ADV
aji-154	403	13	classified	classify	VERB
aji-154	403	14	as	as	ADP
aji-154	403	15	"	"	PUNCT
aji-154	403	16	intrinsic	intrinsic	ADJ
aji-154	403	17	"	"	PUNCT
aji-154	403	18	asthmatics	asthmatic	NOUN
aji-154	403	19	with	with	ADP
aji-154	403	20	help	help	NOUN
aji-154	403	21	of	of	ADP
aji-154	403	22	the	the	DET
aji-154	403	23	leukocyte	leukocyte	NOUN
aji-154	403	24	adherence	adherence	NOUN
aji-154	403	25	inhibition	inhibition	NOUN
aji-154	403	26	test	test	NOUN
aji-154	403	27	.	.	PUNCT
aji-154	404	1	eur	eur	PROPN
aji-154	404	2	j	j	PROPN
aji-154	404	3	clin	clin	PROPN
aji-154	404	4	med	med	PROPN
aji-154	404	5	.	.	PUNCT
aji-154	405	1	2023;4(2):1	2023;4(2):1	PROPN
aji-154	405	2	-	-	PUNCT
aji-154	405	3	7	7	NUM
aji-154	405	4	.	.	NOUN
aji-154	405	5	35	35	NUM
aji-154	405	6	.	.	PUNCT
aji-154	406	1	olivier	olivier	PROPN
aji-154	406	2	ce	ce	PROPN
aji-154	406	3	,	,	PUNCT
aji-154	406	4	pinto	pinto	NOUN
aji-154	406	5	dg	dg	PROPN
aji-154	406	6	,	,	PUNCT
aji-154	406	7	teixeira	teixeira	PROPN
aji-154	406	8	apm	apm	PROPN
aji-154	406	9	,	,	PUNCT
aji-154	406	10	santana	santana	PROPN
aji-154	406	11	jls	jls	PROPN
aji-154	406	12	,	,	PUNCT
aji-154	406	13	santos	santos	PROPN
aji-154	406	14	rapgs	rapgs	PROPN
aji-154	406	15	,	,	PUNCT
aji-154	406	16	lima	lima	PROPN
aji-154	406	17	rps	rps	PROPN
aji-154	406	18	.	.	PUNCT
aji-154	407	1	contribution	contribution	NOUN
aji-154	407	2	of	of	ADP
aji-154	407	3	the	the	DET
aji-154	407	4	leukocyte	leukocyte	NOUN
aji-154	407	5	adherence	adherence	NOUN
aji-154	407	6	inhibition	inhibition	NOUN
aji-154	407	7	test	test	NOUN
aji-154	407	8	to	to	ADP
aji-154	407	9	the	the	DET
aji-154	407	10	diagnosis	diagnosis	NOUN
aji-154	407	11	of	of	ADP
aji-154	407	12	innate	innate	ADJ
aji-154	407	13	non	non	ADJ
aji-154	407	14	–	–	PUNCT
aji-154	407	15	ige	ige	ADJ
aji-154	407	16	-	-	PUNCT
aji-154	407	17	mediated	mediate	VERB
aji-154	407	18	immunoreactivity	immunoreactivity	NOUN
aji-154	407	19	against	against	ADP
aji-154	407	20	alternaria	alternaria	PROPN
aji-154	407	21	alternata	alternata	PROPN
aji-154	407	22	.	.	PUNCT
aji-154	408	1	asian	asian	PROPN
aji-154	408	2	j	j	PROPN
aji-154	408	3	immunol	immunol	NOUN
aji-154	408	4	.	.	PUNCT
aji-154	409	1	2023;6(1):243	2023;6(1):243	X
aji-154	409	2	-	-	PUNCT
aji-154	409	3	251	251	NUM
aji-154	409	4	.	.	PUNCT
aji-154	410	1	36	36	NUM
aji-154	410	2	.	.	PUNCT
aji-154	411	1	olivier	olivier	PROPN
aji-154	411	2	ce	ce	PROPN
aji-154	411	3	,	,	PUNCT
aji-154	411	4	pinto	pinto	NOUN
aji-154	411	5	dg	dg	PROPN
aji-154	411	6	,	,	PUNCT
aji-154	411	7	teixeira	teixeira	PROPN
aji-154	411	8	apm	apm	PROPN
aji-154	411	9	,	,	PUNCT
aji-154	411	10	santana	santana	PROPN
aji-154	411	11	jls	jls	PROPN
aji-154	411	12	,	,	PUNCT
aji-154	411	13	santos	santos	PROPN
aji-154	411	14	rapg	rapg	PROPN
aji-154	411	15	,	,	PUNCT
aji-154	411	16	lima	lima	PROPN
aji-154	411	17	rps	rps	PROPN
aji-154	411	18	.	.	PUNCT
aji-154	412	1	contribution	contribution	NOUN
aji-154	412	2	of	of	ADP
aji-154	412	3	the	the	DET
aji-154	412	4	leukocyte	leukocyte	NOUN
aji-154	412	5	adherence	adherence	NOUN
aji-154	412	6	inhibition	inhibition	NOUN
aji-154	412	7	test	test	NOUN
aji-154	412	8	to	to	ADP
aji-154	412	9	the	the	DET
aji-154	412	10	diagnosis	diagnosis	NOUN
aji-154	412	11	of	of	ADP
aji-154	412	12	innate	innate	ADJ
aji-154	412	13	non	non	ADJ
aji-154	412	14	–	–	PUNCT
aji-154	412	15	ige	ige	ADJ
aji-154	412	16	-	-	PUNCT
aji-154	412	17	mediated	mediate	VERB
aji-154	412	18	immunoreactivity	immunoreactivity	NOUN
aji-154	412	19	against	against	ADP
aji-154	412	20	saccharomyces	saccharomyce	NOUN
aji-154	412	21	cerevisiae	cerevisiae	NOUN
aji-154	412	22	.	.	PUNCT
aji-154	413	1	asian	asian	PROPN
aji-154	413	2	j	j	PROPN
aji-154	413	3	immunol	immunol	NOUN
aji-154	413	4	.	.	PUNCT
aji-154	414	1	2023;6(1):234	2023;6(1):234	NUM
aji-154	414	2	-	-	PUNCT
aji-154	414	3	241	241	NUM
aji-154	414	4	.	.	PUNCT
aji-154	415	1	37	37	NUM
aji-154	415	2	.	.	PUNCT
aji-154	416	1	olivier	olivier	PROPN
aji-154	416	2	ce	ce	PROPN
aji-154	416	3	,	,	PUNCT
aji-154	416	4	pinto	pinto	NOUN
aji-154	416	5	dg	dg	PROPN
aji-154	416	6	,	,	PUNCT
aji-154	416	7	teixeira	teixeira	PROPN
aji-154	416	8	apm	apm	PROPN
aji-154	416	9	,	,	PUNCT
aji-154	416	10	santana	santana	PROPN
aji-154	416	11	jls	jls	PROPN
aji-154	416	12	,	,	PUNCT
aji-154	416	13	santos	santos	PROPN
aji-154	416	14	rapgs	rapgs	PROPN
aji-154	416	15	,	,	PUNCT
aji-154	416	16	lima	lima	PROPN
aji-154	416	17	rps	rps	PROPN
aji-154	416	18	..	..	PUNCT
aji-154	416	19	contribution	contribution	NOUN
aji-154	416	20	of	of	ADP
aji-154	416	21	the	the	DET
aji-154	416	22	leukocyte	leukocyte	NOUN
aji-154	416	23	adherence	adherence	NOUN
aji-154	416	24	inhibition	inhibition	NOUN
aji-154	416	25	test	test	NOUN
aji-154	416	26	in	in	ADP
aji-154	416	27	diagnosing	diagnose	VERB
aji-154	416	28	non	non	ADJ
aji-154	416	29	–	–	PUNCT
aji-154	416	30	igemediated	igemediate	VERB
aji-154	416	31	immunoreactivity	immunoreactivity	NOUN
aji-154	416	32	against	against	ADP
aji-154	416	33	aspergillus	aspergillus	NOUN
aji-154	416	34	fumigatus	fumigatus	NOUN
aji-154	416	35	in	in	ADP
aji-154	416	36	patients	patient	NOUN
aji-154	416	37	with	with	ADP
aji-154	416	38	allergic	allergic	ADJ
aji-154	416	39	rhinitis	rhinitis	NOUN
aji-154	416	40	and	and	CCONJ
aji-154	416	41	asthma	asthma	NOUN
aji-154	416	42	.	.	PUNCT
aji-154	417	1	asian	asian	PROPN
aji-154	417	2	j	j	PROPN
aji-154	417	3	immunol	immunol	NOUN
aji-154	417	4	.	.	PUNCT
aji-154	418	1	2024;7(1):12	2024;7(1):12	NUM
aji-154	418	2	-	-	SYM
aji-154	418	3	20	20	NUM
aji-154	418	4	.	.	PUNCT
aji-154	419	1	38	38	NUM
aji-154	419	2	.	.	PUNCT
aji-154	420	1	olivier	olivier	PROPN
aji-154	420	2	ce	ce	PROPN
aji-154	420	3	,	,	PUNCT
aji-154	420	4	argentão	argentão	PROPN
aji-154	420	5	dgp	dgp	NOUN
aji-154	420	6	,	,	PUNCT
aji-154	420	7	santos	santos	PROPN
aji-154	420	8	rapg	rapg	PROPN
aji-154	420	9	,	,	PUNCT
aji-154	420	10	silva	silva	PROPN
aji-154	420	11	md	md	PROPN
aji-154	420	12	,	,	PUNCT
aji-154	420	13	lima	lima	PROPN
aji-154	420	14	rps	rps	PROPN
aji-154	420	15	,	,	PUNCT
aji-154	420	16	zollner	zollner	NOUN
aji-154	420	17	rl	rl	PROPN
aji-154	420	18	.	.	PROPN
aji-154	420	19	skin	skin	PROPN
aji-154	420	20	scrape	scrape	PROPN
aji-154	420	21	test	test	NOUN
aji-154	420	22	:	:	PUNCT
aji-154	420	23	an	an	DET
aji-154	420	24	inexpensive	inexpensive	ADJ
aji-154	420	25	and	and	CCONJ
aji-154	420	26	painless	painless	ADJ
aji-154	420	27	skin	skin	NOUN
aji-154	420	28	test	test	NOUN
aji-154	420	29	for	for	ADP
aji-154	420	30	recognition	recognition	NOUN
aji-154	420	31	of	of	ADP
aji-154	420	32	immediate	immediate	ADJ
aji-154	420	33	hypersensitivity	hypersensitivity	NOUN
aji-154	420	34	in	in	ADP
aji-154	420	35	children	child	NOUN
aji-154	420	36	and	and	CCONJ
aji-154	420	37	adults	adult	NOUN
aji-154	420	38	.	.	PUNCT
aji-154	421	1	the	the	DET
aji-154	421	2	open	open	ADJ
aji-154	421	3	allergy	allergy	NOUN
aji-154	421	4	journal	journal	PROPN
aji-154	421	5	.	.	PUNCT
aji-154	422	1	2013;6:9	2013;6:9	NUM
aji-154	422	2	-	-	SYM
aji-154	422	3	17	17	NUM
aji-154	422	4	.	.	NOUN
aji-154	423	1	39	39	NUM
aji-154	423	2	.	.	PUNCT
aji-154	424	1	olivier	olivier	PROPN
aji-154	424	2	ce	ce	PROPN
aji-154	424	3	,	,	PUNCT
aji-154	424	4	lima	lima	PROPN
aji-154	424	5	rps	rps	PROPN
aji-154	424	6	,	,	PUNCT
aji-154	424	7	pinto	pinto	NOUN
aji-154	424	8	dg	dg	NOUN
aji-154	424	9	,	,	PUNCT
aji-154	424	10	santos	santos	PROPN
aji-154	424	11	rapg	rapg	PROPN
aji-154	424	12	,	,	PUNCT
aji-154	424	13	silva	silva	PROPN
aji-154	424	14	gkm	gkm	PROPN
aji-154	424	15	,	,	PUNCT
aji-154	424	16	lorena	lorena	PROPN
aji-154	424	17	sl	sl	INTJ
aji-154	424	18	et	et	PROPN
aji-154	424	19	al	al	PROPN
aji-154	424	20	.	.	PROPN
aji-154	425	1	in	in	ADP
aji-154	425	2	search	search	NOUN
aji-154	425	3	of	of	ADP
aji-154	425	4	a	a	DET
aji-154	425	5	tolerance	tolerance	NOUN
aji-154	425	6	-	-	PUNCT
aji-154	425	7	induction	induction	NOUN
aji-154	425	8	strategy	strategy	NOUN
aji-154	425	9	for	for	ADP
aji-154	425	10	cow	cow	NOUN
aji-154	425	11	's	's	PART
aji-154	425	12	milk	milk	NOUN
aji-154	425	13	allergies	allergy	NOUN
aji-154	425	14	:	:	PUNCT
aji-154	425	15	significant	significant	ADJ
aji-154	425	16	reduction	reduction	NOUN
aji-154	425	17	of	of	ADP
aji-154	425	18	beta	beta	NOUN
aji-154	425	19	-	-	PUNCT
aji-154	425	20	lactoglobulin	lactoglobulin	NOUN
aji-154	425	21	allergenicity	allergenicity	NOUN
aji-154	425	22	via	via	ADP
aji-154	425	23	transglutaminase	transglutaminase	NOUN
aji-154	425	24	/	/	SYM
aji-154	425	25	cysteine	cysteine	NOUN
aji-154	425	26	polymerization	polymerization	NOUN
aji-154	425	27	.	.	PUNCT
aji-154	426	1	clinics	clinic	NOUN
aji-154	426	2	.	.	PUNCT
aji-154	427	1	2012;67(10):1171	2012;67(10):1171	NUM
aji-154	427	2	-	-	SYM
aji-154	427	3	1179	1179	NUM
aji-154	427	4	.	.	PUNCT
aji-154	428	1	40	40	NUM
aji-154	428	2	.	.	PUNCT
aji-154	429	1	olivier	olivier	PROPN
aji-154	429	2	ce	ce	PROPN
aji-154	429	3	,	,	PUNCT
aji-154	429	4	santos	santos	PROPN
aji-154	429	5	rapg	rapg	PROPN
aji-154	429	6	,	,	PUNCT
aji-154	429	7	lima	lima	PROPN
aji-154	429	8	rps	rps	PROPN
aji-154	429	9	,	,	PUNCT
aji-154	429	10	argentão	argentão	ADJ
aji-154	429	11	dgp	dgp	NOUN
aji-154	429	12	,	,	PUNCT
aji-154	429	13	silva	silva	NOUN
aji-154	429	14	gkm	gkm	PROPN
aji-154	429	15	,	,	PUNCT
aji-154	429	16	silva	silva	PROPN
aji-154	429	17	md	md	PROPN
aji-154	429	18	.	.	PUNCT
aji-154	430	1	a	a	DET
aji-154	430	2	novel	novel	ADJ
aji-154	430	3	utility	utility	NOUN
aji-154	430	4	for	for	ADP
aji-154	430	5	an	an	DET
aji-154	430	6	old	old	ADJ
aji-154	430	7	method	method	NOUN
aji-154	430	8	:	:	PUNCT
aji-154	430	9	the	the	DET
aji-154	430	10	leukocyte	leukocyte	NOUN
aji-154	430	11	adherence	adherence	NOUN
aji-154	430	12	inhibition	inhibition	NOUN
aji-154	430	13	test	test	NOUN
aji-154	430	14	is	be	AUX
aji-154	430	15	an	an	DET
aji-154	430	16	easy	easy	ADJ
aji-154	430	17	way	way	NOUN
aji-154	430	18	to	to	PART
aji-154	430	19	detect	detect	VERB
aji-154	430	20	the	the	DET
aji-154	430	21	immunoreactive	immunoreactive	ADJ
aji-154	430	22	interference	interference	NOUN
aji-154	430	23	of	of	ADP
aji-154	430	24	the	the	DET
aji-154	430	25	collection	collection	NOUN
aji-154	430	26	tube	tube	NOUN
aji-154	430	27	anticoagulant	anticoagulant	NOUN
aji-154	430	28	on	on	ADP
aji-154	430	29	cellular	cellular	ADJ
aji-154	430	30	immunoassays	immunoassay	NOUN
aji-154	430	31	.	.	PUNCT
aji-154	431	1	j	j	NOUN
aji-154	431	2	cell	cell	NOUN
aji-154	431	3	adhesion	adhesion	NOUN
aji-154	431	4	.	.	PUNCT
aji-154	432	1	2014;1	2014;1	NUM
aji-154	432	2	-	-	SYM
aji-154	432	3	6	6	NUM
aji-154	432	4	.	.	PUNCT
aji-154	433	1	article	article	NOUN
aji-154	433	2	i	i	PROPN
aji-154	433	3	d	d	PROPN
aji-154	433	4	860427	860427	NUM
aji-154	433	5	available	available	ADJ
aji-154	433	6	:	:	PUNCT
aji-154	433	7	http://dx.doi.org/10.1155/2014/86	http://dx.doi.org/10.1155/2014/86	NOUN
aji-154	433	8	0427	0427	NUM
aji-154	433	9	41	41	NUM
aji-154	433	10	.	.	PUNCT
aji-154	434	1	olivier	olivier	PROPN
aji-154	434	2	ce	ce	PROPN
aji-154	434	3	,	,	PUNCT
aji-154	434	4	pinto	pinto	NOUN
aji-154	434	5	dg	dg	PROPN
aji-154	434	6	,	,	PUNCT
aji-154	434	7	lima	lima	PROPN
aji-154	434	8	rps	rps	PROPN
aji-154	434	9	,	,	PUNCT
aji-154	434	10	silva	silva	PROPN
aji-154	434	11	md	md	PROPN
aji-154	434	12	,	,	PUNCT
aji-154	434	13	santos	santos	PROPN
aji-154	434	14	rapg	rapg	PROPN
aji-154	434	15	,	,	PUNCT
aji-154	434	16	teixeira	teixeira	PROPN
aji-154	434	17	apm	apm	PROPN
aji-154	434	18	et	et	PROPN
aji-154	434	19	al	al	PROPN
aji-154	434	20	.	.	PROPN
aji-154	434	21	assessment	assessment	NOUN
aji-154	434	22	of	of	ADP
aji-154	434	23	immunoreactivity	immunoreactivity	NOUN
aji-154	434	24	against	against	ADP
aji-154	434	25	therapeutic	therapeutic	ADJ
aji-154	434	26	options	option	NOUN
aji-154	434	27	employing	employ	VERB
aji-154	434	28	the	the	DET
aji-154	434	29	leukocyte	leukocyte	NOUN
aji-154	434	30	adherence	adherence	NOUN
aji-154	434	31	inhibition	inhibition	NOUN
aji-154	434	32	test	test	NOUN
aji-154	434	33	as	as	ADP
aji-154	434	34	a	a	DET
aji-154	434	35	tool	tool	NOUN
aji-154	434	36	for	for	ADP
aji-154	434	37	precision	precision	NOUN
aji-154	434	38	medicine	medicine	NOUN
aji-154	434	39	.	.	PUNCT
aji-154	435	1	eur	eur	PROPN
aji-154	435	2	j	j	PROPN
aji-154	435	3	clin	clin	PROPN
aji-154	435	4	med	med	PROPN
aji-154	435	5	.	.	PUNCT
aji-154	436	1	2021;2(3):40	2021;2(3):40	NUM
aji-154	436	2	-	-	SYM
aji-154	436	3	45	45	NUM
aji-154	436	4	.	.	PUNCT
aji-154	436	5	42	42	NUM
aji-154	436	6	.	.	PUNCT
aji-154	437	1	olivier	olivier	PROPN
aji-154	437	2	ce	ce	PROPN
aji-154	437	3	,	,	PUNCT
aji-154	437	4	pinto	pinto	NOUN
aji-154	437	5	dg	dg	PROPN
aji-154	437	6	,	,	PUNCT
aji-154	437	7	santos	santos	PROPN
aji-154	437	8	rapg	rapg	PROPN
aji-154	437	9	,	,	PUNCT
aji-154	437	10	lima	lima	PROPN
aji-154	437	11	rps	rps	PROPN
aji-154	437	12	.	.	PUNCT
aji-154	437	13	dextran	dextran	PROPN
aji-154	437	14	's	's	PART
aji-154	437	15	interference	interference	NOUN
aji-154	437	16	over	over	ADP
aji-154	437	17	the	the	DET
aji-154	437	18	leukocyte	leukocyte	NOUN
aji-154	437	19	adherence	adherence	NOUN
aji-154	437	20	inhibition	inhibition	NOUN
aji-154	437	21	test	test	NOUN
aji-154	437	22	.	.	PUNCT
aji-154	438	1	academia	academia	PROPN
aji-154	438	2	letter	letter	PROPN
aji-154	438	3	.	.	PUNCT
aji-154	439	1	2021	2021	NUM
aji-154	439	2	;	;	PUNCT
aji-154	440	1	article	article	NOUN
aji-154	440	2	(	(	PUNCT
aji-154	440	3	number	number	NOUN
aji-154	440	4	):	):	PUNCT
aji-154	440	5	3792	3792	NUM
aji-154	440	6	.	.	PUNCT
aji-154	441	1	43	43	NUM
aji-154	441	2	.	.	PUNCT
aji-154	442	1	olivier	olivier	PROPN
aji-154	442	2	ce	ce	PROPN
aji-154	442	3	,	,	PUNCT
aji-154	442	4	pinto	pinto	NOUN
aji-154	442	5	dg	dg	PROPN
aji-154	442	6	,	,	PUNCT
aji-154	442	7	teixeira	teixeira	PROPN
aji-154	442	8	apm	apm	PROPN
aji-154	442	9	,	,	PUNCT
aji-154	442	10	santana	santana	PROPN
aji-154	442	11	jls	jls	PROPN
aji-154	442	12	,	,	PUNCT
aji-154	442	13	santos	santos	PROPN
aji-154	442	14	rapgs	rapgs	PROPN
aji-154	442	15	,	,	PUNCT
aji-154	442	16	lima	lima	PROPN
aji-154	442	17	rps	rps	PROPN
aji-154	442	18	.	.	PUNCT
aji-154	443	1	contribution	contribution	NOUN
aji-154	443	2	of	of	ADP
aji-154	443	3	the	the	DET
aji-154	443	4	leukocyte	leukocyte	NOUN
aji-154	443	5	adherence	adherence	NOUN
aji-154	443	6	inhibition	inhibition	NOUN
aji-154	443	7	test	test	NOUN
aji-154	443	8	to	to	ADP
aji-154	443	9	the	the	DET
aji-154	443	10	evaluation	evaluation	NOUN
aji-154	443	11	of	of	ADP
aji-154	443	12	cellular	cellular	ADJ
aji-154	443	13	immunoreactivity	immunoreactivity	NOUN
aji-154	443	14	against	against	ADP
aji-154	443	15	latex	latex	NOUN
aji-154	443	16	extracts	extract	NOUN
aji-154	443	17	for	for	ADP
aji-154	443	18	non	non	ADJ
aji-154	443	19	—	—	PUNCT
aji-154	443	20	ige	ige	ADJ
aji-154	443	21	-	-	PUNCT
aji-154	443	22	mediated	mediate	VERB
aji-154	443	23	latex	latex	NOUN
aji-154	443	24	-	-	PUNCT
aji-154	443	25	fruit	fruit	NOUN
aji-154	443	26	-	-	PUNCT
aji-154	443	27	pollen	pollen	NOUN
aji-154	443	28	syndrome	syndrome	NOUN
aji-154	443	29	in	in	ADP
aji-154	443	30	allergic	allergic	ADJ
aji-154	443	31	candidates	candidate	NOUN
aji-154	443	32	to	to	PART
aji-154	443	33	exclusion	exclusion	VERB
aji-154	443	34	diets	diet	NOUN
aji-154	443	35	and	and	CCONJ
aji-154	443	36	allergic	allergic	ADJ
aji-154	443	37	desensitization	desensitization	NOUN
aji-154	443	38	.	.	PUNCT
aji-154	444	1	eur	eur	PROPN
aji-154	444	2	j	j	PROPN
aji-154	444	3	clin	clin	PROPN
aji-154	444	4	med	med	PROPN
aji-154	444	5	.	.	PUNCT
aji-154	444	6	2022	2022	NUM
aji-154	444	7	;	;	PUNCT
aji-154	444	8	3(1):11	3(1):11	NUM
aji-154	444	9	-	-	SYM
aji-154	444	10	17	17	NUM
aji-154	444	11	.	.	PUNCT
aji-154	445	1	44	44	NUM
aji-154	445	2	.	.	PUNCT
aji-154	446	1	olivier	olivier	PROPN
aji-154	446	2	ce	ce	PROPN
aji-154	446	3	,	,	PUNCT
aji-154	446	4	pinto	pinto	NOUN
aji-154	446	5	dg	dg	PROPN
aji-154	446	6	,	,	PUNCT
aji-154	446	7	teixeira	teixeira	PROPN
aji-154	446	8	apm	apm	PROPN
aji-154	446	9	,	,	PUNCT
aji-154	446	10	santana	santana	PROPN
aji-154	446	11	jls	jls	PROPN
aji-154	446	12	,	,	PUNCT
aji-154	446	13	santos	santos	PROPN
aji-154	446	14	rapgs	rapgs	PROPN
aji-154	446	15	,	,	PUNCT
aji-154	446	16	lima	lima	PROPN
aji-154	446	17	rps	rps	PROPN
aji-154	446	18	.	.	PUNCT
aji-154	447	1	contribution	contribution	NOUN
aji-154	447	2	of	of	ADP
aji-154	447	3	the	the	DET
aji-154	447	4	leukocyte	leukocyte	NOUN
aji-154	447	5	adherence	adherence	NOUN
aji-154	447	6	inhibition	inhibition	NOUN
aji-154	447	7	test	test	NOUN
aji-154	447	8	for	for	ADP
aji-154	447	9	the	the	DET
aji-154	447	10	evaluation	evaluation	NOUN
aji-154	447	11	of	of	ADP
aji-154	447	12	immunoreactivity	immunoreactivity	NOUN
aji-154	447	13	against	against	ADP
aji-154	447	14	gluten	gluten	ADJ
aji-154	447	15	extracts	extract	NOUN
aji-154	447	16	in	in	ADP
aji-154	447	17	non	non	ADJ
aji-154	447	18	—	—	PUNCT
aji-154	447	19	ige	ige	ADJ
aji-154	447	20	-	-	PUNCT
aji-154	447	21	mediated	mediate	VERB
aji-154	447	22	/	/	SYM
aji-154	447	23	non	non	ADJ
aji-154	447	24	-	-	ADJ
aji-154	447	25	autoimmune	autoimmune	ADJ
aji-154	447	26	gluten	gluten	NOUN
aji-154	447	27	-	-	PUNCT
aji-154	447	28	related	relate	VERB
aji-154	447	29	disorders	disorder	NOUN
aji-154	447	30	.	.	PUNCT
aji-154	448	1	eur	eur	PROPN
aji-154	448	2	j	j	PROPN
aji-154	448	3	clin	clin	PROPN
aji-154	448	4	med	med	PROPN
aji-154	448	5	.	.	PUNCT
aji-154	449	1	2022;3(2):1	2022;3(2):1	PROPN
aji-154	449	2	-	-	SYM
aji-154	449	3	7	7	NUM
aji-154	449	4	.	.	NOUN
aji-154	449	5	45	45	NUM
aji-154	449	6	.	.	PUNCT
aji-154	450	1	olivier	olivier	PROPN
aji-154	450	2	ce	ce	PROPN
aji-154	450	3	,	,	PUNCT
aji-154	450	4	pinto	pinto	NOUN
aji-154	450	5	dg	dg	PROPN
aji-154	450	6	,	,	PUNCT
aji-154	450	7	teixeira	teixeira	PROPN
aji-154	450	8	apm	apm	PROPN
aji-154	450	9	,	,	PUNCT
aji-154	450	10	santana	santana	PROPN
aji-154	450	11	jls	jls	PROPN
aji-154	450	12	,	,	PUNCT
aji-154	450	13	santos	santos	PROPN
aji-154	450	14	rapgs	rapgs	PROPN
aji-154	450	15	,	,	PUNCT
aji-154	450	16	lima	lima	PROPN
aji-154	450	17	rps	rps	PROPN
aji-154	450	18	.	.	PUNCT
aji-154	451	1	leukocyte	leukocyte	ADJ
aji-154	451	2	adherence	adherence	NOUN
aji-154	451	3	inhibition	inhibition	NOUN
aji-154	451	4	test	test	NOUN
aji-154	451	5	to	to	ADP
aji-154	451	6	the	the	DET
aji-154	451	7	assessment	assessment	NOUN
aji-154	451	8	of	of	ADP
aji-154	451	9	immunoreactivity	immunoreactivity	NOUN
aji-154	451	10	against	against	ADP
aji-154	451	11	cow	cow	NOUN
aji-154	451	12	's	's	PART
aji-154	451	13	milk	milk	NOUN
aji-154	451	14	proteins	protein	NOUN
aji-154	451	15	in	in	ADP
aji-154	451	16	non	non	ADJ
aji-154	451	17	—	—	PUNCT
aji-154	451	18	ige	ige	ADJ
aji-154	451	19	-	-	PUNCT
aji-154	451	20	mediated	mediate	VERB
aji-154	451	21	gastrointestinal	gastrointestinal	ADJ
aji-154	451	22	food	food	NOUN
aji-154	451	23	allergy	allergy	NOUN
aji-154	451	24	.	.	PUNCT
aji-154	452	1	eur	eur	PROPN
aji-154	452	2	j	j	PROPN
aji-154	452	3	clin	clin	PROPN
aji-154	452	4	med	me	VERB
aji-154	452	5	.	.	PUNCT
aji-154	453	1	2022;3(2):38	2022;3(2):38	NUM
aji-154	453	2	-	-	SYM
aji-154	453	3	43	43	NUM
aji-154	453	4	.	.	PUNCT
aji-154	454	1	46	46	NUM
aji-154	454	2	.	.	PUNCT
aji-154	455	1	olivier	olivier	PROPN
aji-154	455	2	ce	ce	PROPN
aji-154	455	3	,	,	PUNCT
aji-154	455	4	pinto	pinto	NOUN
aji-154	455	5	dg	dg	PROPN
aji-154	455	6	,	,	PUNCT
aji-154	455	7	teixeira	teixeira	PROPN
aji-154	455	8	apm	apm	PROPN
aji-154	455	9	,	,	PUNCT
aji-154	455	10	santana	santana	PROPN
aji-154	455	11	jls	jls	PROPN
aji-154	455	12	,	,	PUNCT
aji-154	455	13	santos	santos	PROPN
aji-154	455	14	rapg	rapg	PROPN
aji-154	455	15	,	,	PUNCT
aji-154	455	16	lima	lima	PROPN
aji-154	455	17	rps	rps	PROPN
aji-154	455	18	.	.	PUNCT
aji-154	456	1	contribution	contribution	NOUN
aji-154	456	2	of	of	ADP
aji-154	456	3	the	the	DET
aji-154	456	4	leukocyte	leukocyte	NOUN
aji-154	456	5	adherence	adherence	NOUN
aji-154	456	6	inhibition	inhibition	NOUN
aji-154	456	7	test	test	NOUN
aji-154	456	8	to	to	ADP
aji-154	456	9	the	the	DET
aji-154	456	10	diagnosis	diagnosis	NOUN
aji-154	456	11	of	of	ADP
aji-154	456	12	immunoreactivity	immunoreactivity	NOUN
aji-154	456	13	against	against	ADP
aji-154	456	14	cobalt	cobalt	NOUN
aji-154	456	15	.	.	PUNCT
aji-154	457	1	asian	asian	PROPN
aji-154	457	2	j	j	PROPN
aji-154	457	3	immunol	immunol	NOUN
aji-154	457	4	.	.	PUNCT
aji-154	458	1	2023;6(1):174	2023;6(1):174	X
aji-154	458	2	-	-	PUNCT
aji-154	458	3	184	184	NUM
aji-154	458	4	.	.	PUNCT
aji-154	459	1	47	47	NUM
aji-154	459	2	.	.	PUNCT
aji-154	460	1	olivier	olivier	PROPN
aji-154	460	2	ce	ce	PROPN
aji-154	460	3	,	,	PUNCT
aji-154	460	4	pinto	pinto	NOUN
aji-154	460	5	dg	dg	PROPN
aji-154	460	6	,	,	PUNCT
aji-154	460	7	teixeira	teixeira	PROPN
aji-154	460	8	apm	apm	PROPN
aji-154	460	9	,	,	PUNCT
aji-154	460	10	santana	santana	PROPN
aji-154	460	11	jls	jls	PROPN
aji-154	460	12	,	,	PUNCT
aji-154	460	13	santos	santos	PROPN
aji-154	460	14	rapg	rapg	PROPN
aji-154	460	15	,	,	PUNCT
aji-154	460	16	lima	lima	PROPN
aji-154	460	17	rps	rps	PROPN
aji-154	460	18	.	.	PUNCT
aji-154	461	1	exploring	explore	VERB
aji-154	461	2	the	the	DET
aji-154	461	3	role	role	NOUN
aji-154	461	4	of	of	ADP
aji-154	461	5	leukocyte	leukocyte	NOUN
aji-154	461	6	adherence	adherence	NOUN
aji-154	461	7	inhibition	inhibition	NOUN
aji-154	461	8	test	test	NOUN
aji-154	461	9	in	in	ADP
aji-154	461	10	assessing	assess	VERB
aji-154	461	11	non	non	ADJ
aji-154	461	12	-	-	ADJ
aji-154	461	13	ige	ige	ADJ
aji-154	461	14	mediated	mediate	VERB
aji-154	461	15	immunoreactivity	immunoreactivity	NOUN
aji-154	461	16	to	to	ADP
aji-154	461	17	benzoic	benzoic	NOUN
aji-154	461	18	acid	acid	NOUN
aji-154	461	19	in	in	ADP
aji-154	461	20	allergic	allergic	ADJ
aji-154	461	21	patients	patient	NOUN
aji-154	461	22	.	.	PUNCT
aji-154	462	1	asian	asian	PROPN
aji-154	462	2	j	j	PROPN
aji-154	462	3	immunol	immunol	NOUN
aji-154	462	4	.	.	PUNCT
aji-154	463	1	2024;7(1):63	2024;7(1):63	NUM
aji-154	463	2	-	-	SYM
aji-154	463	3	70	70	NUM
aji-154	463	4	.	.	PUNCT
aji-154	464	1	olivier	olivier	PROPN
aji-154	464	2	et	et	PROPN
aji-154	464	3	al	al	PROPN
aji-154	464	4	.	.	PROPN
aji-154	464	5	;	;	PUNCT
aji-154	464	6	asian	asian	PROPN
aji-154	464	7	j.	j.	PROPN
aji-154	464	8	immunol	immunol	PROPN
aji-154	464	9	.	.	PROPN
aji-154	464	10	,	,	PUNCT
aji-154	464	11	vol	vol	NOUN
aji-154	464	12	.	.	PROPN
aji-154	465	1	7	7	NUM
aji-154	465	2	,	,	PUNCT
aji-154	465	3	no	no	INTJ
aji-154	465	4	.	.	NOUN
aji-154	465	5	1	1	NUM
aji-154	465	6	,	,	PUNCT
aji-154	465	7	pp	pp	ADJ
aji-154	465	8	.	.	PUNCT
aji-154	466	1	316	316	NUM
aji-154	466	2	-	-	SYM
aji-154	466	3	325	325	NUM
aji-154	466	4	,	,	PUNCT
aji-154	466	5	2024	2024	NUM
aji-154	466	6	;	;	PUNCT
aji-154	466	7	article	article	NOUN
aji-154	466	8	no.aji.128121	no.aji.128121	VERB
aji-154	466	9	325	325	NUM
aji-154	466	10	48	48	NUM
aji-154	466	11	.	.	PUNCT
aji-154	467	1	olivier	olivier	PROPN
aji-154	467	2	ce	ce	PROPN
aji-154	467	3	,	,	PUNCT
aji-154	467	4	pinto	pinto	NOUN
aji-154	467	5	dg	dg	PROPN
aji-154	467	6	,	,	PUNCT
aji-154	467	7	teixeira	teixeira	PROPN
aji-154	467	8	apm	apm	PROPN
aji-154	467	9	,	,	PUNCT
aji-154	467	10	santana	santana	PROPN
aji-154	467	11	jls	jls	PROPN
aji-154	467	12	,	,	PUNCT
aji-154	467	13	santos	santos	PROPN
aji-154	467	14	rapgs	rapgs	PROPN
aji-154	467	15	,	,	PUNCT
aji-154	467	16	lima	lima	PROPN
aji-154	467	17	rps	rps	PROPN
aji-154	467	18	.	.	PUNCT
aji-154	468	1	intrinsic	intrinsic	ADJ
aji-154	468	2	atopic	atopic	NOUN
aji-154	468	3	dermatitis	dermatitis	NOUN
aji-154	468	4	:	:	PUNCT
aji-154	468	5	titration	titration	NOUN
aji-154	468	6	of	of	ADP
aji-154	468	7	precipitins	precipitin	NOUN
aji-154	468	8	in	in	ADP
aji-154	468	9	the	the	DET
aji-154	468	10	screening	screening	NOUN
aji-154	468	11	of	of	ADP
aji-154	468	12	food	food	NOUN
aji-154	468	13	allergens	allergen	NOUN
aji-154	468	14	for	for	ADP
aji-154	468	15	prescription	prescription	NOUN
aji-154	468	16	of	of	ADP
aji-154	468	17	elimination	elimination	NOUN
aji-154	468	18	diets	diet	NOUN
aji-154	468	19	and	and	CCONJ
aji-154	468	20	desensitization	desensitization	NOUN
aji-154	468	21	strategies	strategy	NOUN
aji-154	468	22	.	.	PUNCT
aji-154	469	1	eur	eur	PROPN
aji-154	469	2	j	j	PROPN
aji-154	469	3	clin	clin	PROPN
aji-154	469	4	med	med	PROPN
aji-154	469	5	.	.	PUNCT
aji-154	470	1	2021;2(6):1	2021;2(6):1	PROPN
aji-154	470	2	-	-	PUNCT
aji-154	470	3	9	9	NUM
aji-154	470	4	.	.	NUM
aji-154	470	5	49	49	NUM
aji-154	470	6	.	.	PUNCT
aji-154	471	1	olivier	olivier	PROPN
aji-154	471	2	ce	ce	PROPN
aji-154	471	3	,	,	PUNCT
aji-154	471	4	pinto	pinto	NOUN
aji-154	471	5	dg	dg	PROPN
aji-154	471	6	,	,	PUNCT
aji-154	471	7	teixeira	teixeira	PROPN
aji-154	471	8	apm	apm	PROPN
aji-154	471	9	,	,	PUNCT
aji-154	471	10	santana	santana	PROPN
aji-154	471	11	jls	jls	PROPN
aji-154	471	12	,	,	PUNCT
aji-154	471	13	santos	santos	PROPN
aji-154	471	14	rapg	rapg	PROPN
aji-154	471	15	,	,	PUNCT
aji-154	471	16	lima	lima	PROPN
aji-154	471	17	rps	rps	PROPN
aji-154	471	18	.	.	PUNCT
aji-154	472	1	endotyping	endotype	VERB
aji-154	472	2	cellular	cellular	ADJ
aji-154	472	3	and	and	CCONJ
aji-154	472	4	humoral	humoral	ADJ
aji-154	472	5	immunoreactivity	immunoreactivity	NOUN
aji-154	472	6	against	against	ADP
aji-154	472	7	aluminum	aluminum	NOUN
aji-154	472	8	in	in	ADP
aji-154	472	9	allergic	allergic	ADJ
aji-154	472	10	patients	patient	NOUN
aji-154	472	11	:	:	PUNCT
aji-154	472	12	a	a	DET
aji-154	472	13	retrospective	retrospective	ADJ
aji-154	472	14	study	study	NOUN
aji-154	472	15	.	.	PUNCT
aji-154	473	1	asian	asian	PROPN
aji-154	473	2	j	j	PROPN
aji-154	473	3	immunol	immunol	NOUN
aji-154	473	4	.	.	PUNCT
aji-154	474	1	2024;7(1):149	2024;7(1):149	NUM
aji-154	474	2	-	-	SYM
aji-154	474	3	158	158	NUM
aji-154	474	4	.	.	PUNCT
aji-154	475	1	50	50	NUM
aji-154	475	2	.	.	PUNCT
aji-154	476	1	olivier	olivier	PROPN
aji-154	476	2	ce	ce	PROPN
aji-154	476	3	,	,	PUNCT
aji-154	476	4	pinto	pinto	NOUN
aji-154	476	5	dg	dg	PROPN
aji-154	476	6	,	,	PUNCT
aji-154	476	7	teixeira	teixeira	PROPN
aji-154	476	8	apm	apm	PROPN
aji-154	476	9	,	,	PUNCT
aji-154	476	10	miguel	miguel	PROPN
aji-154	476	11	cs	cs	PROPN
aji-154	476	12	,	,	PUNCT
aji-154	476	13	santos	santos	PROPN
aji-154	476	14	rapgs	rapgs	PROPN
aji-154	476	15	,	,	PUNCT
aji-154	476	16	santana	santana	PROPN
aji-154	476	17	jls	jls	PROPN
aji-154	476	18	,	,	PUNCT
aji-154	476	19	lima	lima	PROPN
aji-154	476	20	rps	rps	PROPN
aji-154	476	21	.	.	PUNCT
aji-154	477	1	endotyping	endotype	VERB
aji-154	477	2	cellular	cellular	ADJ
aji-154	477	3	and	and	CCONJ
aji-154	477	4	humoral	humoral	ADJ
aji-154	477	5	immunoreactivity	immunoreactivity	NOUN
aji-154	477	6	against	against	ADP
aji-154	477	7	tartrazine	tartrazine	NOUN
aji-154	477	8	in	in	ADP
aji-154	477	9	allergic	allergic	ADJ
aji-154	477	10	patients	patient	NOUN
aji-154	477	11	:	:	PUNCT
aji-154	477	12	a	a	DET
aji-154	477	13	retrospective	retrospective	ADJ
aji-154	477	14	study	study	NOUN
aji-154	477	15	.	.	PUNCT
aji-154	478	1	asian	asian	PROPN
aji-154	478	2	j	j	PROPN
aji-154	478	3	immunol	immunol	NOUN
aji-154	478	4	.	.	PUNCT
aji-154	479	1	2024;7(1):217	2024;7(1):217	NUM
aji-154	479	2	-	-	SYM
aji-154	479	3	227	227	NUM
aji-154	479	4	.	.	PUNCT
aji-154	480	1	51	51	NUM
aji-154	480	2	.	.	PUNCT
aji-154	481	1	olivier	olivier	PROPN
aji-154	481	2	ce	ce	PROPN
aji-154	481	3	,	,	PUNCT
aji-154	481	4	pinto	pinto	NOUN
aji-154	481	5	dg	dg	PROPN
aji-154	481	6	,	,	PUNCT
aji-154	481	7	teixeira	teixeira	PROPN
aji-154	481	8	apm	apm	PROPN
aji-154	481	9	,	,	PUNCT
aji-154	481	10	miguel	miguel	PROPN
aji-154	481	11	cs	cs	PROPN
aji-154	481	12	,	,	PUNCT
aji-154	481	13	santos	santos	PROPN
aji-154	481	14	rapgs	rapgs	PROPN
aji-154	481	15	,	,	PUNCT
aji-154	481	16	santana	santana	PROPN
aji-154	481	17	jls	jls	PROPN
aji-154	481	18	,	,	PUNCT
aji-154	481	19	lima	lima	PROPN
aji-154	481	20	rps	rps	PROPN
aji-154	481	21	.	.	PUNCT
aji-154	482	1	endotyping	endotype	VERB
aji-154	482	2	cellular	cellular	ADJ
aji-154	482	3	and	and	CCONJ
aji-154	482	4	humoral	humoral	ADJ
aji-154	482	5	immunoreactivity	immunoreactivity	NOUN
aji-154	482	6	against	against	ADP
aji-154	482	7	allium	allium	NOUN
aji-154	482	8	spices	spice	NOUN
aji-154	482	9	and	and	CCONJ
aji-154	482	10	sulfites	sulfite	NOUN
aji-154	482	11	preservatives	preservative	NOUN
aji-154	482	12	in	in	ADP
aji-154	482	13	allergic	allergic	ADJ
aji-154	482	14	patients	patient	NOUN
aji-154	482	15	.	.	PUNCT
aji-154	483	1	a	a	DET
aji-154	483	2	retrospective	retrospective	ADJ
aji-154	483	3	study	study	NOUN
aji-154	483	4	.	.	PUNCT
aji-154	484	1	asian	asian	PROPN
aji-154	484	2	j	j	PROPN
aji-154	484	3	immunol	immunol	NOUN
aji-154	484	4	.	.	PUNCT
aji-154	485	1	2024;7(1	2024;7(1	NUM
aji-154	485	2	)	)	PUNCT
aji-154	485	3	.	.	PUNCT
aji-154	486	1	52	52	NUM
aji-154	486	2	.	.	PUNCT
aji-154	487	1	olivier	olivier	PROPN
aji-154	487	2	ce	ce	PROPN
aji-154	487	3	,	,	PUNCT
aji-154	487	4	pinto	pinto	NOUN
aji-154	487	5	dg	dg	PROPN
aji-154	487	6	,	,	PUNCT
aji-154	487	7	teixeira	teixeira	PROPN
aji-154	487	8	apm	apm	PROPN
aji-154	487	9	,	,	PUNCT
aji-154	487	10	miguel	miguel	PROPN
aji-154	487	11	cs	cs	PROPN
aji-154	487	12	,	,	PUNCT
aji-154	487	13	santos	santos	PROPN
aji-154	487	14	rapgs	rapgs	PROPN
aji-154	487	15	,	,	PUNCT
aji-154	487	16	santana	santana	PROPN
aji-154	487	17	jls	jls	PROPN
aji-154	487	18	,	,	PUNCT
aji-154	487	19	lima	lima	PROPN
aji-154	487	20	rps	rps	PROPN
aji-154	487	21	.	.	PUNCT
aji-154	487	22	endotyping	endotype	VERB
aji-154	487	23	non	non	ADJ
aji-154	487	24	-	-	ADJ
aji-154	487	25	ige	ige	ADJ
aji-154	487	26	-	-	PUNCT
aji-154	487	27	mediated	mediate	VERB
aji-154	487	28	immunoreactivity	immunoreactivity	NOUN
aji-154	487	29	to	to	ADP
aji-154	487	30	dermatophagoides	dermatophagoide	NOUN
aji-154	487	31	farinae	farinae	NOUN
aji-154	487	32	:	:	PUNCT
aji-154	487	33	implications	implication	NOUN
aji-154	487	34	for	for	ADP
aji-154	487	35	allergic	allergic	ADJ
aji-154	487	36	patients	patient	NOUN
aji-154	487	37	.	.	PUNCT
aji-154	488	1	asian	asian	PROPN
aji-154	488	2	j	j	PROPN
aji-154	488	3	immunol	immunol	NOUN
aji-154	488	4	.	.	PUNCT
aji-154	489	1	2024;7(1):90	2024;7(1):90	X
aji-154	489	2	-	-	SYM
aji-154	489	3	99	99	NUM
aji-154	489	4	.	.	PUNCT
aji-154	490	1	53	53	NUM
aji-154	490	2	.	.	PUNCT
aji-154	491	1	williams	williams	PROPN
aji-154	491	2	ca	ca	PROPN
aji-154	491	3	,	,	PUNCT
aji-154	491	4	chase	chase	PROPN
aji-154	491	5	mw	mw	PROPN
aji-154	491	6	.	.	PROPN
aji-154	491	7	chapter	chapter	NOUN
aji-154	491	8	13	13	NUM
aji-154	491	9	precipitation	precipitation	NOUN
aji-154	491	10	reactions	reaction	NOUN
aji-154	491	11	.	.	PUNCT
aji-154	492	1	in	in	ADP
aji-154	492	2	:	:	PUNCT
aji-154	492	3	reactions	reaction	NOUN
aji-154	492	4	of	of	ADP
aji-154	492	5	antibodies	antibody	NOUN
aji-154	492	6	with	with	ADP
aji-154	492	7	soluble	soluble	ADJ
aji-154	492	8	antigens	antigen	NOUN
aji-154	492	9	.	.	PUNCT
aji-154	493	1	vol	vol	NOUN
aji-154	493	2	3	3	NUM
aji-154	493	3	.	.	PUNCT
aji-154	493	4	academic	academic	ADJ
aji-154	493	5	press	press	NOUN
aji-154	493	6	.	.	PUNCT
aji-154	494	1	;	;	PUNCT
aji-154	494	2	1971:1	1971:1	NUM
aji-154	494	3	-	-	SYM
aji-154	494	4	102	102	NUM
aji-154	494	5	.	.	PUNCT
aji-154	495	1	54	54	NUM
aji-154	495	2	.	.	PUNCT
aji-154	496	1	rastogi	rastogi	PROPN
aji-154	496	2	s	s	PROPN
aji-154	496	3	,	,	PUNCT
aji-154	496	4	patel	patel	PROPN
aji-154	496	5	kr	kr	PROPN
aji-154	496	6	,	,	PUNCT
aji-154	496	7	singam	singam	PROPN
aji-154	496	8	v	v	PROPN
aji-154	496	9	,	,	PUNCT
aji-154	496	10	silverberg	silverberg	PROPN
aji-154	496	11	ji	ji	PROPN
aji-154	496	12	.	.	PROPN
aji-154	496	13	allergic	allergic	ADJ
aji-154	496	14	contact	contact	PROPN
aji-154	496	15	dermatitis	dermatitis	NOUN
aji-154	496	16	to	to	ADP
aji-154	496	17	personal	personal	ADJ
aji-154	496	18	care	care	NOUN
aji-154	496	19	products	product	NOUN
aji-154	496	20	and	and	CCONJ
aji-154	496	21	topical	topical	ADJ
aji-154	496	22	medications	medication	NOUN
aji-154	496	23	in	in	ADP
aji-154	496	24	adults	adult	NOUN
aji-154	496	25	with	with	ADP
aji-154	496	26	atopic	atopic	NOUN
aji-154	496	27	dermatitis	dermatitis	NOUN
aji-154	496	28	.	.	PUNCT
aji-154	497	1	j	j	PROPN
aji-154	497	2	am	be	AUX
aji-154	497	3	acad	acad	ADJ
aji-154	497	4	dermatol	dermatol	NOUN
aji-154	497	5	.	.	PUNCT
aji-154	498	1	2018;79(6):1028	2018;79(6):1028	NUM
aji-154	498	2	-	-	SYM
aji-154	498	3	1033	1033	NUM
aji-154	498	4	.	.	PUNCT
aji-154	499	1	e1026	e1026	X
aji-154	499	2	.	.	PUNCT
aji-154	500	1	55	55	NUM
aji-154	500	2	.	.	PUNCT
aji-154	501	1	johnson	johnson	PROPN
aji-154	501	2	h	h	PROPN
aji-154	501	3	,	,	PUNCT
aji-154	501	4	norman	norman	PROPN
aji-154	501	5	t	t	PROPN
aji-154	501	6	,	,	PUNCT
aji-154	501	7	adler	adler	PROPN
aji-154	501	8	bl	bl	PROPN
aji-154	501	9	,	,	PUNCT
aji-154	501	10	yu	yu	PROPN
aji-154	501	11	j.	j.	PROPN
aji-154	501	12	lanolin	lanolin	PROPN
aji-154	501	13	:	:	PUNCT
aji-154	501	14	the	the	DET
aji-154	501	15	2023	2023	NUM
aji-154	501	16	american	american	ADJ
aji-154	501	17	contact	contact	PROPN
aji-154	501	18	dermatitis	dermatitis	PROPN
aji-154	501	19	society	society	NOUN
aji-154	501	20	allergen	allergen	NOUN
aji-154	501	21	of	of	ADP
aji-154	501	22	the	the	DET
aji-154	501	23	year	year	NOUN
aji-154	501	24	.	.	PUNCT
aji-154	502	1	cutis	cutis	NOUN
aji-154	502	2	.	.	PUNCT
aji-154	503	1	2023;112(2):78	2023;112(2):78	PROPN
aji-154	503	2	-	-	PUNCT
aji-154	503	3	81	81	NUM
aji-154	503	4	.	.	PUNCT
aji-154	504	1	56	56	NUM
aji-154	504	2	.	.	PUNCT
aji-154	505	1	olivier	olivier	PROPN
aji-154	505	2	ce	ce	PROPN
aji-154	505	3	.	.	PROPN
aji-154	505	4	allergic	allergic	ADJ
aji-154	505	5	sinusitis	sinusitis	NOUN
aji-154	505	6	,	,	PUNCT
aji-154	505	7	allergic	allergic	ADJ
aji-154	505	8	migraine	migraine	NOUN
aji-154	505	9	,	,	PUNCT
aji-154	505	10	and	and	CCONJ
aji-154	505	11	sinus	sinus	NOUN
aji-154	505	12	headaches	headache	NOUN
aji-154	505	13	.	.	PUNCT
aji-154	506	1	online	online	PROPN
aji-154	506	2	journal	journal	PROPN
aji-154	506	3	of	of	ADP
aji-154	506	4	otolaryngology	otolaryngology	NOUN
aji-154	506	5	and	and	CCONJ
aji-154	506	6	rhinology	rhinology	NOUN
aji-154	506	7	.	.	PUNCT
aji-154	507	1	2024;7(1):ojor.ms.id.000652	2024;7(1):ojor.ms.id.000652	NUM
aji-154	507	2	.	.	PUNCT
aji-154	508	1	57	57	NUM
aji-154	508	2	.	.	PUNCT
aji-154	509	1	chung	chung	PROPN
aji-154	509	2	mk	mk	PROPN
aji-154	509	3	,	,	PUNCT
aji-154	509	4	house	house	PROPN
aji-154	509	5	js	js	PROPN
aji-154	509	6	,	,	PUNCT
aji-154	509	7	akhtari	akhtari	NOUN
aji-154	509	8	fs	fs	PROPN
aji-154	509	9	,	,	PUNCT
aji-154	509	10	et	et	PROPN
aji-154	509	11	al	al	PROPN
aji-154	509	12	.	.	PUNCT
aji-154	509	13	decoding	decode	VERB
aji-154	509	14	the	the	DET
aji-154	509	15	exposome	exposome	NOUN
aji-154	509	16	:	:	PUNCT
aji-154	509	17	data	datum	NOUN
aji-154	509	18	science	science	NOUN
aji-154	509	19	methodologies	methodology	NOUN
aji-154	509	20	and	and	CCONJ
aji-154	509	21	implications	implication	NOUN
aji-154	509	22	in	in	ADP
aji-154	509	23	exposome	exposome	NOUN
aji-154	509	24	-	-	PUNCT
aji-154	509	25	wide	wide	ADJ
aji-154	509	26	association	association	NOUN
aji-154	509	27	studies	study	NOUN
aji-154	509	28	(	(	PUNCT
aji-154	509	29	exwass	exwass	PROPN
aji-154	509	30	)	)	PUNCT
aji-154	509	31	.	.	PUNCT
aji-154	510	1	exposome	exposome	NOUN
aji-154	510	2	.	.	PUNCT
aji-154	511	1	2024;4(1):osae001	2024;4(1):osae001	NUM
aji-154	511	2	.	.	PUNCT
aji-154	512	1	58	58	NUM
aji-154	512	2	.	.	PUNCT
aji-154	513	1	anouar	anouar	PROPN
aji-154	513	2	s	s	PROPN
aji-154	513	3	,	,	PUNCT
aji-154	513	4	hazim	hazim	NOUN
aji-154	513	5	r	r	NOUN
aji-154	513	6	,	,	PUNCT
aji-154	513	7	brahim	brahim	PROPN
aji-154	513	8	a.	a.	NOUN
aji-154	513	9	interferences	interference	VERB
aji-154	513	10	in	in	ADP
aji-154	513	11	immunological	immunological	ADJ
aji-154	513	12	assays	assay	NOUN
aji-154	513	13	:	:	PUNCT
aji-154	513	14	causes	cause	NOUN
aji-154	513	15	,	,	PUNCT
aji-154	513	16	detection	detection	NOUN
aji-154	513	17	,	,	PUNCT
aji-154	513	18	and	and	CCONJ
aji-154	513	19	prevention	prevention	NOUN
aji-154	513	20	.	.	PUNCT
aji-154	514	1	asian	asian	PROPN
aji-154	514	2	j	j	PROPN
aji-154	514	3	immunol	immunol	NOUN
aji-154	514	4	.	.	PUNCT
aji-154	515	1	2024;7(1):71	2024;7(1):71	NUM
aji-154	515	2	-	-	SYM
aji-154	515	3	78	78	NUM
aji-154	515	4	.	.	PUNCT
aji-154	516	1	59	59	NUM
aji-154	516	2	.	.	PUNCT
aji-154	516	3	chiarentin	chiarentin	PROPN
aji-154	516	4	l	l	PROPN
aji-154	516	5	,	,	PUNCT
aji-154	516	6	gonçalves	gonçalves	PROPN
aji-154	516	7	c	c	PROPN
aji-154	516	8	,	,	PUNCT
aji-154	516	9	augusto	augusto	PROPN
aji-154	516	10	c	c	PROPN
aji-154	516	11	,	,	PUNCT
aji-154	516	12	miranda	miranda	PROPN
aji-154	516	13	m	m	PROPN
aji-154	516	14	,	,	PUNCT
aji-154	516	15	cardoso	cardoso	PROPN
aji-154	516	16	c	c	PROPN
aji-154	516	17	,	,	PUNCT
aji-154	516	18	vitorino	vitorino	PROPN
aji-154	516	19	c.	c.	PROPN
aji-154	516	20	drilling	drill	VERB
aji-154	516	21	into	into	ADP
aji-154	516	22	"	"	PUNCT
aji-154	516	23	quality	quality	NOUN
aji-154	516	24	by	by	ADP
aji-154	516	25	design	design	NOUN
aji-154	516	26	"	"	PUNCT
aji-154	516	27	approach	approach	NOUN
aji-154	516	28	for	for	ADP
aji-154	516	29	analytical	analytical	ADJ
aji-154	516	30	methods	method	NOUN
aji-154	516	31	.	.	PUNCT
aji-154	517	1	crit	crit	PROPN
aji-154	517	2	rev	rev	PROPN
aji-154	517	3	analytical	analytical	ADJ
aji-154	517	4	chem	chem	NOUN
aji-154	517	5	.	.	PUNCT
aji-154	518	1	2023:1	2023:1	NUM
aji-154	518	2	-	-	SYM
aji-154	518	3	42	42	NUM
aji-154	518	4	.	.	PUNCT
aji-154	519	1	60	60	NUM
aji-154	519	2	.	.	X
aji-154	519	3	wma	wma	PROPN
aji-154	519	4	.	.	PROPN
aji-154	520	1	world	world	PROPN
aji-154	520	2	medical	medical	PROPN
aji-154	520	3	association	association	PROPN
aji-154	520	4	declaration	declaration	PROPN
aji-154	520	5	of	of	ADP
aji-154	520	6	helsinki	helsinki	PROPN
aji-154	520	7	:	:	PUNCT
aji-154	520	8	ethical	ethical	ADJ
aji-154	520	9	principles	principle	NOUN
aji-154	520	10	for	for	ADP
aji-154	520	11	medical	medical	ADJ
aji-154	520	12	research	research	NOUN
aji-154	520	13	involving	involve	VERB
aji-154	520	14	human	human	ADJ
aji-154	520	15	subjects	subject	NOUN
aji-154	520	16	.	.	PUNCT
aji-154	521	1	jama	jama	NOUN
aji-154	521	2	.	.	PUNCT
aji-154	522	1	2013;310(20):2191	2013;310(20):2191	NUM
aji-154	522	2	2194	2194	NUM
aji-154	522	3	.	.	PUNCT
aji-154	523	1	disclaimer	disclaimer	ADJ
aji-154	523	2	/	/	SYM
aji-154	523	3	publisher	publisher	NOUN
aji-154	523	4	’s	’s	PART
aji-154	523	5	note	note	NOUN
aji-154	523	6	:	:	PUNCT
aji-154	523	7	the	the	DET
aji-154	523	8	statements	statement	NOUN
aji-154	523	9	,	,	PUNCT
aji-154	523	10	opinions	opinion	NOUN
aji-154	523	11	and	and	CCONJ
aji-154	523	12	data	datum	NOUN
aji-154	523	13	contained	contain	VERB
aji-154	523	14	in	in	ADP
aji-154	523	15	all	all	DET
aji-154	523	16	publications	publication	NOUN
aji-154	523	17	are	be	AUX
aji-154	523	18	solely	solely	ADV
aji-154	523	19	those	those	PRON
aji-154	523	20	of	of	ADP
aji-154	523	21	the	the	DET
aji-154	523	22	individual	individual	ADJ
aji-154	523	23	author(s	author(s	PROPN
aji-154	523	24	)	)	PUNCT
aji-154	523	25	and	and	CCONJ
aji-154	523	26	contributor(s	contributor(s	NOUN
aji-154	523	27	)	)	PUNCT
aji-154	523	28	and	and	CCONJ
aji-154	523	29	not	not	PART
aji-154	523	30	of	of	ADP
aji-154	523	31	the	the	DET
aji-154	523	32	publisher	publisher	NOUN
aji-154	523	33	and/or	and/or	CCONJ
aji-154	523	34	the	the	DET
aji-154	523	35	editor(s	editor(s	NOUN
aji-154	523	36	)	)	PUNCT
aji-154	523	37	.	.	PUNCT
aji-154	524	1	this	this	DET
aji-154	524	2	publisher	publisher	NOUN
aji-154	524	3	and/or	and/or	CCONJ
aji-154	524	4	the	the	DET
aji-154	524	5	editor(s	editor(s	NOUN
aji-154	524	6	)	)	PUNCT
aji-154	524	7	disclaim	disclaim	VERB
aji-154	524	8	responsibility	responsibility	NOUN
aji-154	524	9	for	for	ADP
aji-154	524	10	any	any	DET
aji-154	524	11	injury	injury	NOUN
aji-154	524	12	to	to	ADP
aji-154	524	13	people	people	NOUN
aji-154	524	14	or	or	CCONJ
aji-154	524	15	property	property	NOUN
aji-154	524	16	resulting	result	VERB
aji-154	524	17	from	from	ADP
aji-154	524	18	any	any	DET
aji-154	524	19	ideas	idea	NOUN
aji-154	524	20	,	,	PUNCT
aji-154	524	21	methods	method	NOUN
aji-154	524	22	,	,	PUNCT
aji-154	524	23	instructions	instruction	NOUN
aji-154	524	24	or	or	CCONJ
aji-154	524	25	products	product	NOUN
aji-154	524	26	referred	refer	VERB
aji-154	524	27	to	to	ADP
aji-154	524	28	in	in	ADP
aji-154	524	29	the	the	DET
aji-154	524	30	content	content	NOUN
aji-154	524	31	.	.	PUNCT
aji-154	525	1	_	_	PUNCT
aji-154	526	1	_	_	PUNCT
aji-154	527	1	_	_	PUNCT
aji-154	528	1	_	_	PUNCT
aji-154	529	1	_	_	PUNCT
aji-154	530	1	_	_	PUNCT
aji-154	531	1	_	_	PUNCT
aji-154	532	1	_	_	PUNCT
aji-154	533	1	_	_	PUNCT
aji-154	534	1	_	_	PUNCT
aji-154	535	1	_	_	PUNCT
aji-154	536	1	_	_	PUNCT
aji-154	537	1	_	_	PUNCT
aji-154	538	1	_	_	PUNCT
aji-154	539	1	_	_	PUNCT
aji-154	540	1	_	_	PUNCT
aji-154	541	1	_	_	PUNCT
aji-154	542	1	_	_	PUNCT
aji-154	543	1	_	_	PUNCT
aji-154	544	1	_	_	PUNCT
aji-154	545	1	_	_	PUNCT
aji-154	546	1	_	_	PUNCT
aji-154	547	1	_	_	PUNCT
aji-154	548	1	_	_	PUNCT
aji-154	549	1	_	_	PUNCT
aji-154	550	1	_	_	PUNCT
aji-154	551	1	_	_	PUNCT
aji-154	552	1	_	_	PUNCT
aji-154	553	1	_	_	PUNCT
aji-154	554	1	_	_	PUNCT
aji-154	555	1	_	_	PUNCT
aji-154	556	1	_	_	PUNCT
aji-154	557	1	_	_	PUNCT
aji-154	558	1	_	_	PUNCT
aji-154	559	1	_	_	PUNCT
aji-154	560	1	_	_	PUNCT
aji-154	561	1	_	_	PUNCT
aji-154	562	1	_	_	PUNCT
aji-154	563	1	_	_	PUNCT
aji-154	564	1	_	_	PUNCT
aji-154	565	1	_	_	PUNCT
aji-154	566	1	_	_	PUNCT
aji-154	567	1	_	_	PUNCT
aji-154	568	1	_	_	PUNCT
aji-154	569	1	_	_	PUNCT
aji-154	570	1	_	_	PUNCT
aji-154	571	1	_	_	PUNCT
aji-154	572	1	_	_	PUNCT
aji-154	573	1	_	_	PUNCT
aji-154	574	1	_	_	PUNCT
aji-154	575	1	_	_	PUNCT
aji-154	576	1	_	_	PUNCT
aji-154	577	1	_	_	PUNCT
aji-154	578	1	_	_	PUNCT
aji-154	579	1	_	_	PUNCT
aji-154	580	1	_	_	PUNCT
aji-154	581	1	_	_	PUNCT
aji-154	582	1	_	_	PUNCT
aji-154	583	1	_	_	PUNCT
aji-154	584	1	_	_	PUNCT
aji-154	585	1	_	_	PUNCT
aji-154	586	1	_	_	PUNCT
aji-154	587	1	_	_	PUNCT
aji-154	588	1	_	_	PUNCT
aji-154	589	1	_	_	PUNCT
aji-154	590	1	_	_	PUNCT
aji-154	591	1	_	_	PUNCT
aji-154	592	1	_	_	PUNCT
aji-154	593	1	_	_	PUNCT
aji-154	594	1	_	_	PUNCT
aji-154	595	1	_	_	PUNCT
aji-154	596	1	_	_	PUNCT
aji-154	597	1	_	_	PUNCT
aji-154	598	1	_	_	PUNCT
aji-154	599	1	_	_	PUNCT
aji-154	600	1	_	_	PUNCT
aji-154	601	1	_	_	PUNCT
aji-154	602	1	_	_	PUNCT
aji-154	603	1	_	_	PUNCT
aji-154	604	1	_	_	PUNCT
aji-154	605	1	_	_	PUNCT
aji-154	606	1	©	©	PRON
aji-154	606	2	copyright	copyright	NOUN
aji-154	606	3	(	(	PUNCT
aji-154	606	4	2024	2024	NUM
aji-154	606	5	):	):	PUNCT
aji-154	606	6	author(s	author(s	NOUN
aji-154	606	7	)	)	PUNCT
aji-154	606	8	.	.	PUNCT
aji-154	607	1	the	the	DET
aji-154	607	2	licensee	licensee	NOUN
aji-154	607	3	is	be	AUX
aji-154	607	4	the	the	DET
aji-154	607	5	journal	journal	PROPN
aji-154	607	6	publisher	publisher	NOUN
aji-154	607	7	.	.	PUNCT
aji-154	608	1	this	this	PRON
aji-154	608	2	is	be	AUX
aji-154	608	3	an	an	DET
aji-154	608	4	open	open	ADJ
aji-154	608	5	access	access	NOUN
aji-154	608	6	article	article	NOUN
aji-154	608	7	distributed	distribute	VERB
aji-154	608	8	under	under	ADP
aji-154	608	9	the	the	DET
aji-154	608	10	terms	term	NOUN
aji-154	608	11	of	of	ADP
aji-154	608	12	the	the	DET
aji-154	608	13	creative	creative	ADJ
aji-154	608	14	commons	common	NOUN
aji-154	608	15	attribution	attribution	NOUN
aji-154	608	16	license	license	NOUN
aji-154	608	17	(	(	PUNCT
aji-154	608	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-154	608	19	)	)	PUNCT
aji-154	608	20	,	,	PUNCT
aji-154	608	21	which	which	PRON
aji-154	608	22	permits	permit	VERB
aji-154	608	23	unrestricted	unrestricted	ADJ
aji-154	608	24	use	use	NOUN
aji-154	608	25	,	,	PUNCT
aji-154	608	26	distribution	distribution	NOUN
aji-154	608	27	,	,	PUNCT
aji-154	608	28	and	and	CCONJ
aji-154	608	29	reproduction	reproduction	NOUN
aji-154	608	30	in	in	ADP
aji-154	608	31	any	any	DET
aji-154	608	32	medium	medium	NOUN
aji-154	608	33	,	,	PUNCT
aji-154	608	34	provided	provide	VERB
aji-154	608	35	the	the	DET
aji-154	608	36	original	original	ADJ
aji-154	608	37	work	work	NOUN
aji-154	608	38	is	be	AUX
aji-154	608	39	properly	properly	ADV
aji-154	608	40	cited	cite	VERB
aji-154	608	41	.	.	PUNCT
aji-154	609	1	peer	peer	NOUN
aji-154	609	2	-	-	PUNCT
aji-154	609	3	review	review	NOUN
aji-154	609	4	history	history	NOUN
aji-154	609	5	:	:	PUNCT
aji-154	609	6	the	the	DET
aji-154	609	7	peer	peer	NOUN
aji-154	609	8	review	review	NOUN
aji-154	609	9	history	history	NOUN
aji-154	609	10	for	for	ADP
aji-154	609	11	this	this	DET
aji-154	609	12	paper	paper	NOUN
aji-154	609	13	can	can	AUX
aji-154	609	14	be	be	AUX
aji-154	609	15	accessed	access	VERB
aji-154	609	16	here	here	ADV
aji-154	609	17	:	:	PUNCT
aji-154	609	18	https://www.sdiarticle5.com/review-history/128121	https://www.sdiarticle5.com/review-history/128121	PROPN
aji-154	609	19	https://www.sdiarticle5.com/review-history/128121	https://www.sdiarticle5.com/review-history/128121	PROPN